data_2kpi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.593 0.711 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -59.02 162.45 7.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.363 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -59.81 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.442 2.095 . . . . 0.0 112.239 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -51.24 2.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.452 -0.78 . . . . 0.0 109.469 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.0 p -73.11 65.0 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' CYS . 53.9 t-80 -37.89 112.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.004 0.907 . . . . 0.0 110.497 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -174.45 168.72 1.93 Allowed Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.965 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.8 Cg_exo -56.01 145.93 71.94 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.883 2.389 . . . . 0.0 112.759 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.6 mt -121.15 145.15 48.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.0 109.547 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -121.87 121.15 36.5 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.836 0.827 . . . . 0.0 109.081 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.93 137.53 34.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.74 -0.6 . . . . 0.0 109.977 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -139.3 115.02 10.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.027 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.8 -112.93 0.66 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.501 0.667 . . . . 0.0 110.602 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.73 27.03 10.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 108.901 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 41.3 mp0 -141.28 154.7 45.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.135 -0.978 . . . . 0.0 109.355 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.25 134.66 54.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.93 132.95 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.551 0.691 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.36 132.97 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.462 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 11.7 p -124.2 136.85 54.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.76 -161.31 32.21 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.61 -57.51 3.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -1.053 . . . . 0.0 110.056 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -95.41 4.57 53.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.184 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 178.06 5.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.38 -5.13 1.83 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -74.7 155.75 37.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -1.084 . . . . 0.0 110.419 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.8 139.2 53.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-85 -127.33 109.74 21.25 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 157.06 28.58 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -91.75 132.21 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -0.959 . . . . 0.0 109.698 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -118.11 126.32 52.01 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.463 0.649 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 56.3 29.23 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.803 0.811 . . . . 0.0 110.085 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.31 5.34 90.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.0 mt -112.7 131.25 22.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.417 -1.049 . . . . 0.0 109.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 154.33 49.04 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.538 2.158 . . . . 0.0 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.34 122.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -113.09 21.39 15.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.2 mm? -100.19 129.19 46.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.493 1.139 . . . . 0.0 109.924 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.46 -42.28 94.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -62.22 -37.92 87.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.658 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 -9.36 58.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.768 -1.207 . . . . 0.0 109.159 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.16 145.17 37.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -106.83 147.0 30.25 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.807 0.813 . . . . 0.0 109.966 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 9.9 mpt_? -86.17 156.07 57.43 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.696 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo . . . . . 0 N--CA 1.491 1.327 0 C-N-CA 122.344 2.03 . . . . 0.0 112.774 179.244 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.807 0.813 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.537 ' H ' ' HA ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -126.58 168.55 14.09 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-O 122.062 0.934 . . . . 0.0 109.749 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' CYS . 23.8 Cg_exo -63.3 141.59 82.49 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.44 2.094 . . . . 0.0 113.045 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.27 15.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.321 0.582 . . . . 0.0 109.56 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . 29.5 p -172.86 123.4 0.43 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.444 0.64 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.537 ' HA ' ' H ' ' A' ' 13' ' ' CYS . 51.7 p-80 -111.38 115.95 30.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.806 0.813 . . . . 0.0 110.057 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -176.27 173.14 0.87 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-O 121.365 0.602 . . . . 0.0 109.677 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -54.43 147.26 47.93 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.751 2.301 . . . . 0.0 112.664 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.66 141.08 50.71 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.032 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -127.06 135.61 51.03 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.86 0.838 . . . . 0.0 109.687 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -83.4 137.12 34.07 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.669 0.747 . . . . 0.0 110.184 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -173.02 153.87 2.66 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.81 0.814 . . . . 0.0 110.128 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 54.52 33.25 18.52 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.304 0.573 . . . . 0.0 109.886 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.52 19.02 11.66 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -142.16 175.29 9.86 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.635 0.731 . . . . 0.0 110.052 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.71 124.43 48.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.543 0.687 . . . . 0.0 109.548 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.61 137.4 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.914 0.864 . . . . 0.0 110.179 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.7 m -73.27 124.82 26.42 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 m -114.49 108.17 16.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.729 0.776 . . . . 0.0 109.957 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.44 48.41 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.5 -54.8 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.727 -0.866 . . . . 0.0 109.405 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.47 -2.26 31.17 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.61 113.71 25.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.516 -0.74 . . . . 0.0 109.553 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 9.79 0.89 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.84 156.49 38.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.42 131.52 56.74 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.754 0.788 . . . . 0.0 109.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.94 117.82 35.12 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.42 165.39 29.26 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.522 2.148 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.04 134.47 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.675 0.75 . . . . 0.0 110.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -101.48 103.81 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.732 0.777 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 54.33 36.4 25.2 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.423 0.63 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.61 72.09 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.17 98.93 44.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 122.018 -0.696 . . . . 0.0 109.285 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.23 134.6 64.72 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.647 2.232 . . . . 0.0 112.189 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -106.45 96.73 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.592 0.71 . . . . 0.0 109.413 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.0 mt -77.24 45.58 0.46 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 46' ' ' VAL . 89.4 mt -109.38 133.03 53.56 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.187 0.994 . . . . 0.0 109.717 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.14 -36.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.9 -39.85 90.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.595 -0.691 . . . . 0.0 109.358 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 51.0 mp0 -90.92 -6.02 54.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.44 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.98 147.19 50.45 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.489 0.662 . . . . 0.0 109.881 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -117.75 141.08 48.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.011 0.91 . . . . 0.0 110.064 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -94.87 150.95 38.6 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.777 2.318 . . . . 0.0 112.427 179.735 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.677 0.751 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.709 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -79.81 119.19 75.93 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-O 121.212 0.53 . . . . 0.0 109.754 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 52.6 Cg_exo -50.93 144.06 28.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.369 2.046 . . . . 0.0 112.649 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 79.87 -36.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' H ' ' C ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -122.7 -169.09 1.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.834 0.826 . . . . 0.0 109.792 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -135.89 97.55 3.67 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.739 0.78 . . . . 0.0 109.633 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.07 171.2 1.12 Allowed Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.79 172.25 16.65 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.9 2.4 . . . . 0.0 112.652 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.8 mt -114.48 134.26 55.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.699 -0.626 . . . . 0.0 109.618 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 30' ' ' THR . 6.1 pt-20 -111.21 135.48 51.68 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.853 0.835 . . . . 0.0 109.299 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -97.6 133.98 41.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.535 0.684 . . . . 0.0 110.451 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 124.85 27.79 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.85 0.833 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 49.74 -113.68 0.65 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.286 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.51 23.36 13.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.593 -0.692 . . . . 0.0 109.2 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.71 162.0 36.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.705 . . . . 0.0 110.064 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.74 148.13 38.76 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.895 0.855 . . . . 0.0 109.726 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 28' ' ' ILE . 80.9 mt -136.48 152.1 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.27 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -68.19 131.24 45.04 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.086 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 21' ' ' GLU . 3.1 m -91.65 166.91 12.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.092 0.948 . . . . 0.0 110.109 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 147.86 9.73 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.552 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 1.8 pm0 -75.5 -10.33 59.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.755 -0.85 . . . . 0.0 108.781 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.8 -4.73 55.68 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 m -129.46 -145.09 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.572 0.701 . . . . 0.0 109.847 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.41 -15.07 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -49.52 149.07 2.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.773 -0.839 . . . . 0.0 110.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.66 135.4 53.96 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.659 0.742 . . . . 0.0 109.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -124.59 105.88 30.07 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.99 173.3 12.9 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.232 1.955 . . . . 0.0 111.977 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.17 132.34 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.507 0.67 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -124.94 126.4 45.44 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.933 0.873 . . . . 0.0 109.847 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.5 t0 57.54 27.68 14.44 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.446 0.641 . . . . 0.0 109.772 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.06 6.26 89.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.92 130.3 24.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.849 -0.795 . . . . 0.0 109.698 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.92 150.5 61.25 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.681 2.254 . . . . 0.0 112.676 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.79 106.68 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 4.2 mm? -103.08 14.99 30.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.76 133.17 49.2 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.865 0.84 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.45 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.318 0.58 . . . . 0.0 109.63 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -59.44 -39.75 84.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 0.0 109.842 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.85 -5.49 53.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.091 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 154.46 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.493 0.663 . . . . 0.0 110.169 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -100.07 137.58 38.33 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.943 0.878 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -49.21 167.51 0.21 Allowed Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.903 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo . . . . . 0 C--N 1.311 -1.438 0 C-N-CA 122.127 1.884 . . . . 0.0 112.765 179.911 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -88.36 142.88 31.75 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.269 -0.894 . . . . 0.0 110.171 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.89 152.64 52.4 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.188 . . . . 0.0 112.988 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 69.41 -69.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.636 0.732 . . . . 0.0 110.777 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -29.41 68.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 0.0 109.489 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 52.63 88.82 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.005 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -171.37 172.05 2.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.0 148.07 90.45 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.471 2.114 . . . . 0.0 112.588 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.84 142.36 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.927 0.87 . . . . 0.0 110.082 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -110.09 116.84 32.27 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.34 127.71 36.89 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.377 0.608 . . . . 0.0 110.02 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' ASP . 95.6 mtt180 -134.82 132.54 38.78 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 25' ' ' ALA . 5.6 p-10 40.2 -116.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.369 0.604 . . . . 0.0 110.55 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 24' ' ' ASP . . . -111.24 42.07 1.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 109.044 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -153.31 149.54 27.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.19 134.67 54.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.553 0.692 . . . . 0.0 109.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.23 132.04 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.616 0.722 . . . . 0.0 109.966 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -70.72 125.64 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.23 127.78 56.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.571 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.88 -161.18 34.86 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.27 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -79.43 -58.01 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.495 -1.003 . . . . 0.0 109.514 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -95.05 7.67 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.051 -1.03 . . . . 0.0 108.72 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 171.0 15.74 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.41 -6.81 0.34 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.4 154.71 41.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.146 -1.208 . . . . 0.0 110.291 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.97 139.3 54.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 m-85 -124.01 121.26 26.34 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.81 161.86 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.26 131.6 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -103.7 104.57 14.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.866 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.6 t0 53.05 38.74 28.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.902 0.858 . . . . 0.0 110.051 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.64 7.46 78.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 44' ' ' ILE . 43.2 mt -111.84 101.22 50.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.146 -1.208 . . . . 0.0 109.308 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.0 139.99 69.92 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.628 2.218 . . . . 0.0 112.061 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.43 121.73 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.009 . . . . 0.0 109.54 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.4 23.69 14.12 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.3 mm? -100.01 126.27 46.17 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.437 1.113 . . . . 0.0 109.913 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.18 -41.92 92.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.642 0.734 . . . . 0.0 109.525 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.6 t0 -61.14 -34.67 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 109.801 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.6 -11.25 49.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.828 -1.17 . . . . 0.0 109.23 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.97 146.64 26.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.97 . . . . 0.0 110.049 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -112.96 140.6 47.63 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.921 0.867 . . . . 0.0 109.792 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -87.32 153.96 53.97 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.67 -0.644 . . . . 0.0 109.366 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.803 2.335 . . . . 0.0 112.749 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.4 p -68.81 152.37 96.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.3 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 16' ' ' CYS . 39.6 Cg_endo -66.3 145.23 77.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.561 2.174 . . . . 0.0 111.818 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 66.75 -61.17 0.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.575 -0.703 . . . . 0.0 109.815 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -89.79 -173.57 3.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.273 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -136.61 109.96 7.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.463 -0.773 . . . . 0.0 109.61 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.85 176.42 0.48 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.47 159.38 53.08 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.844 2.363 . . . . 0.0 112.485 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.77 143.94 45.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.46 118.37 30.92 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -80.36 128.65 33.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.504 -0.748 . . . . 0.0 109.206 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -130.68 123.6 29.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.483 -0.761 . . . . 0.0 109.202 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 52.82 -96.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.318 0.58 . . . . 0.0 109.69 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.97 30.08 3.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.28 155.17 46.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.845 . . . . 0.0 109.738 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.3 mt -104.54 128.57 52.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.26 131.34 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.454 0.645 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 34' ' ' CYS . 1.7 t -72.13 123.99 24.05 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 -178.75 4.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.041 -1.037 . . . . 0.0 109.685 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.48 148.68 6.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 24.3 mp0 -75.14 -10.86 59.86 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -1.006 . . . . 0.0 108.831 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.87 -3.53 54.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -142.32 -150.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.259 -0.901 . . . . 0.0 109.791 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 145.5 2.74 0.66 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.16 160.32 32.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -1.142 . . . . 0.0 110.039 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.19 137.75 54.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.664 -0.647 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -121.35 107.96 36.38 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.26 150.5 22.65 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.95 1.767 . . . . 0.0 112.44 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.55 132.82 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -117.59 127.63 54.16 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 55.05 30.52 14.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 109.907 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.51 88.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mt -117.5 131.8 23.89 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.394 -1.062 . . . . 0.0 109.3 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.36 145.73 38.82 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.035 1.823 . . . . 0.0 111.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.91 127.15 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.71 32.13 6.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -108.2 131.66 54.43 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.977 0.894 . . . . 0.0 109.767 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.93 -42.23 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.5 -19.28 46.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.91 -13.31 16.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.321 -0.862 . . . . 0.0 109.034 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.09 144.98 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.645 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -109.17 139.32 44.24 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -85.82 154.07 58.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.28 1.987 . . . . 0.0 112.899 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.3 p -100.13 116.04 64.92 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.828 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 49.5 Cg_exo -51.36 146.88 23.35 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.762 1.642 . . . . 0.0 112.79 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 76.41 -35.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.558 -0.714 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -124.95 -166.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 109.137 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 50.4 p-80 -146.96 111.78 5.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.603 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 164.61 158.76 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.183 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' C ' ' OG1' ' A' ' 30' ' ' THR . 32.1 Cg_exo -56.97 177.41 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.362 2.041 . . . . 0.0 112.829 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.1 141.7 49.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.395 -0.816 . . . . 0.0 109.28 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -122.64 134.23 54.5 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.933 0.873 . . . . 0.0 109.743 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.73 138.76 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.645 -0.66 . . . . 0.0 109.531 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -137.76 122.68 18.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.562 -0.711 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.0 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.413 0.625 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.91 28.12 3.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -139.16 160.95 38.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.342 -0.849 . . . . 0.0 109.564 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.0 mt -109.94 119.54 39.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.5 pt -107.8 144.43 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -0.884 . . . . 0.0 109.655 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -70.93 134.39 47.18 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.529 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' C ' ' A' ' 19' ' ' PRO . 6.3 m -73.63 145.9 45.01 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.304 -0.872 . . . . 0.0 109.935 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 140.44 9.57 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 26.7 mp0 -66.17 -45.61 80.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.624 -0.927 . . . . 0.0 109.692 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 57.8 t0 -78.53 -6.73 56.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -87.36 -46.92 9.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 41.78 -103.73 0.04 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.1 mt 41.2 111.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.229 1.014 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.46 127.63 53.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -0.768 . . . . 0.0 109.674 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -114.79 104.34 54.27 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.56 168.83 19.26 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.093 1.862 . . . . 0.0 111.61 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.39 131.5 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.945 . . . . 0.0 109.375 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 43' ' ' GLY . 62.8 ttm-85 -114.19 130.53 56.62 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 56.78 5.66 0.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.403 -0.81 . . . . 0.0 109.888 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 41' ' ' ARG . . . 108.39 -7.68 34.7 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.28 135.0 20.62 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.344 -1.092 . . . . 0.0 109.645 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.36 144.0 32.57 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 112.544 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.93 111.74 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 109.177 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.5 mt -97.47 16.03 21.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.837 . . . . 0.0 108.933 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.1 mm? -94.22 126.33 39.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 109.588 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.28 -42.36 90.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.635 -0.666 . . . . 0.0 109.753 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.55 -38.04 83.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.2 -6.99 56.47 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.23 -0.919 . . . . 0.0 109.358 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.18 39.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.649 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.72 142.03 33.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.452 -0.78 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -88.2 150.63 47.57 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 109.552 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.498 1.759 0 C-N-CA 122.658 2.239 . . . . 0.0 112.702 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -78.79 153.79 78.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.625 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.7 143.24 67.04 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.619 2.213 . . . . 0.0 111.779 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 68.92 -53.56 0.57 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.642 -0.661 . . . . 0.0 109.866 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.74 -173.36 2.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -134.47 109.79 8.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.759 -0.588 . . . . 0.0 109.596 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 173.6 155.39 0.28 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.0 Cg_exo -53.78 153.51 19.29 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.906 1.737 . . . . 0.0 112.647 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 mt -105.26 134.53 48.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -111.54 132.59 54.41 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' OE1' ' CD2' ' A' ' 27' ' ' LEU . 40.2 mm-40 -89.9 127.87 36.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' ALA . 60.6 ttt85 -125.71 108.72 11.8 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.62 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.55 27.27 2.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.478 -0.764 . . . . 0.0 109.286 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -135.22 155.96 49.79 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.425 0.631 . . . . 0.0 109.544 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' CD2' ' OE1' ' A' ' 22' ' ' GLU . 45.4 mt -106.83 130.62 54.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.594 -0.691 . . . . 0.0 109.662 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.55 130.55 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.374 0.607 . . . . 0.0 109.866 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.8 m -64.46 145.87 55.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.297 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.533 ' H ' ' HG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -57.25 -19.39 21.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 108.978 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.65 8.62 87.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -62.66 -43.68 98.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.947 . . . . 0.0 108.958 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -126.77 -9.14 6.12 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.8 p -141.01 -112.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.773 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.49 19.72 0.51 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.61 157.61 33.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.497 -1.002 . . . . 0.0 109.954 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 38' ' ' TYR . . . -129.59 149.64 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.5 0.667 . . . . 0.0 109.91 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 15.7 m-85 -135.48 127.82 17.88 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.57 167.19 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.119 1.879 . . . . 0.0 111.852 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.82 131.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.508 -0.745 . . . . 0.0 109.048 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -103.4 107.41 18.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.387 -0.821 . . . . 0.0 109.68 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.4 t0 53.18 40.83 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.28 90.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.52 104.47 54.35 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.486 -1.008 . . . . 0.0 109.143 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.82 137.79 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.187 1.925 . . . . 0.0 112.396 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.54 101.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.725 . . . . 0.0 109.326 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 mt -93.71 35.28 1.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.745 0.783 . . . . 0.0 109.724 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.65 -43.46 93.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.583 -0.698 . . . . 0.0 109.745 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 6.5 p-10 -60.62 -33.19 72.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.52 -0.738 . . . . 0.0 109.851 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -92.35 10.83 28.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 109.039 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 145.46 54.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.579 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -111.11 137.26 48.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -87.38 151.62 51.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.578 -0.702 . . . . 0.0 109.327 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.496 1.619 0 C-N-CA 122.691 2.26 . . . . 0.0 112.463 179.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.7 t -93.74 140.02 22.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.25 33.0 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.001 1.801 . . . . 0.0 111.619 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -153.52 -75.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 109.157 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' C ' ' H ' ' A' ' 18' ' ' ALA . 1.6 p -87.57 7.04 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.6 m80 54.59 12.0 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' CYS . . . -73.9 151.7 88.7 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.167 -0.958 . . . . 0.0 109.721 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' O ' ' OG1' ' A' ' 30' ' ' THR . 36.4 Cg_endo -66.68 163.2 33.94 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.707 2.271 . . . . 0.0 112.305 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -108.71 148.18 30.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -112.73 134.67 54.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.27 125.92 32.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 28' ' ' ILE . 42.6 ttm180 -132.22 117.44 18.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.533 -0.729 . . . . 0.0 109.194 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 52.47 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.247 0.546 . . . . 0.0 110.14 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -136.92 29.43 2.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.12 160.12 41.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.409 -0.807 . . . . 0.0 109.883 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.59 134.5 51.85 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 23' ' ' ARG . 96.8 mt -115.0 130.6 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.404 0.621 . . . . 0.0 109.657 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.5 t -66.97 131.7 46.4 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 110.224 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 70.9 p -77.09 -1.12 27.47 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.279 -0.888 . . . . 0.0 109.03 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 129.47 19.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.81 -39.65 79.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.588 -0.948 . . . . 0.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -84.88 -5.45 59.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.171 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.03 -70.28 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.0 109.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.82 15.13 54.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.1 mt -76.67 149.06 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -1.169 . . . . 0.0 110.256 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.97 144.37 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -129.84 115.29 17.9 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 156.95 32.23 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.269 1.979 . . . . 0.0 112.755 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.93 129.89 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -127.49 131.76 50.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 54.05 27.85 8.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.251 0.548 . . . . 0.0 110.256 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.33 -3.46 79.55 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 tt -138.84 135.42 17.69 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.268 -1.136 . . . . 0.0 109.919 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.03 155.77 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.272 1.982 . . . . 0.0 112.261 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.49 130.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.527 -0.733 . . . . 0.0 109.415 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.35 34.2 2.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.608 -0.682 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -111.39 137.75 48.76 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.818 0.818 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.47 -42.43 93.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.558 -0.714 . . . . 0.0 109.797 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 1.7 p-10 -60.28 -33.86 72.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -92.42 -7.92 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 108.807 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 149.6 49.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 110.044 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -101.76 138.52 38.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.454 -0.779 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -96.37 160.97 28.48 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.496 1.649 0 C-N-CA 122.291 1.994 . . . . 0.0 112.695 178.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.678 0.751 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.8 t -85.54 125.37 69.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.556 -0.715 . . . . 0.0 109.403 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.15 -21.93 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.963 1.775 . . . . 0.0 111.466 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.63 -25.07 19.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' CYS . 6.9 p -160.55 162.84 33.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.16 1.5 11.09 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 108.931 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.32 123.55 35.96 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.046 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 30' ' ' THR . 52.6 Cg_exo -49.36 163.25 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 0.0 112.615 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -112.0 139.17 47.73 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.636 0.732 . . . . 0.0 109.896 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -113.62 122.69 47.95 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.848 0.833 . . . . 0.0 109.012 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.6 122.71 25.66 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.552 0.691 . . . . 0.0 109.99 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -127.98 117.11 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.638 0.732 . . . . 0.0 109.175 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 52.07 -109.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.479 0.656 . . . . 0.0 110.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.53 26.46 9.86 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -141.74 161.31 38.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.0 mt -111.35 130.3 55.73 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.04 129.84 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.818 0.818 . . . . 0.0 109.791 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.3 131.78 43.94 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 67.9 p -79.81 2.7 22.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.402 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.42 133.42 28.08 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.55 -46.42 76.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.676 -0.896 . . . . 0.0 109.974 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -85.48 -5.16 59.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.4 -69.22 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.07 19.2 2.44 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.21 151.03 41.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.316 -1.108 . . . . 0.0 110.058 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.44 130.53 53.17 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 109.262 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.85 127.36 27.06 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 161.36 28.28 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.9 2.4 . . . . 0.0 112.41 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.87 131.61 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -103.88 104.27 14.23 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.961 0.886 . . . . 0.0 109.797 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 t0 52.82 39.68 29.32 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.878 0.847 . . . . 0.0 110.454 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.17 7.58 79.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mm -111.56 100.37 47.73 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.314 -1.11 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.19 139.7 72.01 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.798 2.332 . . . . 0.0 112.02 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.26 120.74 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.083 -1.011 . . . . 0.0 109.547 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.4 mt -103.61 34.67 2.88 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.1 mt -109.33 128.72 55.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.113 0.959 . . . . 0.0 109.667 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.92 -40.29 87.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.646 0.736 . . . . 0.0 109.586 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.83 -39.67 81.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.568 -0.708 . . . . 0.0 110.166 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.59 -8.07 53.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.955 -1.091 . . . . 0.0 109.198 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 145.78 54.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -103.61 136.64 42.94 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.851 0.834 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 156.82 37.86 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -76.19 170.49 15.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.46 -0.775 . . . . 0.0 109.642 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 72.2 Cg_endo -80.23 -86.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.581 2.187 . . . . 0.0 111.772 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -65.18 -46.36 81.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 24.7 p -93.11 55.03 2.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 108.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 13' ' ' CYS . 86.8 m-70 -41.24 108.94 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 110.763 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -174.07 177.36 0.67 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.586 -0.697 . . . . 0.0 109.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.66 147.79 70.61 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.812 2.341 . . . . 0.0 112.557 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.8 152.15 51.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -122.82 133.99 54.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.8 126.34 32.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.813 -0.554 . . . . 0.0 109.768 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -171.68 157.16 4.57 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.691 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 48.1 t0 56.21 24.27 7.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.618 -0.676 . . . . 0.0 109.344 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . 72.28 15.22 5.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.984 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -142.01 165.61 26.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.8 mt -101.51 119.61 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.7 mt -97.4 131.61 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 m -75.61 143.12 42.48 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.457 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 106.82 4.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.322 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.48 17.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.48 -54.18 43.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.164 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 30.0 p-10 -112.72 7.64 18.67 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 163.89 17.45 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.715 0.769 . . . . 0.0 110.124 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.15 -20.09 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.81 178.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -1.087 . . . . 0.0 110.249 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 139.0 40.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.484 -0.76 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -121.52 120.49 28.81 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.46 164.92 28.07 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.084 1.856 . . . . 0.0 111.852 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.92 132.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -104.61 108.17 19.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 109.538 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.16 38.2 26.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.61 4.39 85.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.2 mt -108.41 104.42 54.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -1.115 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.12 142.11 55.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.092 1.861 . . . . 0.0 112.247 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.23 131.64 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.4 -0.812 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.67 35.38 4.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.4 mt -106.33 131.41 53.58 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.76 0.79 . . . . 0.0 109.424 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.51 -43.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.994 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.54 -38.23 86.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 110.179 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -88.12 -6.45 57.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.057 -1.027 . . . . 0.0 109.242 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.01 46.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.681 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.85 161.2 15.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -90.43 177.1 2.51 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.552 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 N--CA 1.498 1.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.17 -179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 122.215 1.007 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -60.39 159.7 21.95 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-O 121.361 0.601 . . . . 0.0 109.731 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HG2' ' H ' ' A' ' 15' ' ' ALA . 41.4 Cg_endo -68.84 -79.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.614 2.21 . . . . 0.0 111.847 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -58.43 -46.7 85.97 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -104.89 164.94 11.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 109.422 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 49.3 p-80 -115.88 105.58 12.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.868 0.842 . . . . 0.0 110.1 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.26 176.51 0.57 Allowed Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 109.428 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' A' ' 30' ' ' THR . 9.9 Cg_exo -70.1 155.69 64.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.957 2.438 . . . . 0.0 113.013 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.88 139.22 49.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.79 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -111.62 126.73 55.32 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.188 0.994 . . . . 0.0 109.399 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 57.5 mp0 -79.42 141.95 36.38 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.652 0.739 . . . . 0.0 110.558 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.9 tpt180 -143.93 161.46 38.66 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.863 0.84 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . 67.2 t0 -42.6 116.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.586 0.708 . . . . 0.0 110.604 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 24' ' ' ASP . . . 37.0 35.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.763 0.792 . . . . 0.0 110.047 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' CD ' ' NH2' ' A' ' 53' ' ' ARG . 68.9 tt0 -159.81 157.1 28.65 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.058 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.6 mt -126.32 127.59 45.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.573 0.701 . . . . 0.0 109.405 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 98.4 mt -106.8 125.77 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-O 121.923 0.868 . . . . 0.0 109.745 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -73.51 120.17 18.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.781 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -81.7 170.88 15.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.807 0.813 . . . . 0.0 110.184 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 148.71 21.98 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.34 -36.61 68.86 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.781 -0.834 . . . . 0.0 109.351 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.92 -5.23 47.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.739 . . . . 0.0 109.242 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.9 m -102.18 -117.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.3 -7.88 62.24 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.8 mt -68.4 149.71 49.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.987 . . . . 0.0 110.321 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.48 145.42 49.54 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -130.46 115.82 17.3 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.33 164.58 26.43 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.587 2.192 . . . . 0.0 111.941 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -103.32 132.11 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.715 0.769 . . . . 0.0 109.814 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -121.61 129.46 52.84 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.689 0.757 . . . . 0.0 109.638 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 57.33 30.82 19.14 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.511 0.672 . . . . 0.0 109.351 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.84 85.43 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.08 130.32 24.01 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.763 -0.845 . . . . 0.0 109.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.02 141.58 40.44 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.579 2.186 . . . . 0.0 112.09 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.8 t -90.07 128.18 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.71 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -117.79 30.17 7.42 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.297 1.046 . . . . 0.0 109.575 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.11 -42.94 95.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.722 -0.611 . . . . 0.0 109.691 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.89 -17.13 64.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.518 -0.739 . . . . 0.0 109.4 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.63 -12.61 18.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.36 -0.838 . . . . 0.0 108.772 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . -57.14 142.73 41.52 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' NH2' ' CD ' ' A' ' 26' ' ' GLU . 89.2 mtm180 -105.87 146.43 29.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.706 0.765 . . . . 0.0 109.728 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 11.4 mpt_? -83.14 151.76 63.83 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.944 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 C--N 1.308 -1.595 0 C-N-CA 122.759 2.306 . . . . 0.0 112.665 179.893 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -90.1 153.72 46.98 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.684 -0.635 . . . . 0.0 110.266 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' CYS . 36.5 Cg_endo -65.28 141.91 70.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.663 2.242 . . . . 0.0 111.99 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.45 -12.59 0.51 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.603 -0.686 . . . . 0.0 109.243 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -136.54 -167.76 2.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 108.948 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 17' ' ' HIS . 56.5 t-80 -140.95 24.97 2.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.652 -0.655 . . . . 0.0 109.285 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.605 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -99.89 171.8 5.24 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.516 -0.74 . . . . 0.0 109.819 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 30' ' ' THR . 55.4 Cg_endo -77.99 178.12 7.97 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.238 1.959 . . . . 0.0 112.852 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.0 144.09 44.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.635 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -111.41 111.65 22.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.75 132.29 41.5 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.179 0.514 . . . . 0.0 110.014 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -141.53 124.91 16.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.5 -111.6 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.83 -0.544 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.4 34.69 4.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -152.47 155.69 37.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.0 109.827 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 131.29 56.38 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 28' ' ' ILE . 30.0 mm -104.27 130.33 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.46 0.648 . . . . 0.0 109.84 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 t -63.13 114.93 4.04 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.7 m -68.49 144.33 54.67 Favored 'General case' 0 C--O 1.209 -1.061 0 O-C-N 121.158 -0.964 . . . . 0.0 110.328 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.59 145.9 8.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -65.57 -41.39 92.95 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -86.9 -1.09 57.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 30' ' ' THR . 2.2 m -89.35 -79.24 0.33 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.626 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 64.37 -93.38 0.14 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.626 ' O ' ' O ' ' A' ' 35' ' ' GLY . 3.3 mm? 24.74 111.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.069 0.938 . . . . 0.0 111.708 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.27 123.74 44.87 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.52 -0.738 . . . . 0.0 109.335 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -108.0 104.62 54.09 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.67 160.81 28.02 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.288 1.992 . . . . 0.0 112.246 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.76 131.06 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -121.69 127.16 50.45 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.362 0.601 . . . . 0.0 109.584 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 51.7 t0 58.08 26.4 13.57 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.47 0.652 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.66 5.4 89.49 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.63 130.02 23.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.928 . . . . 0.0 109.834 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.32 143.18 47.39 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.367 2.045 . . . . 0.0 112.633 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.69 112.44 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -102.97 18.79 20.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.5 mt -107.88 128.74 54.89 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.638 0.732 . . . . 0.0 109.521 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.7 -41.37 92.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.341 0.591 . . . . 0.0 109.668 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.14 -42.66 81.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.921 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -89.06 -4.84 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.62 156.74 37.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.949 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.5 138.64 39.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.504 -0.748 . . . . 0.0 109.97 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -89.9 155.05 47.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.555 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 N--CA 1.493 1.467 0 C-N-CA 122.377 2.051 . . . . 0.0 112.797 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -67.36 153.61 94.49 Favored Pre-proline 0 C--N 1.296 -1.758 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.954 -178.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.72 -45.92 37.49 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.92 -61.89 1.67 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.625 . . . . 0.0 109.728 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.39 162.21 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -107.62 103.54 12.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.525 -0.734 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . 176.92 158.12 0.46 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.104 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.54 154.47 71.79 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.725 2.284 . . . . 0.0 112.604 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -106.75 148.44 28.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -106.57 127.38 53.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -75.72 130.81 39.27 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.409 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.5 tpt85 -139.03 165.38 27.27 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' H ' ' HG3' ' A' ' 23' ' ' ARG . 67.5 t0 -38.79 103.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.465 0.65 . . . . 0.0 110.411 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 40.6 38.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.428 0.632 . . . . 0.0 110.042 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -157.75 154.28 27.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.935 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -118.94 133.28 55.93 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.25 125.58 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.779 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.69 129.48 41.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -101.62 29.24 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.266 -0.896 . . . . 0.0 108.698 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 34' ' ' CYS . . . -97.95 144.81 17.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.7 -33.46 73.99 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.601 -0.94 . . . . 0.0 109.21 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.66 -3.63 52.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.201 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 11.0 p -144.16 128.52 17.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.71 27.54 2.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.11 157.79 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.451 -1.029 . . . . 0.0 109.89 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.74 141.32 51.93 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.393 0.616 . . . . 0.0 109.723 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-85 -125.02 122.96 25.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.73 161.25 30.75 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.314 2.009 . . . . 0.0 112.487 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -95.77 132.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.126 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -137.21 146.66 45.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.655 -0.653 . . . . 0.0 109.964 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.95 27.28 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.449 0.642 . . . . 0.0 109.675 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.88 7.05 83.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 pt -131.35 149.37 73.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.432 -1.04 . . . . 0.0 109.69 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.33 143.04 51.57 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.624 2.216 . . . . 0.0 112.668 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.25 93.07 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.008 . . . . 0.0 109.005 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 42.49 0.71 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.85 120.19 36.6 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.639 0.733 . . . . 0.0 109.405 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.85 -30.34 49.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 0.0 109.348 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.19 -40.36 97.29 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.32 -6.55 52.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 157.26 27.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 110.011 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -129.48 168.72 15.92 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.813 0.816 . . . . 0.0 109.949 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -76.58 153.52 83.57 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.641 -0.662 . . . . 0.0 109.564 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.495 1.571 0 C-N-CA 122.721 2.281 . . . . 0.0 112.463 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.436 0.636 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -60.07 156.82 35.44 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.627 -0.671 . . . . 0.0 109.534 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.92 -8.11 22.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.436 2.091 . . . . 0.0 111.22 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.52 -47.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.34 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -69.11 -24.53 64.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 18' ' ' ALA . 36.2 t-80 69.9 -26.65 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.733 -0.604 . . . . 0.0 109.865 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.65 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -48.9 -178.71 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.445 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 18' ' ' ALA . 38.1 Cg_endo -86.14 163.38 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.846 2.364 . . . . 0.0 112.606 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.72 151.3 32.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.178 -0.951 . . . . 0.0 109.359 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -122.24 133.65 54.7 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.544 0.688 . . . . 0.0 109.223 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.09 127.67 33.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.879 -0.513 . . . . 0.0 109.774 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -132.66 116.57 16.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.543 -0.723 . . . . 0.0 109.279 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 51.17 -110.76 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.74 -0.6 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.77 26.31 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.83 161.25 38.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -109.96 129.32 55.68 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.13 131.67 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.543 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -69.49 119.67 14.1 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.528 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 2.8 m -89.99 165.17 14.21 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.53 -176.97 18.9 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.98 -57.35 4.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.533 -0.98 . . . . 0.0 110.103 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -114.01 28.07 9.04 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -78.11 -80.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 62.85 -114.86 7.3 Favored Glycine 0 C--O 1.202 -1.853 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.679 ' O ' ' O ' ' A' ' 35' ' ' GLY . 75.1 mt 41.98 121.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.58 1.181 . . . . 0.0 111.453 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.99 133.34 51.79 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.19 -0.944 . . . . 0.0 109.793 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.42 108.68 45.05 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.335 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.99 161.52 23.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.564 2.176 . . . . 0.0 112.352 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -95.26 132.84 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -105.83 108.16 19.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.24 36.95 28.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.584 0.707 . . . . 0.0 109.658 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.26 87.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -110.18 105.02 56.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.534 -0.98 . . . . 0.0 109.715 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.35 134.08 50.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.0 98.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.78 31.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.368 -0.833 . . . . 0.0 109.422 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.45 126.57 55.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.094 0.949 . . . . 0.0 109.592 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -64.6 -39.93 87.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.602 0.715 . . . . 0.0 109.618 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.5 t0 -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -91.04 -9.73 44.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.272 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.71 38.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 109.948 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -111.76 139.45 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.789 0.804 . . . . 0.0 110.05 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -79.9 158.75 72.39 Favored Pre-proline 0 C--N 1.303 -1.42 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.402 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 112.655 179.169 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.1 p -58.46 114.93 9.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.689 -0.632 . . . . 0.0 109.723 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -50.26 -9.64 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.237 1.958 . . . . 0.0 111.515 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -100.95 -72.98 0.66 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.225 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -13.64 51.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.374 -0.829 . . . . 0.0 109.277 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 85.9 t60 55.07 88.68 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.847 0.832 . . . . 0.0 109.835 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.643 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -173.01 170.22 2.12 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.421 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.53 153.78 58.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.06 2.506 . . . . 0.0 112.632 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.27 149.19 36.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.0 109.805 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -117.74 135.09 54.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.37 124.14 36.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.271 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 25' ' ' ALA . 69.0 ttp85 -122.8 112.66 18.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 53.98 -87.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.0 110.192 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -139.56 28.62 2.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 108.848 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.62 154.87 49.67 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.705 0.764 . . . . 0.0 109.907 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.11 134.68 47.8 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.794 0.807 . . . . 0.0 110.002 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.77 129.35 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.673 0.749 . . . . 0.0 110.012 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 125.37 25.03 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.03 127.22 55.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.533 -0.729 . . . . 0.0 109.847 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.97 -172.47 39.0 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -73.1 -57.4 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.558 -0.966 . . . . 0.0 110.032 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -89.58 5.8 44.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.073 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.14 168.97 18.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.959 0.885 . . . . 0.0 110.074 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 -10.29 0.18 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -70.54 157.73 37.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 0.0 110.602 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.84 146.51 50.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.07 129.63 22.56 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.93 164.68 31.26 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.326 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -108.11 132.42 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.522 0.677 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -122.72 128.36 50.44 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.911 0.863 . . . . 0.0 110.04 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 57.52 28.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.72 0.771 . . . . 0.0 109.918 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 3.99 90.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.54 131.41 23.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.5 -1.0 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.06 145.14 54.52 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.592 2.195 . . . . 0.0 112.583 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 83.5 t -89.38 123.91 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.546 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.58 32.26 5.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.2 mt -102.53 132.51 48.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.32 -41.1 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.613 0.721 . . . . 0.0 109.764 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.5 -40.13 86.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.945 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.77 7.96 16.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.99 -1.069 . . . . 0.0 109.247 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.13 58.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.691 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.93 120.43 41.89 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.716 0.77 . . . . 0.0 109.159 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -84.61 151.23 58.26 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.764 2.309 . . . . 0.0 112.801 179.707 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.559 0.695 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -68.69 163.58 53.55 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.23 -83.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.389 2.059 . . . . 0.0 112.057 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.8 77.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.091 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 30.1 p -97.19 66.34 2.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -41.58 119.13 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.99 159.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.464 -0.772 . . . . 0.0 109.187 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.94 137.34 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.962 1.775 . . . . 0.0 112.802 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.4 mt -112.65 148.59 34.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.53 -0.731 . . . . 0.0 110.087 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -113.54 117.66 32.28 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -98.8 123.45 43.05 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.554 -0.716 . . . . 0.0 109.596 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' ALA . 10.3 ptp180 -128.85 125.95 38.76 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.633 -0.667 . . . . 0.0 109.36 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.88 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.316 0.579 . . . . 0.0 109.593 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.43 28.71 1.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -135.48 139.52 44.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.6 -0.687 . . . . 0.0 109.253 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.73 135.78 50.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.622 -0.674 . . . . 0.0 109.555 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.7 132.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.433 0.635 . . . . 0.0 110.121 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.3 m -58.08 123.88 17.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.64 -20.17 17.82 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.05 -1.031 . . . . 0.0 108.62 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.33 137.48 35.36 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.73 -14.5 52.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.238 -1.154 . . . . 0.0 108.882 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -80.11 -4.22 51.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.355 -0.841 . . . . 0.0 109.138 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.02 165.81 35.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.926 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.65 17.01 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.64 159.44 34.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.486 -1.008 . . . . 0.0 109.996 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.32 144.29 49.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.574 0.702 . . . . 0.0 110.275 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 12.1 m-85 -129.86 127.18 22.76 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.15 158.31 30.19 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.168 1.912 . . . . 0.0 111.916 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.72 131.21 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -104.36 108.77 20.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.501 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 53.39 36.86 24.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.8 87.3 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mt -111.04 108.36 57.48 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.4 -1.059 . . . . 0.0 109.387 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.44 135.02 53.95 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.831 1.687 . . . . 0.0 112.121 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -92.81 95.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 108.966 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.1 mt -89.29 64.23 6.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.1 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -121.33 125.77 47.81 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.747 0.784 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.63 -43.51 98.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.72 -40.26 94.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.77 -4.68 59.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.002 -1.061 . . . . 0.0 109.49 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.21 142.57 30.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.135 -0.978 . . . . 0.0 109.601 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -106.04 141.73 36.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 0.0 109.281 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.55 150.63 49.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.0 109.295 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo . . . . . 0 N--CA 1.49 1.294 0 C-N-CA 122.505 2.137 . . . . 0.0 112.873 179.824 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.8 m -59.41 151.07 61.65 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.56 -22.48 58.41 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.04 1.827 . . . . 0.0 111.672 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.93 -30.64 2.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.266 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.6 -168.1 1.63 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.399 -0.813 . . . . 0.0 109.141 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -125.15 19.51 8.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.549 -0.719 . . . . 0.0 109.537 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -95.42 -177.75 0.69 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 18' ' ' ALA . 48.2 Cg_endo -86.73 167.04 8.64 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 113.36 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -112.13 150.04 31.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.135 -0.978 . . . . 0.0 109.647 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -128.46 121.03 28.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.75 135.43 37.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ALA . 78.6 ttt-85 -128.87 104.61 7.71 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 99.0 m-20 -22.28 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 O-C-N 123.59 0.556 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . 155.38 -30.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -178.08 -174.15 0.41 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.706 0.765 . . . . 0.0 110.784 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -105.26 129.58 53.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 131.48 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.681 . . . . 0.0 109.271 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 t -74.87 122.79 23.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.2 m -84.46 157.4 21.36 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.05 -1.031 . . . . 0.0 109.342 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.11 167.67 13.82 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -75.91 -55.11 5.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 109.757 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -80.52 -2.93 48.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 30' ' ' THR . 57.1 m -81.25 -114.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.528 -0.733 . . . . 0.0 109.805 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 36' ' ' LEU . . . 86.68 -62.45 4.25 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' GLY . 66.8 mt -9.43 125.59 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.637 0.732 . . . . 0.0 111.932 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 130.84 55.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.316 -0.865 . . . . 0.0 109.522 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -113.04 119.85 41.7 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.87 164.92 22.53 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.163 1.909 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.24 131.15 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -119.82 126.32 50.7 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.528 0.68 . . . . 0.0 109.697 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.0 t0 56.23 28.39 13.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.68 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -0.08 89.7 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 44' ' ' ILE . 26.3 mm -107.1 131.02 22.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -1.188 . . . . 0.0 109.139 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.32 142.74 27.28 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.306 2.004 . . . . 0.0 112.132 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.63 94.75 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 109.087 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -85.27 39.88 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.346 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.2 mt -111.61 128.0 55.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.784 0.802 . . . . 0.0 109.788 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.75 -41.67 90.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -57.98 -41.21 82.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -90.27 -5.86 55.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.009 -1.057 . . . . 0.0 109.516 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.83 48.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -104.32 143.48 32.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.454 0.645 . . . . 0.0 109.674 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -95.27 113.85 62.49 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.701 -0.624 . . . . 0.0 109.435 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo . . . . . 0 N--CA 1.496 1.658 0 C-N-CA 121.864 1.709 . . . . 0.0 112.805 179.206 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.98 159.02 58.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.397 -0.814 . . . . 0.0 109.813 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.804 2.336 . . . . 0.0 112.012 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.52 -48.25 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.911 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -99.58 159.89 14.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.286 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.522 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 47.3 p-80 -108.58 112.09 24.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.546 -0.721 . . . . 0.0 109.9 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 164.82 156.78 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' O ' ' OG1' ' A' ' 30' ' ' THR . 56.2 Cg_endo -71.01 163.31 39.7 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.688 2.259 . . . . 0.0 111.985 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.4 147.75 45.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.638 -0.664 . . . . 0.0 109.292 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.59 126.82 52.58 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.97 122.75 31.95 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.214 0.53 . . . . 0.0 109.845 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.92 161.26 4.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 52.95 31.48 10.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.35 22.64 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.76 159.47 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.518 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 mp -106.84 125.32 50.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.6 mt -101.82 128.85 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 129.57 38.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.561 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 70.2 p -84.59 170.9 12.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 110.172 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 145.8 16.14 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -68.32 -53.74 22.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.618 -0.931 . . . . 0.0 109.7 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.87 -5.52 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -0.791 . . . . 0.0 109.709 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 1.3 t -116.96 87.47 2.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.32 -141.07 9.14 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt 74.45 160.6 0.23 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.849 0.833 . . . . 0.0 109.759 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.81 150.73 35.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.838 . . . . 0.0 109.54 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.3 m-85 -115.56 134.08 22.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.99 161.5 41.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.044 1.829 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.37 131.85 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -112.44 120.69 42.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.632 -0.668 . . . . 0.0 109.601 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.9 t0 57.16 22.67 7.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.11 -2.28 71.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.87 124.12 39.85 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.396 -1.061 . . . . 0.0 109.151 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.44 142.12 40.06 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.044 1.829 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 t -88.98 118.93 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.074 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.6 mt -100.33 32.22 3.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.477 -0.764 . . . . 0.0 109.317 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.9 mt -107.09 129.07 54.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.942 0.877 . . . . 0.0 109.471 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.74 -42.15 94.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.63 -20.08 53.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.495 -0.753 . . . . 0.0 110.162 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -102.19 2.62 37.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 0.0 108.986 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 145.97 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.812 . . . . 0.0 109.645 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -119.22 141.72 48.65 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.55 0.69 . . . . 0.0 109.347 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 3.0 mtp180 -89.77 177.55 2.38 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 54' ' ' ARG . 36.5 Cg_exo . . . . . 0 N--CA 1.496 1.663 0 C-N-CA 122.657 2.238 . . . . 0.0 112.508 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.832 0.825 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -74.64 150.39 86.59 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.841 -0.537 . . . . 0.0 110.117 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.56 -11.34 26.2 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.766 2.311 . . . . 0.0 111.321 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.0 -53.25 0.98 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.636 -0.665 . . . . 0.0 109.452 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.529 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.47 -29.29 69.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.463 -0.773 . . . . 0.0 109.26 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 63.31 -1.44 0.55 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -79.38 169.33 20.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.543 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.2 153.12 71.99 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.362 2.042 . . . . 0.0 112.439 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.2 mt -111.75 152.69 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.725 0.774 . . . . 0.0 109.703 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' CG ' ' OG1' ' A' ' 30' ' ' THR . 68.3 mm-40 -127.44 139.42 52.83 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.951 0.882 . . . . 0.0 109.734 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.29 128.39 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.57 0.7 . . . . 0.0 109.961 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' ' 24' ' ' ASP . 76.3 ttt180 -124.52 156.92 36.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 23' ' ' ARG . 35.0 t0 17.17 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.637 0.732 . . . . 0.0 110.705 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.6 29.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.637 -0.665 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 54.7 mp0 -144.56 167.27 22.92 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 0.0 110.053 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -97.16 134.56 40.32 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.345 0.593 . . . . 0.0 109.856 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 28' ' ' ILE . 48.8 mm -118.51 131.38 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.924 0.868 . . . . 0.0 110.183 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' OH ' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -70.07 127.71 33.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.447 ' OG1' ' CG ' ' A' ' 21' ' ' GLU . 89.1 m -120.24 125.27 47.72 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.818 0.818 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.23 -163.84 37.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.07 -58.14 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.651 -0.911 . . . . 0.0 109.732 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -96.86 15.06 23.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.51 163.54 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.906 0.86 . . . . 0.0 110.014 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.56 -11.31 0.1 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.24 162.37 14.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 110.169 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.67 142.17 48.96 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.657 0.742 . . . . 0.0 109.684 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -127.94 128.13 23.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.92 166.61 26.58 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.391 2.061 . . . . 0.0 112.379 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -94.04 128.71 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.8 0.809 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -137.89 141.8 40.65 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.63 27.31 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.545 0.688 . . . . 0.0 109.636 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.91 10.84 85.01 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.81 149.55 64.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.466 -1.02 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.18 147.52 54.03 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.371 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 48' ' ' LEU . 97.7 t -84.16 96.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.749 0.785 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.86 38.3 0.45 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 46' ' ' VAL . 53.4 mt -115.71 119.27 35.51 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.155 0.978 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 m -66.04 -29.86 48.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.586 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.98 -43.56 95.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.729 -0.607 . . . . 0.0 109.938 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.7 mp0 -92.05 -4.09 54.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.08 151.42 47.06 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.533 0.682 . . . . 0.0 110.092 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -103.84 143.11 33.26 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.931 0.872 . . . . 0.0 110.024 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 155.92 37.21 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.478 2.119 . . . . 0.0 112.949 179.191 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.932 0.872 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.696 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -59.36 159.52 15.94 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-O 121.45 0.643 . . . . 0.0 109.771 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.81 -79.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.607 2.204 . . . . 0.0 112.363 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.78 98.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.456 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.942 0.877 . . . . 0.0 109.951 -179.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.78 104.45 15.23 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.676 0.751 . . . . 0.0 109.495 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.696 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.86 155.49 1.05 Allowed Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 164.05 35.23 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.706 2.27 . . . . 0.0 113.001 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.21 151.21 33.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.588 0.708 . . . . 0.0 109.596 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -124.89 120.75 32.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.002 0.906 . . . . 0.0 109.604 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -81.13 135.9 35.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.967 0.889 . . . . 0.0 110.211 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -167.59 143.86 4.16 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.846 0.831 . . . . 0.0 109.973 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 54.0 36.42 24.45 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.254 0.549 . . . . 0.0 109.923 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.36 18.6 11.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.806 -0.559 . . . . 0.0 109.562 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.548 ' CD ' HH22 ' A' ' 53' ' ' ARG . 94.3 mt-10 -132.67 159.63 39.04 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.719 0.771 . . . . 0.0 109.679 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.46 126.3 48.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.7 . . . . 0.0 109.909 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.3 mt -108.58 127.3 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.734 0.778 . . . . 0.0 109.686 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.52 119.87 13.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.1 m -105.82 113.13 26.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.659 0.742 . . . . 0.0 109.652 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.53 169.26 42.21 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.62 -50.51 62.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.726 -0.867 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.3 -0.41 49.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.465 -0.772 . . . . 0.0 108.982 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.58 -171.35 3.27 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.721 0.772 . . . . 0.0 110.149 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.99 -9.07 0.96 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.85 160.59 22.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.328 -1.101 . . . . 0.0 110.5 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.88 138.8 48.56 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.58 0.705 . . . . 0.0 109.407 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -124.31 125.07 25.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.28 166.22 24.7 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.412 2.075 . . . . 0.0 112.348 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.16 131.14 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.568 0.699 . . . . 0.0 109.438 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -118.88 120.17 36.52 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.889 0.852 . . . . 0.0 109.76 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 56.87 33.55 23.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.451 0.643 . . . . 0.0 109.797 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.46 -2.36 82.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 44' ' ' ILE . 18.0 mm -99.86 122.85 49.52 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.521 -0.988 . . . . 0.0 109.575 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.17 144.94 27.06 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.676 2.251 . . . . 0.0 112.825 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.6 t -88.5 128.05 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.607 0.718 . . . . 0.0 109.361 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.4 mt -118.4 25.33 10.37 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.12 130.48 46.27 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.316 1.055 . . . . 0.0 109.481 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.85 -42.29 94.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.645 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.19 -38.38 88.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.499 -0.75 . . . . 0.0 109.68 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.0 -8.0 58.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.127 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 146.22 54.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.731 0.777 . . . . 0.0 109.971 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.548 HH22 ' CD ' ' A' ' 26' ' ' GLU . 90.9 mtm180 -102.13 139.34 37.88 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.721 0.772 . . . . 0.0 110.008 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -89.61 151.9 46.45 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.532 2.155 . . . . 0.0 112.689 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 52.8 mmm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 1' ' ' MET . 29.7 Cg_endo -63.86 147.79 92.05 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.84 2.36 . . . . 0.0 112.519 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.9 146.15 42.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -65.69 139.81 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.508 0.67 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.13 -65.88 1.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 62.34 58.52 12.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' GLY . 10.3 mp 55.01 111.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.26 1.029 . . . . 0.0 110.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.608 ' H ' ' CD2' ' A' ' 8' ' ' LEU . 2.0 pt? -73.33 -3.76 29.1 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.038 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.17 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.12 132.37 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.968 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.89 125.27 34.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.35 137.88 15.96 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.299 -0.875 . . . . 0.0 109.204 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -59.02 162.45 7.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.363 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -59.81 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.442 2.095 . . . . 0.0 112.239 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -51.24 2.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.452 -0.78 . . . . 0.0 109.469 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.0 p -73.11 65.0 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' CYS . 53.9 t-80 -37.89 112.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.004 0.907 . . . . 0.0 110.497 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -174.45 168.72 1.93 Allowed Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.965 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.8 Cg_exo -56.01 145.93 71.94 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.883 2.389 . . . . 0.0 112.759 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.6 mt -121.15 145.15 48.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.0 109.547 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -121.87 121.15 36.5 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.836 0.827 . . . . 0.0 109.081 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.93 137.53 34.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.74 -0.6 . . . . 0.0 109.977 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -139.3 115.02 10.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.027 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.8 -112.93 0.66 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.501 0.667 . . . . 0.0 110.602 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.73 27.03 10.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 108.901 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 41.3 mp0 -141.28 154.7 45.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.135 -0.978 . . . . 0.0 109.355 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.25 134.66 54.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.93 132.95 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.551 0.691 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.36 132.97 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.462 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 11.7 p -124.2 136.85 54.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.76 -161.31 32.21 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.61 -57.51 3.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -1.053 . . . . 0.0 110.056 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -95.41 4.57 53.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.184 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 178.06 5.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.38 -5.13 1.83 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -74.7 155.75 37.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -1.084 . . . . 0.0 110.419 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.8 139.2 53.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-85 -127.33 109.74 21.25 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 157.06 28.58 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -91.75 132.21 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -0.959 . . . . 0.0 109.698 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -118.11 126.32 52.01 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.463 0.649 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 56.3 29.23 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.803 0.811 . . . . 0.0 110.085 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.31 5.34 90.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.0 mt -112.7 131.25 22.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.417 -1.049 . . . . 0.0 109.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 154.33 49.04 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.538 2.158 . . . . 0.0 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.34 122.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -113.09 21.39 15.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.2 mm? -100.19 129.19 46.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.493 1.139 . . . . 0.0 109.924 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.46 -42.28 94.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -62.22 -37.92 87.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.658 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 -9.36 58.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.768 -1.207 . . . . 0.0 109.159 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.16 145.17 37.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -106.83 147.0 30.25 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.807 0.813 . . . . 0.0 109.966 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 9.9 mpt_? -86.17 156.07 57.43 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.696 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -46.13 141.35 9.74 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.344 2.03 . . . . 0.0 112.774 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.859 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 mtp . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.36 -18.11 39.05 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.492 2.128 . . . . 0.0 111.412 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -94.95 -10.54 30.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.686 . . . . 0.0 109.214 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -113.94 -53.44 2.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.97 -61.25 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.56 -131.99 47.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.8 tp -80.99 -167.69 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.813 -0.816 . . . . 0.0 110.448 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 90.8 mt -63.7 -42.12 98.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' ILE . 50.8 mt-10 49.07 99.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.516 0.674 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' GLU . 96.3 mt 54.63 111.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.774 0.797 . . . . 0.0 110.261 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 10.2 mp -77.74 148.0 35.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.491 0.663 . . . . 0.0 109.849 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.79 150.93 37.5 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.807 0.813 . . . . 0.0 109.872 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.537 ' H ' ' HA ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -126.58 168.55 14.09 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-O 122.062 0.934 . . . . 0.0 109.749 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' CYS . 23.8 Cg_exo -63.3 141.59 82.49 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.44 2.094 . . . . 0.0 113.045 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.27 15.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.321 0.582 . . . . 0.0 109.56 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . 29.5 p -172.86 123.4 0.43 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.444 0.64 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.537 ' HA ' ' H ' ' A' ' 13' ' ' CYS . 51.7 p-80 -111.38 115.95 30.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.806 0.813 . . . . 0.0 110.057 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -176.27 173.14 0.87 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-O 121.365 0.602 . . . . 0.0 109.677 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -54.43 147.26 47.93 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.751 2.301 . . . . 0.0 112.664 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.66 141.08 50.71 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.032 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -127.06 135.61 51.03 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.86 0.838 . . . . 0.0 109.687 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -83.4 137.12 34.07 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.669 0.747 . . . . 0.0 110.184 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -173.02 153.87 2.66 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.81 0.814 . . . . 0.0 110.128 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 54.52 33.25 18.52 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.304 0.573 . . . . 0.0 109.886 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.52 19.02 11.66 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -142.16 175.29 9.86 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.635 0.731 . . . . 0.0 110.052 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.71 124.43 48.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.543 0.687 . . . . 0.0 109.548 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.61 137.4 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.914 0.864 . . . . 0.0 110.179 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.7 m -73.27 124.82 26.42 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 m -114.49 108.17 16.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.729 0.776 . . . . 0.0 109.957 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.44 48.41 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.5 -54.8 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.727 -0.866 . . . . 0.0 109.405 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.47 -2.26 31.17 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.61 113.71 25.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.516 -0.74 . . . . 0.0 109.553 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 9.79 0.89 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.84 156.49 38.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.42 131.52 56.74 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.754 0.788 . . . . 0.0 109.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.94 117.82 35.12 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.42 165.39 29.26 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.522 2.148 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.04 134.47 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.675 0.75 . . . . 0.0 110.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -101.48 103.81 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.732 0.777 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 54.33 36.4 25.2 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.423 0.63 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.61 72.09 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.17 98.93 44.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 122.018 -0.696 . . . . 0.0 109.285 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.23 134.6 64.72 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.647 2.232 . . . . 0.0 112.189 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -106.45 96.73 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.592 0.71 . . . . 0.0 109.413 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.0 mt -77.24 45.58 0.46 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 46' ' ' VAL . 89.4 mt -109.38 133.03 53.56 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.187 0.994 . . . . 0.0 109.717 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.14 -36.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.9 -39.85 90.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.595 -0.691 . . . . 0.0 109.358 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 51.0 mp0 -90.92 -6.02 54.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.44 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.98 147.19 50.45 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.489 0.662 . . . . 0.0 109.881 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 79.6 ttt-85 -117.75 141.08 48.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.011 0.91 . . . . 0.0 110.064 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -94.87 150.95 38.6 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.0 147.19 84.26 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.777 2.318 . . . . 0.0 112.427 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 53' ' ' ARG . 80.2 mm-40 . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.4 tpt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 1' ' ' MET . 37.4 Cg_endo -67.34 152.51 79.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 3.9 mm? -86.5 -4.59 59.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.777 -0.577 . . . . 0.0 109.458 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 80.2 mm-40 -84.83 -88.1 0.11 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.391 0.615 . . . . 0.0 109.736 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' GLU . . . 57.07 156.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.779 0.8 . . . . 0.0 110.434 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 164.36 54.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.13 130.77 42.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.725 0.774 . . . . 0.0 110.081 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -100.11 -22.37 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 109.214 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -57.88 121.49 10.65 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.626 0.727 . . . . 0.0 110.045 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.0 mp -106.62 -19.81 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.09 148.43 44.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.539 0.685 . . . . 0.0 110.153 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.44 136.08 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.677 0.751 . . . . 0.0 109.871 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.709 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -79.81 119.19 75.93 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-O 121.212 0.53 . . . . 0.0 109.754 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 52.6 Cg_exo -50.93 144.06 28.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.369 2.046 . . . . 0.0 112.649 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 79.87 -36.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' H ' ' C ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -122.7 -169.09 1.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.834 0.826 . . . . 0.0 109.792 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -135.89 97.55 3.67 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.739 0.78 . . . . 0.0 109.633 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.07 171.2 1.12 Allowed Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.79 172.25 16.65 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.9 2.4 . . . . 0.0 112.652 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.8 mt -114.48 134.26 55.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.699 -0.626 . . . . 0.0 109.618 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 30' ' ' THR . 6.1 pt-20 -111.21 135.48 51.68 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.853 0.835 . . . . 0.0 109.299 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -97.6 133.98 41.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.535 0.684 . . . . 0.0 110.451 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 124.85 27.79 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.85 0.833 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 49.74 -113.68 0.65 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.286 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.51 23.36 13.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.593 -0.692 . . . . 0.0 109.2 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.71 162.0 36.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.705 . . . . 0.0 110.064 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.74 148.13 38.76 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.895 0.855 . . . . 0.0 109.726 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 28' ' ' ILE . 80.9 mt -136.48 152.1 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.27 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.19 131.24 45.04 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.086 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 21' ' ' GLU . 3.1 m -91.65 166.91 12.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.092 0.948 . . . . 0.0 110.109 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 147.86 9.73 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.552 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 1.8 pm0 -75.5 -10.33 59.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.755 -0.85 . . . . 0.0 108.781 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.8 -4.73 55.68 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 m -129.46 -145.09 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.572 0.701 . . . . 0.0 109.847 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.41 -15.07 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -49.52 149.07 2.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.773 -0.839 . . . . 0.0 110.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.66 135.4 53.96 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.659 0.742 . . . . 0.0 109.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -124.59 105.88 30.07 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.99 173.3 12.9 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.232 1.955 . . . . 0.0 111.977 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.17 132.34 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.507 0.67 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -124.94 126.4 45.44 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.933 0.873 . . . . 0.0 109.847 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.5 t0 57.54 27.68 14.44 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.446 0.641 . . . . 0.0 109.772 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.06 6.26 89.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.92 130.3 24.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.849 -0.795 . . . . 0.0 109.698 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.92 150.5 61.25 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.681 2.254 . . . . 0.0 112.676 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.79 106.68 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 4.2 mm? -103.08 14.99 30.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.76 133.17 49.2 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.865 0.84 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.45 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.318 0.58 . . . . 0.0 109.63 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -59.44 -39.75 84.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 0.0 109.842 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.85 -5.49 53.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.091 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 154.46 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.493 0.663 . . . . 0.0 110.169 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -100.07 137.58 38.33 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.943 0.878 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -49.21 167.51 0.21 Allowed Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.903 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' OXT' ' A' ' 56' ' ' GLU . 65.5 Cg_exo -48.69 135.06 27.86 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.127 1.884 . . . . 0.0 112.765 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' OXT' ' O ' ' A' ' 55' ' ' PRO . 82.6 tt0 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.847 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.8 ttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 1' ' ' MET . 27.0 Cg_endo -63.8 146.69 92.17 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.732 2.288 . . . . 0.0 112.399 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' PRO . 51.9 mt 59.01 123.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.066 0.936 . . . . 0.0 110.051 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.38 -5.19 59.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.955 . . . . 0.0 108.84 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.98 139.19 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . -90.31 116.85 4.91 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' GLY . 10.3 mp 50.13 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.218 1.008 . . . . 0.0 110.242 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.25 139.85 57.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.67 138.98 56.74 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.733 0.778 . . . . 0.0 110.008 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.2 pt -109.81 -164.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.871 0.843 . . . . 0.0 110.154 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.15 155.26 39.83 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.021 0.915 . . . . 0.0 110.603 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.67 39.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.476 -0.765 . . . . 0.0 109.038 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -88.36 142.88 31.75 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.269 -0.894 . . . . 0.0 110.171 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.89 152.64 52.4 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.188 . . . . 0.0 112.988 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 69.41 -69.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.636 0.732 . . . . 0.0 110.777 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -29.41 68.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 0.0 109.489 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 52.63 88.82 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.005 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -171.37 172.05 2.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.0 148.07 90.45 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.471 2.114 . . . . 0.0 112.588 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.84 142.36 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.927 0.87 . . . . 0.0 110.082 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -110.09 116.84 32.27 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.34 127.71 36.89 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.377 0.608 . . . . 0.0 110.02 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' ASP . 95.6 mtt180 -134.82 132.54 38.78 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 25' ' ' ALA . 5.6 p-10 40.2 -116.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.369 0.604 . . . . 0.0 110.55 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 24' ' ' ASP . . . -111.24 42.07 1.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 109.044 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -153.31 149.54 27.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.19 134.67 54.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.553 0.692 . . . . 0.0 109.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.23 132.04 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.616 0.722 . . . . 0.0 109.966 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 125.64 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.23 127.78 56.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.571 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.88 -161.18 34.86 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.27 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -79.43 -58.01 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.495 -1.003 . . . . 0.0 109.514 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -95.05 7.67 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.051 -1.03 . . . . 0.0 108.72 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 171.0 15.74 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.41 -6.81 0.34 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.4 154.71 41.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.146 -1.208 . . . . 0.0 110.291 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.97 139.3 54.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 m-85 -124.01 121.26 26.34 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.81 161.86 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.26 131.6 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -103.7 104.57 14.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.866 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.6 t0 53.05 38.74 28.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.902 0.858 . . . . 0.0 110.051 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.64 7.46 78.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 44' ' ' ILE . 43.2 mt -111.84 101.22 50.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.146 -1.208 . . . . 0.0 109.308 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.0 139.99 69.92 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.628 2.218 . . . . 0.0 112.061 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.43 121.73 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.009 . . . . 0.0 109.54 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.4 23.69 14.12 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.3 mm? -100.01 126.27 46.17 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.437 1.113 . . . . 0.0 109.913 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.18 -41.92 92.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.642 0.734 . . . . 0.0 109.525 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.6 t0 -61.14 -34.67 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 109.801 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.6 -11.25 49.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.828 -1.17 . . . . 0.0 109.23 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.97 146.64 26.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.97 . . . . 0.0 110.049 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -112.96 140.6 47.63 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.921 0.867 . . . . 0.0 109.792 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -87.32 153.96 53.97 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.67 -0.644 . . . . 0.0 109.366 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.53 144.07 89.33 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.803 2.335 . . . . 0.0 112.749 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 C--N 1.3 -1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.059 179.53 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.51 138.98 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.99 1.793 . . . . 0.0 112.798 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.14 -35.34 0.08 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.2 -2.39 55.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 108.952 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.09 140.77 55.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.21 -29.46 8.81 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 10.2 mp -94.8 121.48 36.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 9' ' ' GLU . 70.0 mt -83.28 -76.65 0.27 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' LEU . 74.6 mm-40 43.87 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.811 0.815 . . . . 0.0 109.968 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.04 146.28 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.723 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 10.3 mp -79.58 137.16 37.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.434 -0.791 . . . . 0.0 109.611 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.27 122.08 8.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.4 p -68.81 152.37 96.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.3 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 16' ' ' CYS . 39.6 Cg_endo -66.3 145.23 77.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.561 2.174 . . . . 0.0 111.818 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 66.75 -61.17 0.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.575 -0.703 . . . . 0.0 109.815 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -89.79 -173.57 3.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.273 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -136.61 109.96 7.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.463 -0.773 . . . . 0.0 109.61 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.85 176.42 0.48 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.47 159.38 53.08 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.844 2.363 . . . . 0.0 112.485 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.77 143.94 45.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.46 118.37 30.92 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -80.36 128.65 33.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.504 -0.748 . . . . 0.0 109.206 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -130.68 123.6 29.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.483 -0.761 . . . . 0.0 109.202 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 52.82 -96.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.318 0.58 . . . . 0.0 109.69 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.97 30.08 3.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.28 155.17 46.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.845 . . . . 0.0 109.738 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.3 mt -104.54 128.57 52.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.26 131.34 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.454 0.645 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 t -72.13 123.99 24.05 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 -178.75 4.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.041 -1.037 . . . . 0.0 109.685 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.48 148.68 6.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 24.3 mp0 -75.14 -10.86 59.86 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -1.006 . . . . 0.0 108.831 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.87 -3.53 54.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.32 -150.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.259 -0.901 . . . . 0.0 109.791 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 145.5 2.74 0.66 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.16 160.32 32.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -1.142 . . . . 0.0 110.039 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.19 137.75 54.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.664 -0.647 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -121.35 107.96 36.38 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.26 150.5 22.65 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.95 1.767 . . . . 0.0 112.44 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.55 132.82 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -117.59 127.63 54.16 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 55.05 30.52 14.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 109.907 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.51 88.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mt -117.5 131.8 23.89 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.394 -1.062 . . . . 0.0 109.3 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.36 145.73 38.82 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.035 1.823 . . . . 0.0 111.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.91 127.15 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.71 32.13 6.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -108.2 131.66 54.43 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.977 0.894 . . . . 0.0 109.767 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.93 -42.23 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.5 -19.28 46.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.91 -13.31 16.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.321 -0.862 . . . . 0.0 109.034 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.09 144.98 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.645 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -109.17 139.32 44.24 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -85.82 154.07 58.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . 59.3 Cg_exo -44.17 141.42 4.79 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.28 1.987 . . . . 0.0 112.899 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 55' ' ' PRO . 82.0 tt0 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.096 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.02 5.61 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.774 2.316 . . . . 0.0 111.435 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 5' ' ' ALA . 73.9 mt -72.73 -79.79 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.587 -0.695 . . . . 0.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 55.08 -82.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 3' ' ' LEU . . . -69.95 -9.52 55.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.19 -10.85 73.83 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.8 mt -74.92 -78.26 0.11 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -1.116 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.6 tp -89.06 128.37 35.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -55.32 -173.07 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -91.65 124.04 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.433 -0.792 . . . . 0.0 109.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -118.93 124.27 46.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.02 147.66 46.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.815 . . . . 0.0 108.886 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.3 p -100.13 116.04 64.92 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.828 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 49.5 Cg_exo -51.36 146.88 23.35 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.762 1.642 . . . . 0.0 112.79 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 76.41 -35.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.558 -0.714 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -124.95 -166.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 109.137 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 50.4 p-80 -146.96 111.78 5.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.603 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 164.61 158.76 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.183 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' C ' ' OG1' ' A' ' 30' ' ' THR . 32.1 Cg_exo -56.97 177.41 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.362 2.041 . . . . 0.0 112.829 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.1 141.7 49.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.395 -0.816 . . . . 0.0 109.28 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -122.64 134.23 54.5 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.933 0.873 . . . . 0.0 109.743 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.73 138.76 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.645 -0.66 . . . . 0.0 109.531 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -137.76 122.68 18.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.562 -0.711 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.0 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.413 0.625 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.91 28.12 3.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -139.16 160.95 38.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.342 -0.849 . . . . 0.0 109.564 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.0 mt -109.94 119.54 39.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.5 pt -107.8 144.43 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -0.884 . . . . 0.0 109.655 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 134.39 47.18 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.529 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' C ' ' A' ' 19' ' ' PRO . 6.3 m -73.63 145.9 45.01 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.304 -0.872 . . . . 0.0 109.935 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 140.44 9.57 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 26.7 mp0 -66.17 -45.61 80.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.624 -0.927 . . . . 0.0 109.692 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 57.8 t0 -78.53 -6.73 56.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -87.36 -46.92 9.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 41.78 -103.73 0.04 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.1 mt 41.2 111.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.229 1.014 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.46 127.63 53.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -0.768 . . . . 0.0 109.674 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -114.79 104.34 54.27 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.56 168.83 19.26 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.093 1.862 . . . . 0.0 111.61 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.39 131.5 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.945 . . . . 0.0 109.375 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 43' ' ' GLY . 62.8 ttm-85 -114.19 130.53 56.62 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 56.78 5.66 0.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.403 -0.81 . . . . 0.0 109.888 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 41' ' ' ARG . . . 108.39 -7.68 34.7 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.28 135.0 20.62 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.344 -1.092 . . . . 0.0 109.645 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.36 144.0 32.57 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 112.544 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.93 111.74 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 109.177 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.5 mt -97.47 16.03 21.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.837 . . . . 0.0 108.933 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.1 mm? -94.22 126.33 39.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 109.588 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.28 -42.36 90.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.635 -0.666 . . . . 0.0 109.753 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.55 -38.04 83.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.2 -6.99 56.47 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.23 -0.919 . . . . 0.0 109.358 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.18 39.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.649 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.72 142.03 33.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.452 -0.78 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -88.2 150.63 47.57 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 109.552 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.13 147.36 79.13 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.658 2.239 . . . . 0.0 112.702 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.708 179.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.19 -14.04 35.71 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.849 2.366 . . . . 0.0 111.738 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.3 mt -79.71 -1.39 38.24 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.598 -0.689 . . . . 0.0 109.255 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -142.19 -28.69 0.61 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.56 143.83 57.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -0.804 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 7' ' ' LEU . . . 42.93 -157.03 0.1 OUTLIER Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 6' ' ' GLY . 1.8 tt 76.86 -59.82 0.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.803 -0.822 . . . . 0.0 109.405 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 mm? 44.73 -107.55 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.571 -0.705 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.13 148.54 47.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.665 0.745 . . . . 0.0 110.395 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -77.58 93.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.38 155.96 33.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.629 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.95 136.61 54.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -78.79 153.79 78.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.625 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.7 143.24 67.04 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.619 2.213 . . . . 0.0 111.779 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 68.92 -53.56 0.57 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.642 -0.661 . . . . 0.0 109.866 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.74 -173.36 2.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -134.47 109.79 8.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.759 -0.588 . . . . 0.0 109.596 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 173.6 155.39 0.28 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.0 Cg_exo -53.78 153.51 19.29 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.906 1.737 . . . . 0.0 112.647 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 mt -105.26 134.53 48.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -111.54 132.59 54.41 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' OE1' ' CD2' ' A' ' 27' ' ' LEU . 40.2 mm-40 -89.9 127.87 36.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' ALA . 60.6 ttt85 -125.71 108.72 11.8 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.62 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.55 27.27 2.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.478 -0.764 . . . . 0.0 109.286 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -135.22 155.96 49.79 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.425 0.631 . . . . 0.0 109.544 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' CD2' ' OE1' ' A' ' 22' ' ' GLU . 45.4 mt -106.83 130.62 54.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.594 -0.691 . . . . 0.0 109.662 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.55 130.55 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.374 0.607 . . . . 0.0 109.866 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.8 m -64.46 145.87 55.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.297 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.533 ' H ' ' HG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -57.25 -19.39 21.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 108.978 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.65 8.62 87.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -62.66 -43.68 98.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.947 . . . . 0.0 108.958 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -126.77 -9.14 6.12 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.8 p -141.01 -112.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.773 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.49 19.72 0.51 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.61 157.61 33.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.497 -1.002 . . . . 0.0 109.954 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 38' ' ' TYR . . . -129.59 149.64 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.5 0.667 . . . . 0.0 109.91 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 15.7 m-85 -135.48 127.82 17.88 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.57 167.19 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.119 1.879 . . . . 0.0 111.852 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.82 131.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.508 -0.745 . . . . 0.0 109.048 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -103.4 107.41 18.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.387 -0.821 . . . . 0.0 109.68 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.4 t0 53.18 40.83 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.28 90.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.52 104.47 54.35 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.486 -1.008 . . . . 0.0 109.143 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.82 137.79 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.187 1.925 . . . . 0.0 112.396 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.54 101.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.725 . . . . 0.0 109.326 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 mt -93.71 35.28 1.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.745 0.783 . . . . 0.0 109.724 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.65 -43.46 93.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.583 -0.698 . . . . 0.0 109.745 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 6.5 p-10 -60.62 -33.19 72.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.52 -0.738 . . . . 0.0 109.851 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -92.35 10.83 28.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 109.039 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 145.46 54.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.579 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -111.11 137.26 48.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -87.38 151.62 51.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.578 -0.702 . . . . 0.0 109.327 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.69 145.73 82.16 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.691 2.26 . . . . 0.0 112.463 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.953 -1.023 . . . . 0.0 108.906 179.501 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.95 146.59 93.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.919 2.413 . . . . 0.0 112.518 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 4' ' ' GLU . 62.6 mt -70.7 117.94 12.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.451 -0.781 . . . . 0.0 109.841 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 3' ' ' LEU . 95.4 mt-10 40.77 -123.74 0.47 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.197 0.522 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.47 70.66 0.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.74 . . . . 0.0 109.242 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 73.78 26.78 68.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' GLY . 51.6 tp 56.31 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.89 . . . . 0.0 109.969 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 7' ' ' LEU . 1.7 tp 38.52 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.771 0.796 . . . . 0.0 111.118 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 42.82 79.04 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.455 0.645 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -92.02 129.76 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.438 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.2 mt -104.51 131.78 51.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.664 -0.647 . . . . 0.0 109.315 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.73 145.46 26.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.166 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.7 t -93.74 140.02 22.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.25 33.0 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.001 1.801 . . . . 0.0 111.619 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -153.52 -75.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 109.157 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' C ' ' H ' ' A' ' 18' ' ' ALA . 1.6 p -87.57 7.04 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.6 m80 54.59 12.0 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' CYS . . . -73.9 151.7 88.7 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.167 -0.958 . . . . 0.0 109.721 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' O ' ' OG1' ' A' ' 30' ' ' THR . 36.4 Cg_endo -66.68 163.2 33.94 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.707 2.271 . . . . 0.0 112.305 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -108.71 148.18 30.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -112.73 134.67 54.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.27 125.92 32.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 28' ' ' ILE . 42.6 ttm180 -132.22 117.44 18.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.533 -0.729 . . . . 0.0 109.194 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 52.47 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.247 0.546 . . . . 0.0 110.14 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -136.92 29.43 2.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.12 160.12 41.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.409 -0.807 . . . . 0.0 109.883 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.59 134.5 51.85 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 23' ' ' ARG . 96.8 mt -115.0 130.6 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.404 0.621 . . . . 0.0 109.657 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.5 t -66.97 131.7 46.4 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 110.224 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 70.9 p -77.09 -1.12 27.47 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.279 -0.888 . . . . 0.0 109.03 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 129.47 19.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.81 -39.65 79.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.588 -0.948 . . . . 0.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -84.88 -5.45 59.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.171 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.03 -70.28 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.0 109.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.82 15.13 54.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.1 mt -76.67 149.06 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -1.169 . . . . 0.0 110.256 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.97 144.37 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -129.84 115.29 17.9 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 156.95 32.23 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.269 1.979 . . . . 0.0 112.755 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.93 129.89 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -127.49 131.76 50.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 54.05 27.85 8.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.251 0.548 . . . . 0.0 110.256 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.33 -3.46 79.55 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 tt -138.84 135.42 17.69 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.268 -1.136 . . . . 0.0 109.919 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.03 155.77 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.272 1.982 . . . . 0.0 112.261 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.49 130.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.527 -0.733 . . . . 0.0 109.415 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.35 34.2 2.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.608 -0.682 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -111.39 137.75 48.76 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.818 0.818 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.47 -42.43 93.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.558 -0.714 . . . . 0.0 109.797 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 1.7 p-10 -60.28 -33.86 72.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -92.42 -7.92 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 108.807 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 149.6 49.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 110.044 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -101.76 138.52 38.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.454 -0.779 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -96.37 160.97 28.48 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.09 140.54 40.24 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.291 1.994 . . . . 0.0 112.695 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.794 -1.098 . . . . 0.0 109.04 179.657 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.64 144.33 97.7 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.739 2.293 . . . . 0.0 112.395 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.93 144.05 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.16 0.981 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 47.67 78.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.823 0.82 . . . . 0.0 109.888 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.19 145.0 55.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.644 0.735 . . . . 0.0 110.119 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.2 -83.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.9 mm? -84.45 -1.89 56.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -1.057 . . . . 0.0 109.433 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.16 113.56 24.76 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.737 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 58.95 68.11 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.618 0.723 . . . . 0.0 109.57 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.4 tt -109.0 129.21 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.596 -0.69 . . . . 0.0 109.708 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.78 125.01 49.94 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.724 0.773 . . . . 0.0 109.791 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.46 148.39 22.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.678 0.751 . . . . 0.0 109.317 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.8 t -85.54 125.37 69.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.556 -0.715 . . . . 0.0 109.403 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.15 -21.93 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.963 1.775 . . . . 0.0 111.466 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.63 -25.07 19.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' CYS . 6.9 p -160.55 162.84 33.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.16 1.5 11.09 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 108.931 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.32 123.55 35.96 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.046 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 30' ' ' THR . 52.6 Cg_exo -49.36 163.25 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 0.0 112.615 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -112.0 139.17 47.73 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.636 0.732 . . . . 0.0 109.896 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -113.62 122.69 47.95 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.848 0.833 . . . . 0.0 109.012 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.6 122.71 25.66 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.552 0.691 . . . . 0.0 109.99 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -127.98 117.11 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.638 0.732 . . . . 0.0 109.175 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 52.07 -109.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.479 0.656 . . . . 0.0 110.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.53 26.46 9.86 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -141.74 161.31 38.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.0 mt -111.35 130.3 55.73 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.04 129.84 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.818 0.818 . . . . 0.0 109.791 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.3 131.78 43.94 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 67.9 p -79.81 2.7 22.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.402 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.42 133.42 28.08 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.55 -46.42 76.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.676 -0.896 . . . . 0.0 109.974 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -85.48 -5.16 59.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.4 -69.22 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.07 19.2 2.44 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.21 151.03 41.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.316 -1.108 . . . . 0.0 110.058 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.44 130.53 53.17 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 109.262 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.85 127.36 27.06 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 161.36 28.28 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.9 2.4 . . . . 0.0 112.41 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.87 131.61 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -103.88 104.27 14.23 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.961 0.886 . . . . 0.0 109.797 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 t0 52.82 39.68 29.32 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.878 0.847 . . . . 0.0 110.454 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.17 7.58 79.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mm -111.56 100.37 47.73 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.314 -1.11 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.19 139.7 72.01 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.798 2.332 . . . . 0.0 112.02 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.26 120.74 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.083 -1.011 . . . . 0.0 109.547 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.4 mt -103.61 34.67 2.88 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.1 mt -109.33 128.72 55.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.113 0.959 . . . . 0.0 109.667 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.92 -40.29 87.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.646 0.736 . . . . 0.0 109.586 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.83 -39.67 81.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.568 -0.708 . . . . 0.0 110.166 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.59 -8.07 53.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.955 -1.091 . . . . 0.0 109.198 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 145.78 54.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -103.61 136.64 42.94 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.851 0.834 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 156.82 37.86 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.47 137.31 19.67 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.787 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 9.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 1' ' ' MET . 30.4 Cg_endo -64.11 147.85 91.43 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.516 2.144 . . . . 0.0 112.061 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.5 152.55 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.61 0.719 . . . . 0.0 109.611 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -84.43 16.68 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.432 -0.793 . . . . 0.0 109.135 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 139.65 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.443 -0.786 . . . . 0.0 109.894 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 8' ' ' LEU . . . 156.45 123.32 0.78 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 8.6 mp 54.09 3.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.396 -1.061 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.56 ' H ' ' C ' ' A' ' 6' ' ' GLY . 2.9 tt -63.4 -45.57 90.42 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.115 -0.991 . . . . 0.0 109.219 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -117.19 -52.96 2.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.835 . . . . 0.0 110.169 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.2 122.57 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -0.966 . . . . 0.0 109.552 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.44 153.73 26.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.548 -0.72 . . . . 0.0 109.693 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.41 141.28 41.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.501 -0.749 . . . . 0.0 109.085 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -76.19 170.49 15.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.46 -0.775 . . . . 0.0 109.642 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 72.2 Cg_endo -80.23 -86.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.581 2.187 . . . . 0.0 111.772 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -65.18 -46.36 81.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 24.7 p -93.11 55.03 2.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 108.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 13' ' ' CYS . 86.8 m-70 -41.24 108.94 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 110.763 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -174.07 177.36 0.67 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.586 -0.697 . . . . 0.0 109.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.66 147.79 70.61 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.812 2.341 . . . . 0.0 112.557 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.8 152.15 51.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -122.82 133.99 54.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.8 126.34 32.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.813 -0.554 . . . . 0.0 109.768 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -171.68 157.16 4.57 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.691 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 48.1 t0 56.21 24.27 7.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.618 -0.676 . . . . 0.0 109.344 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . 72.28 15.22 5.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.984 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -142.01 165.61 26.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.8 mt -101.51 119.61 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.7 mt -97.4 131.61 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 m -75.61 143.12 42.48 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.457 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 106.82 4.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.322 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.48 17.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.48 -54.18 43.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.164 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 30.0 p-10 -112.72 7.64 18.67 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 163.89 17.45 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.715 0.769 . . . . 0.0 110.124 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.15 -20.09 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.81 178.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -1.087 . . . . 0.0 110.249 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 139.0 40.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.484 -0.76 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -121.52 120.49 28.81 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.46 164.92 28.07 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.084 1.856 . . . . 0.0 111.852 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.92 132.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -104.61 108.17 19.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 109.538 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.16 38.2 26.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.61 4.39 85.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.2 mt -108.41 104.42 54.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -1.115 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.12 142.11 55.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.092 1.861 . . . . 0.0 112.247 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.23 131.64 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.4 -0.812 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.67 35.38 4.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.4 mt -106.33 131.41 53.58 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.76 0.79 . . . . 0.0 109.424 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.51 -43.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.994 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.54 -38.23 86.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 110.179 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -88.12 -6.45 57.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.057 -1.027 . . . . 0.0 109.242 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.01 46.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.681 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.85 161.2 15.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -90.43 177.1 2.51 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.552 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.8 144.92 99.37 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.17 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.641 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 96.1 mmm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 1' ' ' MET . 51.7 Cg_endo -67.74 145.22 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.704 2.27 . . . . 0.0 112.481 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' GLU . 69.7 mt -98.07 129.4 44.91 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.735 0.779 . . . . 0.0 110.005 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 3' ' ' LEU . 84.7 tt0 51.95 103.8 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.778 0.799 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.42 141.94 58.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.819 0.818 . . . . 0.0 110.105 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.21 42.31 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD2' ' H ' ' A' ' 7' ' ' LEU . 1.3 pt? -77.56 -1.17 29.34 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.655 -0.909 . . . . 0.0 109.503 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' LEU . 76.5 mt 41.35 91.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.606 0.717 . . . . 0.0 110.406 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.12 138.24 58.49 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.08 0.943 . . . . 0.0 109.762 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -77.67 149.85 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.974 0.892 . . . . 0.0 110.331 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.5 mt -72.72 150.83 42.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.779 0.8 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -128.88 126.66 40.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.215 1.007 . . . . 0.0 109.852 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -60.39 159.7 21.95 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-O 121.361 0.601 . . . . 0.0 109.731 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HG2' ' H ' ' A' ' 15' ' ' ALA . 41.4 Cg_endo -68.84 -79.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.614 2.21 . . . . 0.0 111.847 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -58.43 -46.7 85.97 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -104.89 164.94 11.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 109.422 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 49.3 p-80 -115.88 105.58 12.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.868 0.842 . . . . 0.0 110.1 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.26 176.51 0.57 Allowed Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 109.428 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' A' ' 30' ' ' THR . 9.9 Cg_exo -70.1 155.69 64.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.957 2.438 . . . . 0.0 113.013 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.88 139.22 49.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.79 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -111.62 126.73 55.32 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.188 0.994 . . . . 0.0 109.399 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.5 mp0 -79.42 141.95 36.38 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.652 0.739 . . . . 0.0 110.558 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.9 tpt180 -143.93 161.46 38.66 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.863 0.84 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . 67.2 t0 -42.6 116.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.586 0.708 . . . . 0.0 110.604 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 24' ' ' ASP . . . 37.0 35.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.763 0.792 . . . . 0.0 110.047 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' CD ' ' NH2' ' A' ' 53' ' ' ARG . 68.9 tt0 -159.81 157.1 28.65 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.058 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.6 mt -126.32 127.59 45.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.573 0.701 . . . . 0.0 109.405 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 98.4 mt -106.8 125.77 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-O 121.923 0.868 . . . . 0.0 109.745 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -73.51 120.17 18.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.781 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -81.7 170.88 15.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.807 0.813 . . . . 0.0 110.184 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 148.71 21.98 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.34 -36.61 68.86 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.781 -0.834 . . . . 0.0 109.351 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.92 -5.23 47.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.739 . . . . 0.0 109.242 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.9 m -102.18 -117.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.3 -7.88 62.24 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.8 mt -68.4 149.71 49.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.987 . . . . 0.0 110.321 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.48 145.42 49.54 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -130.46 115.82 17.3 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.33 164.58 26.43 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.587 2.192 . . . . 0.0 111.941 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -103.32 132.11 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.715 0.769 . . . . 0.0 109.814 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -121.61 129.46 52.84 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.689 0.757 . . . . 0.0 109.638 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 57.33 30.82 19.14 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.511 0.672 . . . . 0.0 109.351 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.84 85.43 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.08 130.32 24.01 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.763 -0.845 . . . . 0.0 109.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.02 141.58 40.44 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.579 2.186 . . . . 0.0 112.09 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.8 t -90.07 128.18 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.71 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -117.79 30.17 7.42 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.297 1.046 . . . . 0.0 109.575 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.11 -42.94 95.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.722 -0.611 . . . . 0.0 109.691 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.89 -17.13 64.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.518 -0.739 . . . . 0.0 109.4 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.63 -12.61 18.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.36 -0.838 . . . . 0.0 108.772 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . -57.14 142.73 41.52 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' NH2' ' CD ' ' A' ' 26' ' ' GLU . 89.2 mtm180 -105.87 146.43 29.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.706 0.765 . . . . 0.0 109.728 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 11.4 mpt_? -83.14 151.76 63.83 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.944 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.11 149.78 76.84 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.759 2.306 . . . . 0.0 112.665 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.523 179.33 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.15 140.21 92.13 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.732 2.288 . . . . 0.0 112.102 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.64 123.29 48.72 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.421 0.629 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 58.2 mp0 -92.23 123.86 35.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.648 -0.657 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 7' ' ' LEU . . . -170.47 131.04 0.9 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.42 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.93 6.85 6.07 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 10.4 mp -83.13 -10.22 58.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 0.0 109.109 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.99 147.02 49.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.538 -0.726 . . . . 0.0 110.455 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -57.66 139.28 54.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.762 -0.586 . . . . 0.0 109.741 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -135.37 132.68 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.475 0.655 . . . . 0.0 109.944 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.33 148.2 47.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.732 -0.605 . . . . 0.0 109.898 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.73 133.53 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.637 -0.664 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -90.1 153.72 46.98 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.684 -0.635 . . . . 0.0 110.266 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' CYS . 36.5 Cg_endo -65.28 141.91 70.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.663 2.242 . . . . 0.0 111.99 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.45 -12.59 0.51 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.603 -0.686 . . . . 0.0 109.243 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -136.54 -167.76 2.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 108.948 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 17' ' ' HIS . 56.5 t-80 -140.95 24.97 2.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.652 -0.655 . . . . 0.0 109.285 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.605 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -99.89 171.8 5.24 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.516 -0.74 . . . . 0.0 109.819 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 30' ' ' THR . 55.4 Cg_endo -77.99 178.12 7.97 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.238 1.959 . . . . 0.0 112.852 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.0 144.09 44.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.635 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -111.41 111.65 22.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.75 132.29 41.5 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.179 0.514 . . . . 0.0 110.014 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -141.53 124.91 16.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.5 -111.6 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.83 -0.544 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.4 34.69 4.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -152.47 155.69 37.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.0 109.827 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 131.29 56.38 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 28' ' ' ILE . 30.0 mm -104.27 130.33 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.46 0.648 . . . . 0.0 109.84 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 t -63.13 114.93 4.04 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.7 m -68.49 144.33 54.67 Favored 'General case' 0 C--O 1.209 -1.061 0 O-C-N 121.158 -0.964 . . . . 0.0 110.328 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.59 145.9 8.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -65.57 -41.39 92.95 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -86.9 -1.09 57.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 30' ' ' THR . 2.2 m -89.35 -79.24 0.33 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.626 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 64.37 -93.38 0.14 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.626 ' O ' ' O ' ' A' ' 35' ' ' GLY . 3.3 mm? 24.74 111.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.069 0.938 . . . . 0.0 111.708 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.27 123.74 44.87 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.52 -0.738 . . . . 0.0 109.335 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -108.0 104.62 54.09 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.67 160.81 28.02 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.288 1.992 . . . . 0.0 112.246 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.76 131.06 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -121.69 127.16 50.45 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.362 0.601 . . . . 0.0 109.584 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 51.7 t0 58.08 26.4 13.57 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.47 0.652 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.66 5.4 89.49 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.63 130.02 23.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.928 . . . . 0.0 109.834 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.32 143.18 47.39 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.367 2.045 . . . . 0.0 112.633 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.69 112.44 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -102.97 18.79 20.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.5 mt -107.88 128.74 54.89 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.638 0.732 . . . . 0.0 109.521 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.7 -41.37 92.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.341 0.591 . . . . 0.0 109.668 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.14 -42.66 81.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.921 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -89.06 -4.84 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.62 156.74 37.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.949 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.5 138.64 39.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.504 -0.748 . . . . 0.0 109.97 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -89.9 155.05 47.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.555 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -45.7 139.69 10.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.377 2.051 . . . . 0.0 112.797 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.989 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 4.4 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 1' ' ' MET . 30.8 Cg_endo -60.86 146.66 97.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.323 2.015 . . . . 0.0 112.317 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.469 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -77.41 146.91 36.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.424 -0.797 . . . . 0.0 109.45 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 58.6 mp0 -68.43 128.69 37.52 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.584 0.707 . . . . 0.0 110.154 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.14 -9.11 58.83 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.522 -0.736 . . . . 0.0 109.121 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . -152.48 -134.81 2.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.0 mp 56.06 111.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.68 -0.894 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' LEU . 62.2 mt 46.0 99.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.775 0.798 . . . . 0.0 110.022 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.18 -12.11 47.88 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.13 128.17 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.946 . . . . 0.0 109.637 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.3 mt -107.13 130.0 54.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.643 0.735 . . . . 0.0 109.356 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.98 158.03 16.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -67.36 153.61 94.49 Favored Pre-proline 0 C--N 1.296 -1.758 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.954 -178.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.72 -45.92 37.49 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.92 -61.89 1.67 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.625 . . . . 0.0 109.728 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.39 162.21 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -107.62 103.54 12.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.525 -0.734 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . 176.92 158.12 0.46 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.104 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.54 154.47 71.79 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.725 2.284 . . . . 0.0 112.604 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -106.75 148.44 28.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -106.57 127.38 53.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -75.72 130.81 39.27 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.5 tpt85 -139.03 165.38 27.27 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' H ' ' HG3' ' A' ' 23' ' ' ARG . 67.5 t0 -38.79 103.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.465 0.65 . . . . 0.0 110.411 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 40.6 38.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.428 0.632 . . . . 0.0 110.042 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -157.75 154.28 27.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.935 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -118.94 133.28 55.93 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.25 125.58 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.779 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.69 129.48 41.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -101.62 29.24 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.266 -0.896 . . . . 0.0 108.698 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 34' ' ' CYS . . . -97.95 144.81 17.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.7 -33.46 73.99 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.601 -0.94 . . . . 0.0 109.21 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.66 -3.63 52.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.201 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 11.0 p -144.16 128.52 17.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.71 27.54 2.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.11 157.79 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.451 -1.029 . . . . 0.0 109.89 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.74 141.32 51.93 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.393 0.616 . . . . 0.0 109.723 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-85 -125.02 122.96 25.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.73 161.25 30.75 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.314 2.009 . . . . 0.0 112.487 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -95.77 132.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.126 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -137.21 146.66 45.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.655 -0.653 . . . . 0.0 109.964 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.95 27.28 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.449 0.642 . . . . 0.0 109.675 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.88 7.05 83.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 pt -131.35 149.37 73.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.432 -1.04 . . . . 0.0 109.69 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.33 143.04 51.57 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.624 2.216 . . . . 0.0 112.668 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.25 93.07 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.008 . . . . 0.0 109.005 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 42.49 0.71 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.85 120.19 36.6 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.639 0.733 . . . . 0.0 109.405 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.85 -30.34 49.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 0.0 109.348 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.19 -40.36 97.29 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.32 -6.55 52.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 157.26 27.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 110.011 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -129.48 168.72 15.92 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.813 0.816 . . . . 0.0 109.949 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -76.58 153.52 83.57 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.641 -0.662 . . . . 0.0 109.564 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.16 145.86 89.73 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.721 2.281 . . . . 0.0 112.463 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.129 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.38 -165.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.786 2.324 . . . . 0.0 112.719 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt 58.49 41.69 22.22 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.675 0.75 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -163.52 40.58 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.03 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.0 -10.07 59.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.112 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 92.98 -57.21 2.51 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 6' ' ' GLY . 43.3 tp 58.67 145.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.904 0.859 . . . . 0.0 110.406 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.2 tp -70.0 133.2 47.0 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.468 -0.77 . . . . 0.0 110.179 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.0 137.88 57.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.7 0.762 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 10' ' ' ILE . 96.1 mt -84.07 -4.43 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.46 128.51 47.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.853 . . . . 0.0 109.519 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.8 134.36 24.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.431 -0.793 . . . . 0.0 109.484 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -60.07 156.82 35.44 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.627 -0.671 . . . . 0.0 109.534 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.92 -8.11 22.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.436 2.091 . . . . 0.0 111.22 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.52 -47.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.34 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -69.11 -24.53 64.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 18' ' ' ALA . 36.2 t-80 69.9 -26.65 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.733 -0.604 . . . . 0.0 109.865 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.65 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -48.9 -178.71 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.445 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 18' ' ' ALA . 38.1 Cg_endo -86.14 163.38 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.846 2.364 . . . . 0.0 112.606 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.72 151.3 32.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.178 -0.951 . . . . 0.0 109.359 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -122.24 133.65 54.7 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.544 0.688 . . . . 0.0 109.223 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.09 127.67 33.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.879 -0.513 . . . . 0.0 109.774 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -132.66 116.57 16.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.543 -0.723 . . . . 0.0 109.279 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 51.17 -110.76 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.74 -0.6 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.77 26.31 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.83 161.25 38.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -109.96 129.32 55.68 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.13 131.67 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.543 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -69.49 119.67 14.1 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.528 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 2.8 m -89.99 165.17 14.21 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.53 -176.97 18.9 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.98 -57.35 4.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.533 -0.98 . . . . 0.0 110.103 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -114.01 28.07 9.04 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -78.11 -80.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 62.85 -114.86 7.3 Favored Glycine 0 C--O 1.202 -1.853 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.679 ' O ' ' O ' ' A' ' 35' ' ' GLY . 75.1 mt 41.98 121.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.58 1.181 . . . . 0.0 111.453 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.99 133.34 51.79 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.19 -0.944 . . . . 0.0 109.793 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.42 108.68 45.05 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.335 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.99 161.52 23.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.564 2.176 . . . . 0.0 112.352 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -95.26 132.84 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -105.83 108.16 19.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.24 36.95 28.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.584 0.707 . . . . 0.0 109.658 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.26 87.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -110.18 105.02 56.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.534 -0.98 . . . . 0.0 109.715 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.35 134.08 50.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.0 98.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.78 31.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.368 -0.833 . . . . 0.0 109.422 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.45 126.57 55.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.094 0.949 . . . . 0.0 109.592 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -64.6 -39.93 87.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.602 0.715 . . . . 0.0 109.618 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.5 t0 -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -91.04 -9.73 44.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.272 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.71 38.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 109.948 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -111.76 139.45 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.789 0.804 . . . . 0.0 110.05 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -79.9 158.75 72.39 Favored Pre-proline 0 C--N 1.303 -1.42 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.402 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.75 139.41 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 112.655 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.901 -179.789 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.16 -6.38 17.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.672 2.248 . . . . 0.0 110.812 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.71 135.83 54.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.727 0.775 . . . . 0.0 110.067 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.54 133.78 56.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.803 0.811 . . . . 0.0 110.314 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 6' ' ' GLY . . . -81.03 -6.62 59.01 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . . . -41.88 123.13 3.02 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt -69.1 -9.71 54.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -1.0 . . . . 0.0 109.071 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 4.0 mm? -65.36 -31.86 73.2 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.48 -0.762 . . . . 0.0 109.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.78 -25.23 67.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 pt -108.12 38.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.37 -0.832 . . . . 0.0 109.211 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.68 119.88 40.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.499 -0.751 . . . . 0.0 109.185 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.09 130.84 53.61 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 109.413 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.1 p -58.46 114.93 9.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.689 -0.632 . . . . 0.0 109.723 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -50.26 -9.64 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.237 1.958 . . . . 0.0 111.515 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -100.95 -72.98 0.66 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.225 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -13.64 51.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.374 -0.829 . . . . 0.0 109.277 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 85.9 t60 55.07 88.68 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.847 0.832 . . . . 0.0 109.835 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.643 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -173.01 170.22 2.12 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.421 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.53 153.78 58.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.06 2.506 . . . . 0.0 112.632 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.27 149.19 36.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.0 109.805 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -117.74 135.09 54.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.37 124.14 36.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.271 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 25' ' ' ALA . 69.0 ttp85 -122.8 112.66 18.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 53.98 -87.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.0 110.192 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -139.56 28.62 2.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 108.848 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.62 154.87 49.67 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.705 0.764 . . . . 0.0 109.907 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.11 134.68 47.8 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.794 0.807 . . . . 0.0 110.002 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.77 129.35 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.673 0.749 . . . . 0.0 110.012 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 125.37 25.03 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.03 127.22 55.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.533 -0.729 . . . . 0.0 109.847 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.97 -172.47 39.0 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -73.1 -57.4 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.558 -0.966 . . . . 0.0 110.032 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -89.58 5.8 44.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.073 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.14 168.97 18.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.959 0.885 . . . . 0.0 110.074 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 -10.29 0.18 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -70.54 157.73 37.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 0.0 110.602 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.84 146.51 50.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.07 129.63 22.56 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.93 164.68 31.26 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.326 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -108.11 132.42 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.522 0.677 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -122.72 128.36 50.44 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.911 0.863 . . . . 0.0 110.04 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 57.52 28.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.72 0.771 . . . . 0.0 109.918 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 3.99 90.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.54 131.41 23.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.5 -1.0 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.06 145.14 54.52 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.592 2.195 . . . . 0.0 112.583 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 83.5 t -89.38 123.91 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.546 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.58 32.26 5.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.2 mt -102.53 132.51 48.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.32 -41.1 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.613 0.721 . . . . 0.0 109.764 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.5 -40.13 86.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.945 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.77 7.96 16.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.99 -1.069 . . . . 0.0 109.247 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.13 58.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.691 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.93 120.43 41.89 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.716 0.77 . . . . 0.0 109.159 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -84.61 151.23 58.26 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 56' ' ' GLU . 54.1 Cg_endo -67.14 146.26 75.82 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.764 2.309 . . . . 0.0 112.801 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 55' ' ' PRO . 80.4 mm-40 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.899 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 2' ' ' PRO . 9.9 mmt . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -14.65 -111.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 123.907 3.071 . . . . 0.0 114.992 -176.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.5 mt -75.74 123.66 25.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 118.993 -2.317 . . . . 0.0 112.35 -177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -97.44 -13.74 21.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.11 -25.89 68.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 109.06 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.3 -24.08 63.05 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.59 -40.32 96.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 109.367 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.15 145.5 46.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.989 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.42 97.71 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.44 137.21 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.534 -0.729 . . . . 0.0 109.27 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt -68.74 150.44 47.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.21 150.44 36.13 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.559 0.695 . . . . 0.0 109.881 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -68.69 163.58 53.55 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.23 -83.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.389 2.059 . . . . 0.0 112.057 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.8 77.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.091 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 30.1 p -97.19 66.34 2.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -41.58 119.13 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.508 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.99 159.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.464 -0.772 . . . . 0.0 109.187 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.94 137.34 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.962 1.775 . . . . 0.0 112.802 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.4 mt -112.65 148.59 34.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.53 -0.731 . . . . 0.0 110.087 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -113.54 117.66 32.28 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -98.8 123.45 43.05 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.554 -0.716 . . . . 0.0 109.596 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' ALA . 10.3 ptp180 -128.85 125.95 38.76 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.633 -0.667 . . . . 0.0 109.36 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.88 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.316 0.579 . . . . 0.0 109.593 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.43 28.71 1.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -135.48 139.52 44.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.6 -0.687 . . . . 0.0 109.253 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.73 135.78 50.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.622 -0.674 . . . . 0.0 109.555 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.7 132.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.433 0.635 . . . . 0.0 110.121 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.3 m -58.08 123.88 17.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.64 -20.17 17.82 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.05 -1.031 . . . . 0.0 108.62 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.33 137.48 35.36 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.73 -14.5 52.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.238 -1.154 . . . . 0.0 108.882 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -80.11 -4.22 51.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.355 -0.841 . . . . 0.0 109.138 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.02 165.81 35.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.926 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.65 17.01 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.64 159.44 34.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.486 -1.008 . . . . 0.0 109.996 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.32 144.29 49.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.574 0.702 . . . . 0.0 110.275 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 12.1 m-85 -129.86 127.18 22.76 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.15 158.31 30.19 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.168 1.912 . . . . 0.0 111.916 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.72 131.21 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -104.36 108.77 20.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.501 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 53.39 36.86 24.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.8 87.3 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mt -111.04 108.36 57.48 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.4 -1.059 . . . . 0.0 109.387 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.44 135.02 53.95 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.831 1.687 . . . . 0.0 112.121 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -92.81 95.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 108.966 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.1 mt -89.29 64.23 6.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.1 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -121.33 125.77 47.81 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.747 0.784 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.63 -43.51 98.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.72 -40.26 94.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.77 -4.68 59.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.002 -1.061 . . . . 0.0 109.49 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.21 142.57 30.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.135 -0.978 . . . . 0.0 109.601 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -106.04 141.73 36.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 0.0 109.281 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.55 150.63 49.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.0 109.295 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -38.43 136.31 0.63 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.505 2.137 . . . . 0.0 112.873 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.552 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 7.2 mtt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 18.1 Cg_endo -58.77 145.44 96.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.036 1.824 . . . . 0.0 111.963 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' GLY . 76.0 mt -74.82 141.41 44.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.664 0.745 . . . . 0.0 110.368 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 44.0 -127.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.585 -0.697 . . . . 0.0 110.14 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.75 -10.2 59.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.472 -0.768 . . . . 0.0 109.672 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 3' ' ' LEU . . . 82.4 72.6 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.9 mm? -78.52 134.34 37.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 109.606 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' GLU . 78.0 mt -75.91 144.46 41.1 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.595 0.712 . . . . 0.0 110.311 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 8' ' ' LEU . 49.1 tp10 51.14 99.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -104.99 -23.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.213 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.86 141.48 28.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 109.333 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.79 147.27 27.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.511 -0.743 . . . . 0.0 109.182 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.8 m -59.41 151.07 61.65 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.56 -22.48 58.41 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.04 1.827 . . . . 0.0 111.672 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.93 -30.64 2.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.266 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -168.1 1.63 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.399 -0.813 . . . . 0.0 109.141 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -125.15 19.51 8.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.549 -0.719 . . . . 0.0 109.537 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -95.42 -177.75 0.69 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 18' ' ' ALA . 48.2 Cg_endo -86.73 167.04 8.64 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 113.36 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -112.13 150.04 31.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.135 -0.978 . . . . 0.0 109.647 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -128.46 121.03 28.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.75 135.43 37.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ALA . 78.6 ttt-85 -128.87 104.61 7.71 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 99.0 m-20 -22.28 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 O-C-N 123.59 0.556 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . 155.38 -30.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -178.08 -174.15 0.41 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.706 0.765 . . . . 0.0 110.784 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -105.26 129.58 53.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 131.48 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.681 . . . . 0.0 109.271 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 t -74.87 122.79 23.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.2 m -84.46 157.4 21.36 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.05 -1.031 . . . . 0.0 109.342 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.11 167.67 13.82 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -75.91 -55.11 5.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 109.757 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -80.52 -2.93 48.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 30' ' ' THR . 57.1 m -81.25 -114.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.528 -0.733 . . . . 0.0 109.805 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 36' ' ' LEU . . . 86.68 -62.45 4.25 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' GLY . 66.8 mt -9.43 125.59 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.637 0.732 . . . . 0.0 111.932 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 130.84 55.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.316 -0.865 . . . . 0.0 109.522 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -113.04 119.85 41.7 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.87 164.92 22.53 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.163 1.909 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.24 131.15 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -119.82 126.32 50.7 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.528 0.68 . . . . 0.0 109.697 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.0 t0 56.23 28.39 13.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.68 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -0.08 89.7 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 44' ' ' ILE . 26.3 mm -107.1 131.02 22.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -1.188 . . . . 0.0 109.139 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.32 142.74 27.28 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.306 2.004 . . . . 0.0 112.132 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.63 94.75 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 109.087 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -85.27 39.88 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.346 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.2 mt -111.61 128.0 55.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.784 0.802 . . . . 0.0 109.788 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.75 -41.67 90.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -57.98 -41.21 82.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -90.27 -5.86 55.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.009 -1.057 . . . . 0.0 109.516 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.83 48.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -104.32 143.48 32.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.454 0.645 . . . . 0.0 109.674 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -95.27 113.85 62.49 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.701 -0.624 . . . . 0.0 109.435 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -52.57 143.29 46.42 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.864 1.709 . . . . 0.0 112.805 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.518 179.219 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.34 -46.67 30.76 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.42 2.08 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tt -170.51 114.65 0.46 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.808 . . . . 0.0 108.992 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.33 137.53 57.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.08 46.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.68 . . . . 0.0 110.272 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.82 -78.66 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 9.8 mp -73.63 146.3 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.1 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.9 mm? -69.38 133.81 48.26 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.554 0.693 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.89 -8.14 38.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 tt -47.07 129.07 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 109.707 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -77.51 146.5 36.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.617 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.16 141.24 22.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.98 159.02 58.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.397 -0.814 . . . . 0.0 109.813 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.804 2.336 . . . . 0.0 112.012 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.52 -48.25 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.911 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -99.58 159.89 14.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.286 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.522 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 47.3 p-80 -108.58 112.09 24.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.546 -0.721 . . . . 0.0 109.9 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 164.82 156.78 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' O ' ' OG1' ' A' ' 30' ' ' THR . 56.2 Cg_endo -71.01 163.31 39.7 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.688 2.259 . . . . 0.0 111.985 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.4 147.75 45.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.638 -0.664 . . . . 0.0 109.292 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.59 126.82 52.58 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.97 122.75 31.95 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.214 0.53 . . . . 0.0 109.845 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.92 161.26 4.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 52.95 31.48 10.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.35 22.64 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.76 159.47 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.518 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 mp -106.84 125.32 50.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.6 mt -101.82 128.85 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 129.57 38.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.561 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 70.2 p -84.59 170.9 12.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 110.172 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 145.8 16.14 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -68.32 -53.74 22.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.618 -0.931 . . . . 0.0 109.7 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.87 -5.52 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -0.791 . . . . 0.0 109.709 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 1.3 t -116.96 87.47 2.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.32 -141.07 9.14 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt 74.45 160.6 0.23 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.849 0.833 . . . . 0.0 109.759 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.81 150.73 35.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.838 . . . . 0.0 109.54 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.3 m-85 -115.56 134.08 22.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.99 161.5 41.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.044 1.829 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.37 131.85 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -112.44 120.69 42.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.632 -0.668 . . . . 0.0 109.601 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.9 t0 57.16 22.67 7.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.11 -2.28 71.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.87 124.12 39.85 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.396 -1.061 . . . . 0.0 109.151 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.44 142.12 40.06 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.044 1.829 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 t -88.98 118.93 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.074 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.6 mt -100.33 32.22 3.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.477 -0.764 . . . . 0.0 109.317 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.9 mt -107.09 129.07 54.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.942 0.877 . . . . 0.0 109.471 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.74 -42.15 94.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.63 -20.08 53.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.495 -0.753 . . . . 0.0 110.162 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -102.19 2.62 37.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 0.0 108.986 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 145.97 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.812 . . . . 0.0 109.645 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -119.22 141.72 48.65 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.55 0.69 . . . . 0.0 109.347 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 3.0 mtp180 -89.77 177.55 2.38 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' GLU . 36.5 Cg_exo -59.61 145.86 96.89 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.657 2.238 . . . . 0.0 112.508 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' PRO . 10.1 tm-20 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.675 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.554 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.35 113.18 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.028 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.03 -41.08 99.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.19 140.8 0.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.784 0.802 . . . . 0.0 109.928 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.02 88.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.79 0.805 . . . . 0.0 109.84 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.4 156.11 52.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.47 128.2 34.66 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.805 0.812 . . . . 0.0 110.047 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.33 -42.47 96.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 59.55 106.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.696 0.76 . . . . 0.0 110.099 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.21 149.22 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.785 0.802 . . . . 0.0 110.158 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.5 mt -68.85 135.26 50.84 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.864 0.84 . . . . 0.0 110.099 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.42 153.95 29.7 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.832 0.825 . . . . 0.0 109.912 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -74.64 150.39 86.59 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.841 -0.537 . . . . 0.0 110.117 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.56 -11.34 26.2 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.766 2.311 . . . . 0.0 111.321 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.0 -53.25 0.98 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.636 -0.665 . . . . 0.0 109.452 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.529 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.47 -29.29 69.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.463 -0.773 . . . . 0.0 109.26 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 63.31 -1.44 0.55 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . -79.38 169.33 20.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.543 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.2 153.12 71.99 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.362 2.042 . . . . 0.0 112.439 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.2 mt -111.75 152.69 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.725 0.774 . . . . 0.0 109.703 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' CG ' ' OG1' ' A' ' 30' ' ' THR . 68.3 mm-40 -127.44 139.42 52.83 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.951 0.882 . . . . 0.0 109.734 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.29 128.39 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.57 0.7 . . . . 0.0 109.961 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' ' 24' ' ' ASP . 76.3 ttt180 -124.52 156.92 36.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 23' ' ' ARG . 35.0 t0 17.17 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.637 0.732 . . . . 0.0 110.705 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.6 29.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.637 -0.665 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 54.7 mp0 -144.56 167.27 22.92 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 0.0 110.053 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -97.16 134.56 40.32 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.345 0.593 . . . . 0.0 109.856 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 28' ' ' ILE . 48.8 mm -118.51 131.38 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.924 0.868 . . . . 0.0 110.183 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' OH ' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -70.07 127.71 33.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.447 ' OG1' ' CG ' ' A' ' 21' ' ' GLU . 89.1 m -120.24 125.27 47.72 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.818 0.818 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.23 -163.84 37.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.07 -58.14 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.651 -0.911 . . . . 0.0 109.732 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -96.86 15.06 23.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.51 163.54 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.906 0.86 . . . . 0.0 110.014 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.56 -11.31 0.1 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.24 162.37 14.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 110.169 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.67 142.17 48.96 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.657 0.742 . . . . 0.0 109.684 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -127.94 128.13 23.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.92 166.61 26.58 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.391 2.061 . . . . 0.0 112.379 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -94.04 128.71 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.8 0.809 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -137.89 141.8 40.65 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.63 27.31 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.545 0.688 . . . . 0.0 109.636 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.91 10.84 85.01 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.81 149.55 64.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.466 -1.02 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.18 147.52 54.03 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.371 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 48' ' ' LEU . 97.7 t -84.16 96.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.749 0.785 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.86 38.3 0.45 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 46' ' ' VAL . 53.4 mt -115.71 119.27 35.51 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.155 0.978 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 m -66.04 -29.86 48.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.586 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.98 -43.56 95.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.729 -0.607 . . . . 0.0 109.938 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.7 mp0 -92.05 -4.09 54.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.08 151.42 47.06 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.533 0.682 . . . . 0.0 110.092 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -103.84 143.11 33.26 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.931 0.872 . . . . 0.0 110.024 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 155.92 37.21 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' GLU . 51.0 Cg_exo -47.55 138.96 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.478 2.119 . . . . 0.0 112.949 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' PRO . 80.8 tt0 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.769 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 61.7 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 1' ' ' MET . 55.2 Cg_endo -69.72 147.8 63.91 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.674 2.25 . . . . 0.0 112.499 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 4' ' ' GLU . 63.0 mt 54.94 -176.13 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.779 0.8 . . . . 0.0 110.313 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' LEU . 71.4 mm-40 55.09 163.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.848 0.832 . . . . 0.0 110.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -169.05 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.69 158.5 21.88 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.2 143.05 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.684 -0.892 . . . . 0.0 110.003 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.51 144.27 46.23 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.973 0.892 . . . . 0.0 110.118 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 57.8 mp0 -84.49 -108.4 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.344 0.592 . . . . 0.0 110.071 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.9 pt -92.85 141.44 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.985 0.898 . . . . 0.0 110.36 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 153.06 20.89 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.917 0.865 . . . . 0.0 109.918 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.66 147.86 30.44 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.932 0.872 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.696 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -59.36 159.52 15.94 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-O 121.45 0.643 . . . . 0.0 109.771 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.81 -79.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.607 2.204 . . . . 0.0 112.363 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.78 98.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.456 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.942 0.877 . . . . 0.0 109.951 -179.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.78 104.45 15.23 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.676 0.751 . . . . 0.0 109.495 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.696 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.86 155.49 1.05 Allowed Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 164.05 35.23 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.706 2.27 . . . . 0.0 113.001 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.21 151.21 33.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.588 0.708 . . . . 0.0 109.596 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -124.89 120.75 32.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.002 0.906 . . . . 0.0 109.604 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -81.13 135.9 35.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.967 0.889 . . . . 0.0 110.211 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -167.59 143.86 4.16 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.846 0.831 . . . . 0.0 109.973 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 54.0 36.42 24.45 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.254 0.549 . . . . 0.0 109.923 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.36 18.6 11.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.806 -0.559 . . . . 0.0 109.562 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' CD ' HH22 ' A' ' 53' ' ' ARG . 94.3 mt-10 -132.67 159.63 39.04 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.719 0.771 . . . . 0.0 109.679 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.46 126.3 48.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.7 . . . . 0.0 109.909 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.3 mt -108.58 127.3 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.734 0.778 . . . . 0.0 109.686 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.52 119.87 13.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.1 m -105.82 113.13 26.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.659 0.742 . . . . 0.0 109.652 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.53 169.26 42.21 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.62 -50.51 62.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.726 -0.867 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.3 -0.41 49.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.465 -0.772 . . . . 0.0 108.982 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.58 -171.35 3.27 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.721 0.772 . . . . 0.0 110.149 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.99 -9.07 0.96 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.85 160.59 22.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.328 -1.101 . . . . 0.0 110.5 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.88 138.8 48.56 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.58 0.705 . . . . 0.0 109.407 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -124.31 125.07 25.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.28 166.22 24.7 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.412 2.075 . . . . 0.0 112.348 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.16 131.14 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.568 0.699 . . . . 0.0 109.438 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -118.88 120.17 36.52 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.889 0.852 . . . . 0.0 109.76 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 56.87 33.55 23.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.451 0.643 . . . . 0.0 109.797 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.46 -2.36 82.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 44' ' ' ILE . 18.0 mm -99.86 122.85 49.52 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.521 -0.988 . . . . 0.0 109.575 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.17 144.94 27.06 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.676 2.251 . . . . 0.0 112.825 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.6 t -88.5 128.05 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.607 0.718 . . . . 0.0 109.361 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.4 mt -118.4 25.33 10.37 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.12 130.48 46.27 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.316 1.055 . . . . 0.0 109.481 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.85 -42.29 94.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.645 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.19 -38.38 88.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.499 -0.75 . . . . 0.0 109.68 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.0 -8.0 58.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.127 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 146.22 54.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.731 0.777 . . . . 0.0 109.971 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.548 HH22 ' CD ' ' A' ' 26' ' ' GLU . 90.9 mtm180 -102.13 139.34 37.88 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.721 0.772 . . . . 0.0 110.008 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -89.61 151.9 46.45 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.94 145.42 90.08 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.532 2.155 . . . . 0.0 112.689 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 C--N 1.3 -1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.3 179.468 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.593 0.711 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.02 162.45 7.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.363 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -59.81 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.442 2.095 . . . . 0.0 112.239 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -51.24 2.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.452 -0.78 . . . . 0.0 109.469 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.0 p -73.11 65.0 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' CYS . 53.9 t-80 -37.89 112.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.004 0.907 . . . . 0.0 110.497 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.45 168.72 1.93 Allowed Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.965 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 32.8 Cg_exo -56.01 145.93 71.94 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.883 2.389 . . . . 0.0 112.759 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 13' ' ' CYS . 76.6 mt -121.15 145.15 48.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.0 109.547 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -121.87 121.15 36.5 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.836 0.827 . . . . 0.0 109.081 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.93 137.53 34.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.74 -0.6 . . . . 0.0 109.977 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -139.3 115.02 10.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.027 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.8 -112.93 0.66 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.501 0.667 . . . . 0.0 110.602 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.73 27.03 10.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 108.901 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 41.3 mp0 -141.28 154.7 45.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.135 -0.978 . . . . 0.0 109.355 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.25 134.66 54.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.93 132.95 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.551 0.691 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.36 132.97 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.462 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.426 ' HG1' ' C ' ' A' ' 19' ' ' PRO . 11.7 p -124.2 136.85 54.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.76 -161.31 32.21 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.61 -57.51 3.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -1.053 . . . . 0.0 110.056 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -95.41 4.57 53.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.184 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -74.56 178.06 5.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.38 -5.13 1.83 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -74.7 155.75 37.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -1.084 . . . . 0.0 110.419 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.8 139.2 53.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-85 -127.33 109.74 21.25 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 157.06 28.58 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -91.75 132.21 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -0.959 . . . . 0.0 109.698 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -118.11 126.32 52.01 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.463 0.649 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 56.3 29.23 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.803 0.811 . . . . 0.0 110.085 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.31 5.34 90.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.0 mt -112.7 131.25 22.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.417 -1.049 . . . . 0.0 109.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 154.33 49.04 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.538 2.158 . . . . 0.0 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.34 122.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.44 ' C ' HD22 ' A' ' 48' ' ' LEU . 89.3 mt -113.09 21.39 15.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' C ' ' A' ' 47' ' ' LEU . 4.2 mm? -100.19 129.19 46.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.493 1.139 . . . . 0.0 109.924 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.46 -42.28 94.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -62.22 -37.92 87.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.658 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 -9.36 58.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.768 -1.207 . . . . 0.0 109.159 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.16 145.17 37.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -106.83 147.0 30.25 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.807 0.813 . . . . 0.0 109.966 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 9.9 mpt_? -86.17 156.07 57.43 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.696 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo . . . . . 0 N--CA 1.491 1.327 0 C-N-CA 122.344 2.03 . . . . 0.0 112.774 179.244 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.807 0.813 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.581 ' H ' ' HA ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -126.58 168.55 14.09 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-O 122.062 0.934 . . . . 0.0 109.749 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' CYS . 23.8 Cg_exo -63.3 141.59 82.49 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.44 2.094 . . . . 0.0 113.045 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.27 15.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.321 0.582 . . . . 0.0 109.56 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . 29.5 p -172.86 123.4 0.43 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.444 0.64 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.581 ' HA ' ' H ' ' A' ' 13' ' ' CYS . 51.7 p-80 -111.38 115.95 30.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.806 0.813 . . . . 0.0 110.057 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -176.27 173.14 0.87 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-O 121.365 0.602 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 43.2 Cg_exo -54.43 147.26 47.93 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.751 2.301 . . . . 0.0 112.664 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.577 HD21 ' SG ' ' A' ' 13' ' ' CYS . 83.4 mt -120.66 141.08 50.71 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.032 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -127.06 135.61 51.03 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.86 0.838 . . . . 0.0 109.687 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -83.4 137.12 34.07 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.669 0.747 . . . . 0.0 110.184 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -173.02 153.87 2.66 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.81 0.814 . . . . 0.0 110.128 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 96.8 m-20 54.52 33.25 18.52 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.304 0.573 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.52 19.02 11.66 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -142.16 175.29 9.86 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.635 0.731 . . . . 0.0 110.052 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.71 124.43 48.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.543 0.687 . . . . 0.0 109.548 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.61 137.4 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.914 0.864 . . . . 0.0 110.179 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.7 m -73.27 124.82 26.42 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 m -114.49 108.17 16.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.729 0.776 . . . . 0.0 109.957 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.44 48.41 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.5 -54.8 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.727 -0.866 . . . . 0.0 109.405 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.47 -2.26 31.17 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -93.61 113.71 25.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.516 -0.74 . . . . 0.0 109.553 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 9.79 0.89 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.84 156.49 38.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.42 131.52 56.74 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.754 0.788 . . . . 0.0 109.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.94 117.82 35.12 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.42 165.39 29.26 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.522 2.148 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.04 134.47 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.675 0.75 . . . . 0.0 110.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -101.48 103.81 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.732 0.777 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 54.33 36.4 25.2 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.423 0.63 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.61 72.09 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.17 98.93 44.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 122.018 -0.696 . . . . 0.0 109.285 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.23 134.6 64.72 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.647 2.232 . . . . 0.0 112.189 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.45 96.73 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.592 0.71 . . . . 0.0 109.413 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.0 mt -77.24 45.58 0.46 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.38 133.03 53.56 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.187 0.994 . . . . 0.0 109.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.14 -36.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.9 -39.85 90.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.595 -0.691 . . . . 0.0 109.358 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 51.0 mp0 -90.92 -6.02 54.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.44 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.98 147.19 50.45 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.489 0.662 . . . . 0.0 109.881 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -117.75 141.08 48.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.011 0.91 . . . . 0.0 110.064 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -94.87 150.95 38.6 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.777 2.318 . . . . 0.0 112.427 179.735 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.677 0.751 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.709 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -79.81 119.19 75.93 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-O 121.212 0.53 . . . . 0.0 109.754 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 52.6 Cg_exo -50.93 144.06 28.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.369 2.046 . . . . 0.0 112.649 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 79.87 -36.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.7 -169.09 1.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.834 0.826 . . . . 0.0 109.792 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -135.89 97.55 3.67 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.739 0.78 . . . . 0.0 109.633 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.07 171.2 1.12 Allowed Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 2.8 Cg_exo -74.79 172.25 16.65 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.9 2.4 . . . . 0.0 112.652 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.8 mt -114.48 134.26 55.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.699 -0.626 . . . . 0.0 109.618 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 30' ' ' THR . 6.1 pt-20 -111.21 135.48 51.68 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.853 0.835 . . . . 0.0 109.299 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -97.6 133.98 41.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.535 0.684 . . . . 0.0 110.451 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 124.85 27.79 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.85 0.833 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 49.74 -113.68 0.65 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.286 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.51 23.36 13.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.593 -0.692 . . . . 0.0 109.2 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.71 162.0 36.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.705 . . . . 0.0 110.064 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.74 148.13 38.76 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.895 0.855 . . . . 0.0 109.726 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.48 152.1 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.27 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -68.19 131.24 45.04 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.086 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 21' ' ' GLU . 3.1 m -91.65 166.91 12.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.092 0.948 . . . . 0.0 110.109 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 30' ' ' THR . . . 85.26 147.86 9.73 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.641 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 1.8 pm0 -75.5 -10.33 59.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.755 -0.85 . . . . 0.0 108.781 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.8 -4.73 55.68 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 34.9 m -129.46 -145.09 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.572 0.701 . . . . 0.0 109.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 148.41 -15.07 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -49.52 149.07 2.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.773 -0.839 . . . . 0.0 110.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . . . -113.66 135.4 53.96 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.659 0.742 . . . . 0.0 109.662 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -124.59 105.88 30.07 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.99 173.3 12.9 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.232 1.955 . . . . 0.0 111.977 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.17 132.34 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.507 0.67 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -124.94 126.4 45.44 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.933 0.873 . . . . 0.0 109.847 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.5 t0 57.54 27.68 14.44 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.446 0.641 . . . . 0.0 109.772 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.06 6.26 89.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.92 130.3 24.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.849 -0.795 . . . . 0.0 109.698 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.92 150.5 61.25 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.681 2.254 . . . . 0.0 112.676 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.1 t -91.79 106.68 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 46' ' ' VAL . 4.2 mm? -103.08 14.99 30.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.76 133.17 49.2 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.865 0.84 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.45 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.318 0.58 . . . . 0.0 109.63 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -59.44 -39.75 84.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 0.0 109.842 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.85 -5.49 53.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.091 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 154.46 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.493 0.663 . . . . 0.0 110.169 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.599 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 89.1 mtm180 -100.07 137.58 38.33 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.943 0.878 . . . . 0.0 110.096 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -49.21 167.51 0.21 Allowed Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.903 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo . . . . . 0 C--N 1.311 -1.438 0 C-N-CA 122.127 1.884 . . . . 0.0 112.765 179.911 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -88.36 142.88 31.75 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.269 -0.894 . . . . 0.0 110.171 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 72.4 Cg_endo -72.89 152.64 52.4 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.188 . . . . 0.0 112.988 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 69.41 -69.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.636 0.732 . . . . 0.0 110.777 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -29.41 68.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 0.0 109.489 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 52.63 88.82 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.005 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -171.37 172.05 2.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 24.6 Cg_exo -60.0 148.07 90.45 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.471 2.114 . . . . 0.0 112.588 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.84 142.36 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.927 0.87 . . . . 0.0 110.082 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -110.09 116.84 32.27 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.34 127.71 36.89 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.377 0.608 . . . . 0.0 110.02 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' ASP . 95.6 mtt180 -134.82 132.54 38.78 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 25' ' ' ALA . 5.6 p-10 40.2 -116.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.369 0.604 . . . . 0.0 110.55 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 24' ' ' ASP . . . -111.24 42.07 1.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 109.044 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -153.31 149.54 27.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.2 mp -116.19 134.67 54.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.553 0.692 . . . . 0.0 109.429 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.23 132.04 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.616 0.722 . . . . 0.0 109.966 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -70.72 125.64 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.23 127.78 56.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.571 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.88 -161.18 34.86 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.27 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -79.43 -58.01 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.495 -1.003 . . . . 0.0 109.514 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -95.05 7.67 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.051 -1.03 . . . . 0.0 108.72 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 171.0 15.74 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.41 -6.81 0.34 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.4 154.71 41.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.146 -1.208 . . . . 0.0 110.291 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.97 139.3 54.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 m-85 -124.01 121.26 26.34 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.81 161.86 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.26 131.6 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -103.7 104.57 14.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.866 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.6 t0 53.05 38.74 28.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.902 0.858 . . . . 0.0 110.051 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.64 7.46 78.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -111.84 101.22 50.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.146 -1.208 . . . . 0.0 109.308 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.0 139.99 69.92 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.628 2.218 . . . . 0.0 112.061 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 48' ' ' LEU . 94.2 t -89.43 121.73 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.009 . . . . 0.0 109.54 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 48' ' ' LEU . 49.4 mt -109.4 23.69 14.12 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' H ' HG12 ' A' ' 46' ' ' VAL . 4.3 mm? -100.01 126.27 46.17 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.437 1.113 . . . . 0.0 109.913 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.18 -41.92 92.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.642 0.734 . . . . 0.0 109.525 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.6 t0 -61.14 -34.67 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 109.801 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.6 -11.25 49.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.828 -1.17 . . . . 0.0 109.23 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.97 146.64 26.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.97 . . . . 0.0 110.049 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -112.96 140.6 47.63 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.921 0.867 . . . . 0.0 109.792 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -87.32 153.96 53.97 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.67 -0.644 . . . . 0.0 109.366 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.803 2.335 . . . . 0.0 112.749 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.4 p -68.81 152.37 96.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.3 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 16' ' ' CYS . 39.6 Cg_endo -66.3 145.23 77.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.561 2.174 . . . . 0.0 111.818 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 66.75 -61.17 0.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.575 -0.703 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -89.79 -173.57 3.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.273 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -136.61 109.96 7.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.463 -0.773 . . . . 0.0 109.61 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.85 176.42 0.48 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 7.5 Cg_exo -70.47 159.38 53.08 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.844 2.363 . . . . 0.0 112.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.77 143.94 45.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.46 118.37 30.92 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -80.36 128.65 33.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.504 -0.748 . . . . 0.0 109.206 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -130.68 123.6 29.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.483 -0.761 . . . . 0.0 109.202 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 52.82 -96.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.318 0.58 . . . . 0.0 109.69 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.97 30.08 3.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.28 155.17 46.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.845 . . . . 0.0 109.738 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.3 mt -104.54 128.57 52.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.26 131.34 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.454 0.645 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 34' ' ' CYS . 1.7 t -72.13 123.99 24.05 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 -178.75 4.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.041 -1.037 . . . . 0.0 109.685 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.48 148.68 6.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 24.3 mp0 -75.14 -10.86 59.86 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -1.006 . . . . 0.0 108.831 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.87 -3.53 54.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -142.32 -150.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.259 -0.901 . . . . 0.0 109.791 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 145.5 2.74 0.66 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.16 160.32 32.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -1.142 . . . . 0.0 110.039 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.19 137.75 54.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.664 -0.647 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -121.35 107.96 36.38 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.26 150.5 22.65 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.95 1.767 . . . . 0.0 112.44 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.55 132.82 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -117.59 127.63 54.16 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 55.05 30.52 14.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 109.907 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.51 88.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mt -117.5 131.8 23.89 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.394 -1.062 . . . . 0.0 109.3 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.36 145.73 38.82 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.035 1.823 . . . . 0.0 111.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 48' ' ' LEU . 58.8 t -100.91 127.15 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.71 32.13 6.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 46' ' ' VAL . 72.7 mt -108.2 131.66 54.43 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.977 0.894 . . . . 0.0 109.767 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.93 -42.23 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.5 -19.28 46.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.91 -13.31 16.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.321 -0.862 . . . . 0.0 109.034 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.09 144.98 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.645 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -109.17 139.32 44.24 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -85.82 154.07 58.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.28 1.987 . . . . 0.0 112.899 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.3 p -100.13 116.04 64.92 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.828 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.5 Cg_exo -51.36 146.88 23.35 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.762 1.642 . . . . 0.0 112.79 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 76.41 -35.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.558 -0.714 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -124.95 -166.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 109.137 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.657 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 50.4 p-80 -146.96 111.78 5.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.61 158.76 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.183 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' C ' ' OG1' ' A' ' 30' ' ' THR . 32.1 Cg_exo -56.97 177.41 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.362 2.041 . . . . 0.0 112.829 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt -120.1 141.7 49.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.395 -0.816 . . . . 0.0 109.28 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -122.64 134.23 54.5 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.933 0.873 . . . . 0.0 109.743 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.73 138.76 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.645 -0.66 . . . . 0.0 109.531 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -137.76 122.68 18.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.562 -0.711 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.0 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.413 0.625 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.91 28.12 3.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -139.16 160.95 38.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.342 -0.849 . . . . 0.0 109.564 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.0 mt -109.94 119.54 39.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.5 pt -107.8 144.43 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -0.884 . . . . 0.0 109.655 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -70.93 134.39 47.18 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.529 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' C ' ' A' ' 19' ' ' PRO . 6.3 m -73.63 145.9 45.01 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.304 -0.872 . . . . 0.0 109.935 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 140.44 9.57 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 26.7 mp0 -66.17 -45.61 80.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.624 -0.927 . . . . 0.0 109.692 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 57.8 t0 -78.53 -6.73 56.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -87.36 -46.92 9.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 41.78 -103.73 0.04 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.1 mt 41.2 111.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.229 1.014 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.46 127.63 53.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -0.768 . . . . 0.0 109.674 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -114.79 104.34 54.27 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.56 168.83 19.26 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.093 1.862 . . . . 0.0 111.61 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.39 131.5 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.945 . . . . 0.0 109.375 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 43' ' ' GLY . 62.8 ttm-85 -114.19 130.53 56.62 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 56.78 5.66 0.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.403 -0.81 . . . . 0.0 109.888 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ARG . . . 108.39 -7.68 34.7 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.28 135.0 20.62 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.344 -1.092 . . . . 0.0 109.645 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.36 144.0 32.57 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 112.544 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.93 111.74 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 109.177 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.5 mt -97.47 16.03 21.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.837 . . . . 0.0 108.933 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 48' ' ' LEU . 4.1 mm? -94.22 126.33 39.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 109.588 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.28 -42.36 90.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.635 -0.666 . . . . 0.0 109.753 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.55 -38.04 83.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.2 -6.99 56.47 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.23 -0.919 . . . . 0.0 109.358 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.18 39.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.649 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.72 142.03 33.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.452 -0.78 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -88.2 150.63 47.57 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 109.552 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.498 1.759 0 C-N-CA 122.658 2.239 . . . . 0.0 112.702 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -78.79 153.79 78.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.625 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 38.1 Cg_endo -66.7 143.24 67.04 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.619 2.213 . . . . 0.0 111.779 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 68.92 -53.56 0.57 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.642 -0.661 . . . . 0.0 109.866 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.74 -173.36 2.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 54.6 t-80 -134.47 109.79 8.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.759 -0.588 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 173.6 155.39 0.28 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.0 Cg_exo -53.78 153.51 19.29 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.906 1.737 . . . . 0.0 112.647 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 mt -105.26 134.53 48.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -111.54 132.59 54.41 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' OE1' ' CD2' ' A' ' 27' ' ' LEU . 40.2 mm-40 -89.9 127.87 36.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' ALA . 60.6 ttt85 -125.71 108.72 11.8 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.62 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.55 27.27 2.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.478 -0.764 . . . . 0.0 109.286 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -135.22 155.96 49.79 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.425 0.631 . . . . 0.0 109.544 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' CD2' ' OE1' ' A' ' 22' ' ' GLU . 45.4 mt -106.83 130.62 54.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.594 -0.691 . . . . 0.0 109.662 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.55 130.55 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.374 0.607 . . . . 0.0 109.866 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.8 m -64.46 145.87 55.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.297 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -57.25 -19.39 21.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 108.978 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.65 8.62 87.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -62.66 -43.68 98.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.947 . . . . 0.0 108.958 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -126.77 -9.14 6.12 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.8 p -141.01 -112.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.773 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.49 19.72 0.51 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.61 157.61 33.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.497 -1.002 . . . . 0.0 109.954 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 38' ' ' TYR . . . -129.59 149.64 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.5 0.667 . . . . 0.0 109.91 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 15.7 m-85 -135.48 127.82 17.88 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.57 167.19 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.119 1.879 . . . . 0.0 111.852 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.82 131.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.508 -0.745 . . . . 0.0 109.048 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -103.4 107.41 18.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.387 -0.821 . . . . 0.0 109.68 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.4 t0 53.18 40.83 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.28 90.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.52 104.47 54.35 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.486 -1.008 . . . . 0.0 109.143 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.82 137.79 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.187 1.925 . . . . 0.0 112.396 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.54 101.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.725 . . . . 0.0 109.326 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 mt -93.71 35.28 1.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.745 0.783 . . . . 0.0 109.724 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.65 -43.46 93.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.583 -0.698 . . . . 0.0 109.745 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 6.5 p-10 -60.62 -33.19 72.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.52 -0.738 . . . . 0.0 109.851 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -92.35 10.83 28.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 109.039 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 145.46 54.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.579 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -111.11 137.26 48.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -87.38 151.62 51.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.578 -0.702 . . . . 0.0 109.327 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.496 1.619 0 C-N-CA 122.691 2.26 . . . . 0.0 112.463 179.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.7 t -93.74 140.02 22.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.25 33.0 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.001 1.801 . . . . 0.0 111.619 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -153.52 -75.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 109.157 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' C ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -87.57 7.04 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.6 m80 54.59 12.0 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 16' ' ' CYS . . . -73.9 151.7 88.7 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.167 -0.958 . . . . 0.0 109.721 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.68 163.2 33.94 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.707 2.271 . . . . 0.0 112.305 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -108.71 148.18 30.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -112.73 134.67 54.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.27 125.92 32.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 28' ' ' ILE . 42.6 ttm180 -132.22 117.44 18.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.533 -0.729 . . . . 0.0 109.194 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 52.47 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.247 0.546 . . . . 0.0 110.14 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -136.92 29.43 2.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.12 160.12 41.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.409 -0.807 . . . . 0.0 109.883 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.59 134.5 51.85 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 23' ' ' ARG . 96.8 mt -115.0 130.6 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.404 0.621 . . . . 0.0 109.657 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.5 t -66.97 131.7 46.4 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 110.224 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -77.09 -1.12 27.47 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.279 -0.888 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 129.47 19.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.81 -39.65 79.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.588 -0.948 . . . . 0.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -84.88 -5.45 59.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.171 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -94.03 -70.28 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.0 109.27 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.82 15.13 54.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 34' ' ' CYS . 91.1 mt -76.67 149.06 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -1.169 . . . . 0.0 110.256 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.97 144.37 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -129.84 115.29 17.9 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 156.95 32.23 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.269 1.979 . . . . 0.0 112.755 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.93 129.89 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -127.49 131.76 50.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 54.05 27.85 8.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.251 0.548 . . . . 0.0 110.256 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.33 -3.46 79.55 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 tt -138.84 135.42 17.69 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.268 -1.136 . . . . 0.0 109.919 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.03 155.77 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.272 1.982 . . . . 0.0 112.261 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 48' ' ' LEU . 21.8 t -87.49 130.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.527 -0.733 . . . . 0.0 109.415 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.35 34.2 2.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.608 -0.682 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' H ' HG12 ' A' ' 46' ' ' VAL . 68.7 mt -111.39 137.75 48.76 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.818 0.818 . . . . 0.0 109.595 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.47 -42.43 93.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.558 -0.714 . . . . 0.0 109.797 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 1.7 p-10 -60.28 -33.86 72.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -92.42 -7.92 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 108.807 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 149.6 49.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 110.044 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -101.76 138.52 38.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.454 -0.779 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -96.37 160.97 28.48 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.496 1.649 0 C-N-CA 122.291 1.994 . . . . 0.0 112.695 178.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.678 0.751 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.8 t -85.54 125.37 69.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.556 -0.715 . . . . 0.0 109.403 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.15 -21.93 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.963 1.775 . . . . 0.0 111.466 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . . . -91.63 -25.07 19.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' CYS . 6.9 p -160.55 162.84 33.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.16 1.5 11.09 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 108.931 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.32 123.55 35.96 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.046 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.36 163.25 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 0.0 112.615 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -112.0 139.17 47.73 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.636 0.732 . . . . 0.0 109.896 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -113.62 122.69 47.95 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.848 0.833 . . . . 0.0 109.012 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.6 122.71 25.66 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.552 0.691 . . . . 0.0 109.99 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -127.98 117.11 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.638 0.732 . . . . 0.0 109.175 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 52.07 -109.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.479 0.656 . . . . 0.0 110.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.53 26.46 9.86 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -141.74 161.31 38.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.0 mt -111.35 130.3 55.73 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.04 129.84 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.818 0.818 . . . . 0.0 109.791 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.3 131.78 43.94 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.9 p -79.81 2.7 22.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.42 133.42 28.08 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.55 -46.42 76.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.676 -0.896 . . . . 0.0 109.974 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -85.48 -5.16 59.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -95.4 -69.22 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.07 19.2 2.44 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 34' ' ' CYS . 87.9 mt -73.21 151.03 41.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.316 -1.108 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.44 130.53 53.17 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 109.262 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.85 127.36 27.06 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 161.36 28.28 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.9 2.4 . . . . 0.0 112.41 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.87 131.61 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -103.88 104.27 14.23 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.961 0.886 . . . . 0.0 109.797 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 t0 52.82 39.68 29.32 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.878 0.847 . . . . 0.0 110.454 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.17 7.58 79.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mm -111.56 100.37 47.73 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.314 -1.11 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.19 139.7 72.01 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.798 2.332 . . . . 0.0 112.02 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 48' ' ' LEU . 60.4 t -97.26 120.74 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.083 -1.011 . . . . 0.0 109.547 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.4 mt -103.61 34.67 2.88 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HG12 ' A' ' 46' ' ' VAL . 75.1 mt -109.33 128.72 55.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.113 0.959 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.92 -40.29 87.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.646 0.736 . . . . 0.0 109.586 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.83 -39.67 81.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.568 -0.708 . . . . 0.0 110.166 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.59 -8.07 53.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.955 -1.091 . . . . 0.0 109.198 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 145.78 54.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -103.61 136.64 42.94 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.851 0.834 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 156.82 37.86 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -76.19 170.49 15.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.46 -0.775 . . . . 0.0 109.642 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 72.2 Cg_endo -80.23 -86.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.581 2.187 . . . . 0.0 111.772 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -46.36 81.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 24.7 p -93.11 55.03 2.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 108.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 13' ' ' CYS . 86.8 m-70 -41.24 108.94 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 110.763 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.07 177.36 0.67 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.586 -0.697 . . . . 0.0 109.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.597 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 14.5 Cg_exo -68.66 147.79 70.61 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.812 2.341 . . . . 0.0 112.557 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.8 152.15 51.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -122.82 133.99 54.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.8 126.34 32.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.813 -0.554 . . . . 0.0 109.768 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -171.68 157.16 4.57 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.691 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 48.1 t0 56.21 24.27 7.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.618 -0.676 . . . . 0.0 109.344 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 72.28 15.22 5.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.984 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -142.01 165.61 26.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.8 mt -101.51 119.61 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.7 mt -97.4 131.61 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 m -75.61 143.12 42.48 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.457 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 106.82 4.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.322 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.48 17.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.48 -54.18 43.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.164 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 30.0 p-10 -112.72 7.64 18.67 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -86.28 163.89 17.45 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.715 0.769 . . . . 0.0 110.124 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.15 -20.09 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.81 178.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -1.087 . . . . 0.0 110.249 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 139.0 40.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.484 -0.76 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -121.52 120.49 28.81 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.46 164.92 28.07 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.084 1.856 . . . . 0.0 111.852 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.92 132.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -104.61 108.17 19.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 109.538 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.16 38.2 26.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.61 4.39 85.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.2 mt -108.41 104.42 54.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -1.115 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.12 142.11 55.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.092 1.861 . . . . 0.0 112.247 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 48' ' ' LEU . 69.0 t -95.23 131.64 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.4 -0.812 . . . . 0.0 109.395 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.67 35.38 4.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HG12 ' A' ' 46' ' ' VAL . 67.4 mt -106.33 131.41 53.58 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.76 0.79 . . . . 0.0 109.424 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.51 -43.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.994 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.54 -38.23 86.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 110.179 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -88.12 -6.45 57.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.057 -1.027 . . . . 0.0 109.242 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.01 46.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.681 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.85 161.2 15.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -90.43 177.1 2.51 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.552 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 N--CA 1.498 1.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.17 -179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 122.215 1.007 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -60.39 159.7 21.95 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-O 121.361 0.601 . . . . 0.0 109.731 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.84 -79.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.614 2.21 . . . . 0.0 111.847 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.7 85.97 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -104.89 164.94 11.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 109.422 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 49.3 p-80 -115.88 105.58 12.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.868 0.842 . . . . 0.0 110.1 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.26 176.51 0.57 Allowed Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 109.428 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 9.9 Cg_exo -70.1 155.69 64.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.957 2.438 . . . . 0.0 113.013 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.88 139.22 49.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.79 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -111.62 126.73 55.32 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.188 0.994 . . . . 0.0 109.399 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.5 mp0 -79.42 141.95 36.38 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.652 0.739 . . . . 0.0 110.558 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.9 tpt180 -143.93 161.46 38.66 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.863 0.84 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . 67.2 t0 -42.6 116.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.586 0.708 . . . . 0.0 110.604 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 24' ' ' ASP . . . 37.0 35.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.763 0.792 . . . . 0.0 110.047 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' CD ' ' NH2' ' A' ' 53' ' ' ARG . 68.9 tt0 -159.81 157.1 28.65 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.058 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.6 mt -126.32 127.59 45.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.573 0.701 . . . . 0.0 109.405 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 98.4 mt -106.8 125.77 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-O 121.923 0.868 . . . . 0.0 109.745 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -73.51 120.17 18.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.781 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -81.7 170.88 15.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.807 0.813 . . . . 0.0 110.184 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 148.71 21.98 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.34 -36.61 68.86 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.781 -0.834 . . . . 0.0 109.351 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.92 -5.23 47.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.739 . . . . 0.0 109.242 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 81.9 m -102.18 -117.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.3 -7.88 62.24 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.8 mt -68.4 149.71 49.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.987 . . . . 0.0 110.321 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.48 145.42 49.54 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 52' ' ' ALA . 80.2 m-85 -130.46 115.82 17.3 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.33 164.58 26.43 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.587 2.192 . . . . 0.0 111.941 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -103.32 132.11 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.715 0.769 . . . . 0.0 109.814 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -121.61 129.46 52.84 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.689 0.757 . . . . 0.0 109.638 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 57.33 30.82 19.14 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.511 0.672 . . . . 0.0 109.351 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.84 85.43 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.08 130.32 24.01 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.763 -0.845 . . . . 0.0 109.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.02 141.58 40.44 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.579 2.186 . . . . 0.0 112.09 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 48' ' ' LEU . 89.8 t -90.07 128.18 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.71 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.402 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.2 mt -117.79 30.17 7.42 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' H ' HG12 ' A' ' 46' ' ' VAL . 11.2 mp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.297 1.046 . . . . 0.0 109.575 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.11 -42.94 95.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.722 -0.611 . . . . 0.0 109.691 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.89 -17.13 64.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.518 -0.739 . . . . 0.0 109.4 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.63 -12.61 18.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.36 -0.838 . . . . 0.0 108.772 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . -57.14 142.73 41.52 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' NH2' ' CD ' ' A' ' 26' ' ' GLU . 89.2 mtm180 -105.87 146.43 29.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.706 0.765 . . . . 0.0 109.728 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 11.4 mpt_? -83.14 151.76 63.83 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.944 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 C--N 1.308 -1.595 0 C-N-CA 122.759 2.306 . . . . 0.0 112.665 179.893 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -90.1 153.72 46.98 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.684 -0.635 . . . . 0.0 110.266 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -65.28 141.91 70.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.663 2.242 . . . . 0.0 111.99 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 70.45 -12.59 0.51 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.603 -0.686 . . . . 0.0 109.243 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -136.54 -167.76 2.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 108.948 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 17' ' ' HIS . 56.5 t-80 -140.95 24.97 2.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.652 -0.655 . . . . 0.0 109.285 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -99.89 171.8 5.24 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.516 -0.74 . . . . 0.0 109.819 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.4 Cg_endo -77.99 178.12 7.97 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.238 1.959 . . . . 0.0 112.852 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 13' ' ' CYS . 92.2 mt -115.0 144.09 44.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.635 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -111.41 111.65 22.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.8 pt-20 -74.75 132.29 41.5 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.179 0.514 . . . . 0.0 110.014 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -141.53 124.91 16.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.5 -111.6 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.83 -0.544 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.4 34.69 4.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -152.47 155.69 37.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.0 109.827 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 131.29 56.38 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.27 130.33 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.46 0.648 . . . . 0.0 109.84 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 t -63.13 114.93 4.04 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.7 m -68.49 144.33 54.67 Favored 'General case' 0 C--O 1.209 -1.061 0 O-C-N 121.158 -0.964 . . . . 0.0 110.328 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.59 145.9 8.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -65.57 -41.39 92.95 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -86.9 -1.09 57.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 30' ' ' THR . 2.2 m -89.35 -79.24 0.33 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.626 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 64.37 -93.38 0.14 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.626 ' O ' ' O ' ' A' ' 35' ' ' GLY . 3.3 mm? 24.74 111.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.069 0.938 . . . . 0.0 111.708 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.27 123.74 44.87 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.52 -0.738 . . . . 0.0 109.335 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -108.0 104.62 54.09 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.67 160.81 28.02 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.288 1.992 . . . . 0.0 112.246 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.76 131.06 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -121.69 127.16 50.45 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.362 0.601 . . . . 0.0 109.584 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 51.7 t0 58.08 26.4 13.57 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.47 0.652 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.66 5.4 89.49 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.63 130.02 23.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.928 . . . . 0.0 109.834 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.32 143.18 47.39 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.367 2.045 . . . . 0.0 112.633 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.69 112.44 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -102.97 18.79 20.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.5 mt -107.88 128.74 54.89 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.638 0.732 . . . . 0.0 109.521 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.7 -41.37 92.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.341 0.591 . . . . 0.0 109.668 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.14 -42.66 81.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.921 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -89.06 -4.84 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.62 156.74 37.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.949 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.5 138.64 39.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.504 -0.748 . . . . 0.0 109.97 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -89.9 155.05 47.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.555 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 N--CA 1.493 1.467 0 C-N-CA 122.377 2.051 . . . . 0.0 112.797 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -67.36 153.61 94.49 Favored Pre-proline 0 C--N 1.296 -1.758 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.954 -178.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.72 -45.92 37.49 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.92 -61.89 1.67 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.625 . . . . 0.0 109.728 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.39 162.21 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 61.1 t-80 -107.62 103.54 12.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.525 -0.734 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . 176.92 158.12 0.46 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.104 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 27.3 Cg_endo -64.54 154.47 71.79 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.725 2.284 . . . . 0.0 112.604 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -106.75 148.44 28.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -106.57 127.38 53.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -75.72 130.81 39.27 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.5 tpt85 -139.03 165.38 27.27 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 23' ' ' ARG . 67.5 t0 -38.79 103.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.465 0.65 . . . . 0.0 110.411 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 40.6 38.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.428 0.632 . . . . 0.0 110.042 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -157.75 154.28 27.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.935 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -118.94 133.28 55.93 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.25 125.58 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.779 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.69 129.48 41.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -101.62 29.24 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.266 -0.896 . . . . 0.0 108.698 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 34' ' ' CYS . . . -97.95 144.81 17.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.7 -33.46 73.99 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.601 -0.94 . . . . 0.0 109.21 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.66 -3.63 52.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.201 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 11.0 p -144.16 128.52 17.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.71 27.54 2.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.11 157.79 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.451 -1.029 . . . . 0.0 109.89 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.74 141.32 51.93 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.393 0.616 . . . . 0.0 109.723 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-85 -125.02 122.96 25.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.73 161.25 30.75 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.314 2.009 . . . . 0.0 112.487 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -95.77 132.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.126 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -137.21 146.66 45.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.655 -0.653 . . . . 0.0 109.964 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.95 27.28 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.449 0.642 . . . . 0.0 109.675 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.88 7.05 83.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 pt -131.35 149.37 73.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.432 -1.04 . . . . 0.0 109.69 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.33 143.04 51.57 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.624 2.216 . . . . 0.0 112.668 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.25 93.07 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.008 . . . . 0.0 109.005 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 42.49 0.71 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.85 120.19 36.6 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.639 0.733 . . . . 0.0 109.405 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' VAL . 6.2 m -65.85 -30.34 49.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 0.0 109.348 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.19 -40.36 97.29 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.32 -6.55 52.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 157.26 27.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 110.011 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -129.48 168.72 15.92 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.813 0.816 . . . . 0.0 109.949 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -76.58 153.52 83.57 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.641 -0.662 . . . . 0.0 109.564 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.495 1.571 0 C-N-CA 122.721 2.281 . . . . 0.0 112.463 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.436 0.636 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -60.07 156.82 35.44 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.627 -0.671 . . . . 0.0 109.534 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.92 -8.11 22.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.436 2.091 . . . . 0.0 111.22 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.52 -47.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.34 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -69.11 -24.53 64.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 18' ' ' ALA . 36.2 t-80 69.9 -26.65 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.733 -0.604 . . . . 0.0 109.865 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -48.9 -178.71 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.445 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.678 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 38.1 Cg_endo -86.14 163.38 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.846 2.364 . . . . 0.0 112.606 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.72 151.3 32.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.178 -0.951 . . . . 0.0 109.359 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -122.24 133.65 54.7 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.544 0.688 . . . . 0.0 109.223 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.09 127.67 33.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.879 -0.513 . . . . 0.0 109.774 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -132.66 116.57 16.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.543 -0.723 . . . . 0.0 109.279 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 51.17 -110.76 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.74 -0.6 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 40' ' ' VAL . . . -115.77 26.31 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.83 161.25 38.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -109.96 129.32 55.68 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.13 131.67 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.543 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -69.49 119.67 14.1 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.528 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 2.8 m -89.99 165.17 14.21 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.53 -176.97 18.9 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.98 -57.35 4.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.533 -0.98 . . . . 0.0 110.103 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -114.01 28.07 9.04 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -78.11 -80.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 62.85 -114.86 7.3 Favored Glycine 0 C--O 1.202 -1.853 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 ' O ' ' O ' ' A' ' 35' ' ' GLY . 75.1 mt 41.98 121.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.58 1.181 . . . . 0.0 111.453 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.99 133.34 51.79 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.19 -0.944 . . . . 0.0 109.793 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.42 108.68 45.05 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.335 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.99 161.52 23.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.564 2.176 . . . . 0.0 112.352 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 25' ' ' ALA . 90.7 t -95.26 132.84 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.806 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -105.83 108.16 19.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.24 36.95 28.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.584 0.707 . . . . 0.0 109.658 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.26 87.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -110.18 105.02 56.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.534 -0.98 . . . . 0.0 109.715 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.35 134.08 50.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.0 98.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.78 31.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.368 -0.833 . . . . 0.0 109.422 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.45 126.57 55.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.094 0.949 . . . . 0.0 109.592 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -64.6 -39.93 87.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.602 0.715 . . . . 0.0 109.618 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.5 t0 -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -91.04 -9.73 44.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.272 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.71 38.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 109.948 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -111.76 139.45 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.789 0.804 . . . . 0.0 110.05 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -79.9 158.75 72.39 Favored Pre-proline 0 C--N 1.303 -1.42 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.402 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 112.655 179.169 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.1 p -58.46 114.93 9.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.689 -0.632 . . . . 0.0 109.723 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -50.26 -9.64 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.237 1.958 . . . . 0.0 111.515 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -100.95 -72.98 0.66 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.225 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -13.64 51.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.374 -0.829 . . . . 0.0 109.277 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 85.9 t60 55.07 88.68 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.847 0.832 . . . . 0.0 109.835 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.643 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -173.01 170.22 2.12 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.421 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 35.8 Cg_exo -60.53 153.78 58.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.06 2.506 . . . . 0.0 112.632 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.27 149.19 36.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.0 109.805 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -117.74 135.09 54.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.37 124.14 36.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.271 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 25' ' ' ALA . 69.0 ttp85 -122.8 112.66 18.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 53.98 -87.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.0 110.192 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -139.56 28.62 2.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 108.848 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' C ' HD22 ' A' ' 27' ' ' LEU . 98.1 mt-10 -137.62 154.87 49.67 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.705 0.764 . . . . 0.0 109.907 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.436 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.8 mm? -105.11 134.68 47.8 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.794 0.807 . . . . 0.0 110.002 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.77 129.35 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.673 0.749 . . . . 0.0 110.012 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 125.37 25.03 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.03 127.22 55.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.533 -0.729 . . . . 0.0 109.847 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.97 -172.47 39.0 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -73.1 -57.4 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.558 -0.966 . . . . 0.0 110.032 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -89.58 5.8 44.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.073 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -80.14 168.97 18.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.959 0.885 . . . . 0.0 110.074 -179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 -10.29 0.18 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -70.54 157.73 37.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 0.0 110.602 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.84 146.51 50.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.07 129.63 22.56 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.93 164.68 31.26 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.326 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -108.11 132.42 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.522 0.677 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -122.72 128.36 50.44 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.911 0.863 . . . . 0.0 110.04 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 57.52 28.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.72 0.771 . . . . 0.0 109.918 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 3.99 90.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.54 131.41 23.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.5 -1.0 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.06 145.14 54.52 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.592 2.195 . . . . 0.0 112.583 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 48' ' ' LEU . 83.5 t -89.38 123.91 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.546 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.58 32.26 5.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' H ' HG12 ' A' ' 46' ' ' VAL . 77.2 mt -102.53 132.51 48.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.32 -41.1 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.613 0.721 . . . . 0.0 109.764 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.5 -40.13 86.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.945 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.77 7.96 16.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.99 -1.069 . . . . 0.0 109.247 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.13 58.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.691 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.93 120.43 41.89 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.716 0.77 . . . . 0.0 109.159 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -84.61 151.23 58.26 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.764 2.309 . . . . 0.0 112.801 179.707 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.559 0.695 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.69 163.58 53.55 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.23 -83.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.389 2.059 . . . . 0.0 112.057 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.8 77.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.091 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 30.1 p -97.19 66.34 2.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -41.58 119.13 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -176.99 159.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.464 -0.772 . . . . 0.0 109.187 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.94 137.34 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.962 1.775 . . . . 0.0 112.802 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' SG ' ' A' ' 13' ' ' CYS . 73.4 mt -112.65 148.59 34.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.53 -0.731 . . . . 0.0 110.087 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -113.54 117.66 32.28 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -98.8 123.45 43.05 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.554 -0.716 . . . . 0.0 109.596 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' ALA . 10.3 ptp180 -128.85 125.95 38.76 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.633 -0.667 . . . . 0.0 109.36 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.88 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.316 0.579 . . . . 0.0 109.593 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.43 28.71 1.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -135.48 139.52 44.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.6 -0.687 . . . . 0.0 109.253 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.9 mp -109.73 135.78 50.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.622 -0.674 . . . . 0.0 109.555 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.7 132.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.433 0.635 . . . . 0.0 110.121 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.3 m -58.08 123.88 17.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.64 -20.17 17.82 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.05 -1.031 . . . . 0.0 108.62 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -66.33 137.48 35.36 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.73 -14.5 52.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.238 -1.154 . . . . 0.0 108.882 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -80.11 -4.22 51.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.355 -0.841 . . . . 0.0 109.138 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -157.02 165.81 35.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.65 17.01 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.64 159.44 34.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.486 -1.008 . . . . 0.0 109.996 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.32 144.29 49.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.574 0.702 . . . . 0.0 110.275 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 12.1 m-85 -129.86 127.18 22.76 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.15 158.31 30.19 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.168 1.912 . . . . 0.0 111.916 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.72 131.21 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -104.36 108.77 20.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.501 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 53.39 36.86 24.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.8 87.3 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mt -111.04 108.36 57.48 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.4 -1.059 . . . . 0.0 109.387 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.44 135.02 53.95 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.831 1.687 . . . . 0.0 112.121 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -92.81 95.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 108.966 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.1 mt -89.29 64.23 6.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.1 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -121.33 125.77 47.81 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.747 0.784 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.63 -43.51 98.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.72 -40.26 94.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.77 -4.68 59.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.002 -1.061 . . . . 0.0 109.49 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.21 142.57 30.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.135 -0.978 . . . . 0.0 109.601 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -106.04 141.73 36.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 0.0 109.281 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.55 150.63 49.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.0 109.295 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo . . . . . 0 N--CA 1.49 1.294 0 C-N-CA 122.505 2.137 . . . . 0.0 112.873 179.824 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.8 m -59.41 151.07 61.65 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.56 -22.48 58.41 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.04 1.827 . . . . 0.0 111.672 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.93 -30.64 2.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.266 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.6 -168.1 1.63 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.399 -0.813 . . . . 0.0 109.141 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -125.15 19.51 8.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.549 -0.719 . . . . 0.0 109.537 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -95.42 -177.75 0.69 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.652 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 48.2 Cg_endo -86.73 167.04 8.64 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 113.36 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -112.13 150.04 31.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.135 -0.978 . . . . 0.0 109.647 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -128.46 121.03 28.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.75 135.43 37.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ALA . 78.6 ttt-85 -128.87 104.61 7.71 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 99.0 m-20 -22.28 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 O-C-N 123.59 0.556 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . 155.38 -30.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -178.08 -174.15 0.41 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.706 0.765 . . . . 0.0 110.784 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -105.26 129.58 53.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 131.48 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.681 . . . . 0.0 109.271 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 t -74.87 122.79 23.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.2 m -84.46 157.4 21.36 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.05 -1.031 . . . . 0.0 109.342 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.11 167.67 13.82 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -75.91 -55.11 5.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 109.757 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -80.52 -2.93 48.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 57.1 m -81.25 -114.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.528 -0.733 . . . . 0.0 109.805 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 36' ' ' LEU . . . 86.68 -62.45 4.25 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' GLY . 66.8 mt -9.43 125.59 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.637 0.732 . . . . 0.0 111.932 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 130.84 55.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.316 -0.865 . . . . 0.0 109.522 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -113.04 119.85 41.7 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.87 164.92 22.53 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.163 1.909 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.24 131.15 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -119.82 126.32 50.7 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.528 0.68 . . . . 0.0 109.697 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.0 t0 56.23 28.39 13.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.68 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -0.08 89.7 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mm -107.1 131.02 22.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -1.188 . . . . 0.0 109.139 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.32 142.74 27.28 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.306 2.004 . . . . 0.0 112.132 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.63 94.75 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 109.087 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -85.27 39.88 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.346 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.2 mt -111.61 128.0 55.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.784 0.802 . . . . 0.0 109.788 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.75 -41.67 90.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -57.98 -41.21 82.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -90.27 -5.86 55.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.009 -1.057 . . . . 0.0 109.516 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.83 48.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -104.32 143.48 32.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.454 0.645 . . . . 0.0 109.674 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -95.27 113.85 62.49 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.701 -0.624 . . . . 0.0 109.435 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo . . . . . 0 N--CA 1.496 1.658 0 C-N-CA 121.864 1.709 . . . . 0.0 112.805 179.206 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.98 159.02 58.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.397 -0.814 . . . . 0.0 109.813 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.804 2.336 . . . . 0.0 112.012 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.52 -48.25 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.911 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -99.58 159.89 14.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.286 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.656 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 47.3 p-80 -108.58 112.09 24.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.546 -0.721 . . . . 0.0 109.9 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.82 156.78 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.01 163.31 39.7 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.688 2.259 . . . . 0.0 111.985 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.4 147.75 45.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.638 -0.664 . . . . 0.0 109.292 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.59 126.82 52.58 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.97 122.75 31.95 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.214 0.53 . . . . 0.0 109.845 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.92 161.26 4.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 98.2 m-20 52.95 31.48 10.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.35 22.64 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 110.281 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.76 159.47 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.518 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 27' ' ' LEU . 8.2 mp -106.84 125.32 50.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.6 mt -101.82 128.85 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 129.57 38.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.561 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.2 p -84.59 170.9 12.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 145.8 16.14 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -68.32 -53.74 22.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.618 -0.931 . . . . 0.0 109.7 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.87 -5.52 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -0.791 . . . . 0.0 109.709 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 1.3 t -116.96 87.47 2.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.32 -141.07 9.14 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt 74.45 160.6 0.23 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.849 0.833 . . . . 0.0 109.759 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.81 150.73 35.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.838 . . . . 0.0 109.54 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.3 m-85 -115.56 134.08 22.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.99 161.5 41.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.044 1.829 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.37 131.85 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -112.44 120.69 42.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.632 -0.668 . . . . 0.0 109.601 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.9 t0 57.16 22.67 7.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.11 -2.28 71.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.87 124.12 39.85 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.396 -1.061 . . . . 0.0 109.151 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.44 142.12 40.06 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.044 1.829 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 48' ' ' LEU . 25.9 t -88.98 118.93 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.074 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.6 mt -100.33 32.22 3.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.477 -0.764 . . . . 0.0 109.317 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' H ' HG12 ' A' ' 46' ' ' VAL . 76.9 mt -107.09 129.07 54.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.942 0.877 . . . . 0.0 109.471 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.74 -42.15 94.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.63 -20.08 53.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.495 -0.753 . . . . 0.0 110.162 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -102.19 2.62 37.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 0.0 108.986 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 145.97 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.812 . . . . 0.0 109.645 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -119.22 141.72 48.65 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.55 0.69 . . . . 0.0 109.347 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 3.0 mtp180 -89.77 177.55 2.38 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 54' ' ' ARG . 36.5 Cg_exo . . . . . 0 N--CA 1.496 1.663 0 C-N-CA 122.657 2.238 . . . . 0.0 112.508 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.832 0.825 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -74.64 150.39 86.59 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.841 -0.537 . . . . 0.0 110.117 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.56 -11.34 26.2 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.766 2.311 . . . . 0.0 111.321 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.0 -53.25 0.98 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.636 -0.665 . . . . 0.0 109.452 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.47 -29.29 69.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.463 -0.773 . . . . 0.0 109.26 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 63.31 -1.44 0.55 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.797 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -79.38 169.33 20.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.543 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.712 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.7 Cg_endo -69.2 153.12 71.99 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.362 2.042 . . . . 0.0 112.439 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD21 ' SG ' ' A' ' 13' ' ' CYS . 50.2 mt -111.75 152.69 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.725 0.774 . . . . 0.0 109.703 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' CG ' ' OG1' ' A' ' 30' ' ' THR . 68.3 mm-40 -127.44 139.42 52.83 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.951 0.882 . . . . 0.0 109.734 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.29 128.39 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.57 0.7 . . . . 0.0 109.961 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' ' 24' ' ' ASP . 76.3 ttt180 -124.52 156.92 36.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 23' ' ' ARG . 35.0 t0 17.17 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.637 0.732 . . . . 0.0 110.705 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.6 29.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.637 -0.665 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 54.7 mp0 -144.56 167.27 22.92 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 0.0 110.053 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -97.16 134.56 40.32 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.345 0.593 . . . . 0.0 109.856 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.51 131.38 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.924 0.868 . . . . 0.0 110.183 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.07 127.71 33.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.447 ' OG1' ' CG ' ' A' ' 21' ' ' GLU . 89.1 m -120.24 125.27 47.72 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.818 0.818 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.23 -163.84 37.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.07 -58.14 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.651 -0.911 . . . . 0.0 109.732 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -96.86 15.06 23.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -90.51 163.54 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.906 0.86 . . . . 0.0 110.014 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.56 -11.31 0.1 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.24 162.37 14.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 110.169 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.67 142.17 48.96 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.657 0.742 . . . . 0.0 109.684 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -127.94 128.13 23.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.92 166.61 26.58 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.391 2.061 . . . . 0.0 112.379 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -94.04 128.71 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.8 0.809 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -137.89 141.8 40.65 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.63 27.31 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.545 0.688 . . . . 0.0 109.636 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.91 10.84 85.01 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.81 149.55 64.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.466 -1.02 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.18 147.52 54.03 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.371 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 48' ' ' LEU . 97.7 t -84.16 96.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.749 0.785 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.86 38.3 0.45 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 46' ' ' VAL . 53.4 mt -115.71 119.27 35.51 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.155 0.978 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 m -66.04 -29.86 48.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.586 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.98 -43.56 95.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.729 -0.607 . . . . 0.0 109.938 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.7 mp0 -92.05 -4.09 54.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.08 151.42 47.06 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.533 0.682 . . . . 0.0 110.092 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -103.84 143.11 33.26 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.931 0.872 . . . . 0.0 110.024 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 155.92 37.21 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.478 2.119 . . . . 0.0 112.949 179.191 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.932 0.872 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.696 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -59.36 159.52 15.94 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-O 121.45 0.643 . . . . 0.0 109.771 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.81 -79.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.607 2.204 . . . . 0.0 112.363 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.78 98.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.456 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.942 0.877 . . . . 0.0 109.951 -179.487 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.78 104.45 15.23 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.676 0.751 . . . . 0.0 109.495 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 30' ' ' THR . . . -177.86 155.49 1.05 Allowed Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 164.05 35.23 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.706 2.27 . . . . 0.0 113.001 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.21 151.21 33.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.588 0.708 . . . . 0.0 109.596 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -124.89 120.75 32.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.002 0.906 . . . . 0.0 109.604 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -81.13 135.9 35.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.967 0.889 . . . . 0.0 110.211 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -167.59 143.86 4.16 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.846 0.831 . . . . 0.0 109.973 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.1 t70 54.0 36.42 24.45 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.254 0.549 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.36 18.6 11.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.806 -0.559 . . . . 0.0 109.562 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 53' ' ' ARG . 94.3 mt-10 -132.67 159.63 39.04 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.719 0.771 . . . . 0.0 109.679 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.46 126.3 48.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.7 . . . . 0.0 109.909 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.3 mt -108.58 127.3 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.734 0.778 . . . . 0.0 109.686 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.52 119.87 13.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.729 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 25.1 m -105.82 113.13 26.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.659 0.742 . . . . 0.0 109.652 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.53 169.26 42.21 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.62 -50.51 62.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.726 -0.867 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.3 -0.41 49.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.465 -0.772 . . . . 0.0 108.982 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 94.1 m -81.58 -171.35 3.27 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.721 0.772 . . . . 0.0 110.149 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.99 -9.07 0.96 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.85 160.59 22.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.328 -1.101 . . . . 0.0 110.5 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.88 138.8 48.56 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.58 0.705 . . . . 0.0 109.407 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -124.31 125.07 25.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.28 166.22 24.7 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.412 2.075 . . . . 0.0 112.348 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.16 131.14 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.568 0.699 . . . . 0.0 109.438 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -118.88 120.17 36.52 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.889 0.852 . . . . 0.0 109.76 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 56.87 33.55 23.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.451 0.643 . . . . 0.0 109.797 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.46 -2.36 82.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -99.86 122.85 49.52 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.521 -0.988 . . . . 0.0 109.575 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.17 144.94 27.06 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.676 2.251 . . . . 0.0 112.825 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 48' ' ' LEU . 81.6 t -88.5 128.05 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.607 0.718 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.4 mt -118.4 25.33 10.37 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -100.12 130.48 46.27 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.316 1.055 . . . . 0.0 109.481 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.85 -42.29 94.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.645 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.19 -38.38 88.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.499 -0.75 . . . . 0.0 109.68 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.0 -8.0 58.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.127 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 146.22 54.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.731 0.777 . . . . 0.0 109.971 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 26' ' ' GLU . 90.9 mtm180 -102.13 139.34 37.88 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.721 0.772 . . . . 0.0 110.008 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -89.61 151.9 46.45 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.532 2.155 . . . . 0.0 112.689 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 52.8 mmm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 1' ' ' MET . 29.7 Cg_endo -63.86 147.79 92.05 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.84 2.36 . . . . 0.0 112.519 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.9 146.15 42.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -65.69 139.81 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.508 0.67 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.13 -65.88 1.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 62.34 58.52 12.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.3 mp 55.01 111.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.26 1.029 . . . . 0.0 110.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.739 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.0 pt? -73.33 -3.76 29.1 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.038 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.17 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 7' ' ' LEU . 21.4 tt -73.12 132.37 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.89 125.27 34.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.35 137.88 15.96 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.299 -0.875 . . . . 0.0 109.204 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.02 162.45 7.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.363 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -59.81 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.442 2.095 . . . . 0.0 112.239 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -51.24 2.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.452 -0.78 . . . . 0.0 109.469 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.0 p -73.11 65.0 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' CYS . 53.9 t-80 -37.89 112.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.004 0.907 . . . . 0.0 110.497 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.45 168.72 1.93 Allowed Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.965 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 32.8 Cg_exo -56.01 145.93 71.94 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.883 2.389 . . . . 0.0 112.759 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 13' ' ' CYS . 76.6 mt -121.15 145.15 48.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.0 109.547 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -121.87 121.15 36.5 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.836 0.827 . . . . 0.0 109.081 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.93 137.53 34.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.74 -0.6 . . . . 0.0 109.977 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -139.3 115.02 10.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.027 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.8 -112.93 0.66 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.501 0.667 . . . . 0.0 110.602 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.73 27.03 10.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 108.901 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 41.3 mp0 -141.28 154.7 45.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.135 -0.978 . . . . 0.0 109.355 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.25 134.66 54.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.93 132.95 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.551 0.691 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.36 132.97 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.462 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.426 ' HG1' ' C ' ' A' ' 19' ' ' PRO . 11.7 p -124.2 136.85 54.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.76 -161.31 32.21 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.61 -57.51 3.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -1.053 . . . . 0.0 110.056 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -95.41 4.57 53.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.184 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -74.56 178.06 5.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.38 -5.13 1.83 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -74.7 155.75 37.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -1.084 . . . . 0.0 110.419 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.8 139.2 53.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-85 -127.33 109.74 21.25 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 157.06 28.58 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -91.75 132.21 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -0.959 . . . . 0.0 109.698 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -118.11 126.32 52.01 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.463 0.649 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 56.3 29.23 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.803 0.811 . . . . 0.0 110.085 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.31 5.34 90.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.0 mt -112.7 131.25 22.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.417 -1.049 . . . . 0.0 109.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 154.33 49.04 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.538 2.158 . . . . 0.0 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.34 122.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.44 ' C ' HD22 ' A' ' 48' ' ' LEU . 89.3 mt -113.09 21.39 15.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' C ' ' A' ' 47' ' ' LEU . 4.2 mm? -100.19 129.19 46.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.493 1.139 . . . . 0.0 109.924 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.46 -42.28 94.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -62.22 -37.92 87.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.658 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 -9.36 58.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.768 -1.207 . . . . 0.0 109.159 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.16 145.17 37.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -106.83 147.0 30.25 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.807 0.813 . . . . 0.0 109.966 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 9.9 mpt_? -86.17 156.07 57.43 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.696 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -46.13 141.35 9.74 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.344 2.03 . . . . 0.0 112.774 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.859 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 mtp . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.36 -18.11 39.05 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.492 2.128 . . . . 0.0 111.412 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -94.95 -10.54 30.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.686 . . . . 0.0 109.214 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -113.94 -53.44 2.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.97 -61.25 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.56 -131.99 47.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.8 tp -80.99 -167.69 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.813 -0.816 . . . . 0.0 110.448 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' GLU . 90.8 mt -63.7 -42.12 98.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' ILE . 50.8 mt-10 49.07 99.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.516 0.674 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' GLU . 96.3 mt 54.63 111.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.774 0.797 . . . . 0.0 110.261 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.2 mp -77.74 148.0 35.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.491 0.663 . . . . 0.0 109.849 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.79 150.93 37.5 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.807 0.813 . . . . 0.0 109.872 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.581 ' H ' ' HA ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -126.58 168.55 14.09 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-O 122.062 0.934 . . . . 0.0 109.749 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' CYS . 23.8 Cg_exo -63.3 141.59 82.49 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.44 2.094 . . . . 0.0 113.045 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.27 15.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.321 0.582 . . . . 0.0 109.56 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . 29.5 p -172.86 123.4 0.43 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.444 0.64 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.581 ' HA ' ' H ' ' A' ' 13' ' ' CYS . 51.7 p-80 -111.38 115.95 30.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.806 0.813 . . . . 0.0 110.057 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -176.27 173.14 0.87 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-O 121.365 0.602 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 43.2 Cg_exo -54.43 147.26 47.93 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.751 2.301 . . . . 0.0 112.664 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.577 HD21 ' SG ' ' A' ' 13' ' ' CYS . 83.4 mt -120.66 141.08 50.71 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.032 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -127.06 135.61 51.03 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.86 0.838 . . . . 0.0 109.687 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -83.4 137.12 34.07 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.669 0.747 . . . . 0.0 110.184 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -173.02 153.87 2.66 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.81 0.814 . . . . 0.0 110.128 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 96.8 m-20 54.52 33.25 18.52 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.304 0.573 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.52 19.02 11.66 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -142.16 175.29 9.86 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.635 0.731 . . . . 0.0 110.052 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.71 124.43 48.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.543 0.687 . . . . 0.0 109.548 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.61 137.4 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.914 0.864 . . . . 0.0 110.179 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.7 m -73.27 124.82 26.42 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 m -114.49 108.17 16.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.729 0.776 . . . . 0.0 109.957 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.44 48.41 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.5 -54.8 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.727 -0.866 . . . . 0.0 109.405 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.47 -2.26 31.17 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -93.61 113.71 25.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.516 -0.74 . . . . 0.0 109.553 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 9.79 0.89 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.84 156.49 38.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.42 131.52 56.74 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.754 0.788 . . . . 0.0 109.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.94 117.82 35.12 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.42 165.39 29.26 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.522 2.148 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.04 134.47 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.675 0.75 . . . . 0.0 110.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -101.48 103.81 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.732 0.777 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 54.33 36.4 25.2 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.423 0.63 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.61 72.09 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.17 98.93 44.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 122.018 -0.696 . . . . 0.0 109.285 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.23 134.6 64.72 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.647 2.232 . . . . 0.0 112.189 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.45 96.73 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.592 0.71 . . . . 0.0 109.413 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.0 mt -77.24 45.58 0.46 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.38 133.03 53.56 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.187 0.994 . . . . 0.0 109.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.14 -36.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.9 -39.85 90.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.595 -0.691 . . . . 0.0 109.358 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 51.0 mp0 -90.92 -6.02 54.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.44 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.98 147.19 50.45 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.489 0.662 . . . . 0.0 109.881 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 79.6 ttt-85 -117.75 141.08 48.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.011 0.91 . . . . 0.0 110.064 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -94.87 150.95 38.6 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.0 147.19 84.26 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.777 2.318 . . . . 0.0 112.427 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 53' ' ' ARG . 80.2 mm-40 . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.4 tpt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 1' ' ' MET . 37.4 Cg_endo -67.34 152.51 79.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.9 mm? -86.5 -4.59 59.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.777 -0.577 . . . . 0.0 109.458 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 80.2 mm-40 -84.83 -88.1 0.11 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.391 0.615 . . . . 0.0 109.736 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' GLU . . . 57.07 156.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.779 0.8 . . . . 0.0 110.434 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 164.36 54.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.13 130.77 42.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.725 0.774 . . . . 0.0 110.081 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -100.11 -22.37 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 109.214 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -57.88 121.49 10.65 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.626 0.727 . . . . 0.0 110.045 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.0 mp -106.62 -19.81 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.09 148.43 44.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.539 0.685 . . . . 0.0 110.153 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.44 136.08 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.677 0.751 . . . . 0.0 109.871 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.709 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -79.81 119.19 75.93 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-O 121.212 0.53 . . . . 0.0 109.754 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 52.6 Cg_exo -50.93 144.06 28.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.369 2.046 . . . . 0.0 112.649 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 79.87 -36.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.7 -169.09 1.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.834 0.826 . . . . 0.0 109.792 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -135.89 97.55 3.67 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.739 0.78 . . . . 0.0 109.633 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.07 171.2 1.12 Allowed Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 2.8 Cg_exo -74.79 172.25 16.65 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.9 2.4 . . . . 0.0 112.652 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.8 mt -114.48 134.26 55.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.699 -0.626 . . . . 0.0 109.618 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 30' ' ' THR . 6.1 pt-20 -111.21 135.48 51.68 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.853 0.835 . . . . 0.0 109.299 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -97.6 133.98 41.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.535 0.684 . . . . 0.0 110.451 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 124.85 27.79 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.85 0.833 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 49.74 -113.68 0.65 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.286 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.51 23.36 13.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.593 -0.692 . . . . 0.0 109.2 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.71 162.0 36.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.705 . . . . 0.0 110.064 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.74 148.13 38.76 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.895 0.855 . . . . 0.0 109.726 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.48 152.1 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.27 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -68.19 131.24 45.04 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.086 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 21' ' ' GLU . 3.1 m -91.65 166.91 12.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.092 0.948 . . . . 0.0 110.109 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 30' ' ' THR . . . 85.26 147.86 9.73 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.641 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 1.8 pm0 -75.5 -10.33 59.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.755 -0.85 . . . . 0.0 108.781 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.8 -4.73 55.68 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 34.9 m -129.46 -145.09 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.572 0.701 . . . . 0.0 109.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 148.41 -15.07 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -49.52 149.07 2.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.773 -0.839 . . . . 0.0 110.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . . . -113.66 135.4 53.96 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.659 0.742 . . . . 0.0 109.662 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -124.59 105.88 30.07 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.99 173.3 12.9 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.232 1.955 . . . . 0.0 111.977 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.17 132.34 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.507 0.67 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -124.94 126.4 45.44 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.933 0.873 . . . . 0.0 109.847 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.5 t0 57.54 27.68 14.44 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.446 0.641 . . . . 0.0 109.772 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.06 6.26 89.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.92 130.3 24.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.849 -0.795 . . . . 0.0 109.698 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.92 150.5 61.25 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.681 2.254 . . . . 0.0 112.676 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.1 t -91.79 106.68 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 46' ' ' VAL . 4.2 mm? -103.08 14.99 30.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.76 133.17 49.2 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.865 0.84 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.45 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.318 0.58 . . . . 0.0 109.63 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -59.44 -39.75 84.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 0.0 109.842 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.85 -5.49 53.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.091 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 154.46 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.493 0.663 . . . . 0.0 110.169 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.599 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 89.1 mtm180 -100.07 137.58 38.33 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.943 0.878 . . . . 0.0 110.096 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -49.21 167.51 0.21 Allowed Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.903 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' OXT' ' A' ' 56' ' ' GLU . 65.5 Cg_exo -48.69 135.06 27.86 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.127 1.884 . . . . 0.0 112.765 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' OXT' ' O ' ' A' ' 55' ' ' PRO . 82.6 tt0 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.847 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.8 ttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 1' ' ' MET . 27.0 Cg_endo -63.8 146.69 92.17 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.732 2.288 . . . . 0.0 112.399 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' PRO . 51.9 mt 59.01 123.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.066 0.936 . . . . 0.0 110.051 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.38 -5.19 59.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.955 . . . . 0.0 108.84 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.98 139.19 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . -90.31 116.85 4.91 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.3 mp 50.13 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.218 1.008 . . . . 0.0 110.242 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.25 139.85 57.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.67 138.98 56.74 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.733 0.778 . . . . 0.0 110.008 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.2 pt -109.81 -164.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.871 0.843 . . . . 0.0 110.154 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.15 155.26 39.83 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.021 0.915 . . . . 0.0 110.603 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.67 39.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.476 -0.765 . . . . 0.0 109.038 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -88.36 142.88 31.75 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.269 -0.894 . . . . 0.0 110.171 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 72.4 Cg_endo -72.89 152.64 52.4 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.188 . . . . 0.0 112.988 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 69.41 -69.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.636 0.732 . . . . 0.0 110.777 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -29.41 68.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 0.0 109.489 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 52.63 88.82 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.005 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -171.37 172.05 2.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 24.6 Cg_exo -60.0 148.07 90.45 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.471 2.114 . . . . 0.0 112.588 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.84 142.36 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.927 0.87 . . . . 0.0 110.082 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -110.09 116.84 32.27 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.34 127.71 36.89 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.377 0.608 . . . . 0.0 110.02 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' ASP . 95.6 mtt180 -134.82 132.54 38.78 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 25' ' ' ALA . 5.6 p-10 40.2 -116.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.369 0.604 . . . . 0.0 110.55 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 24' ' ' ASP . . . -111.24 42.07 1.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 109.044 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -153.31 149.54 27.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.2 mp -116.19 134.67 54.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.553 0.692 . . . . 0.0 109.429 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.23 132.04 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.616 0.722 . . . . 0.0 109.966 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 125.64 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.23 127.78 56.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.571 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.88 -161.18 34.86 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.27 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -79.43 -58.01 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.495 -1.003 . . . . 0.0 109.514 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -95.05 7.67 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.051 -1.03 . . . . 0.0 108.72 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 171.0 15.74 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.41 -6.81 0.34 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.4 154.71 41.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.146 -1.208 . . . . 0.0 110.291 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.97 139.3 54.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 m-85 -124.01 121.26 26.34 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.81 161.86 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.26 131.6 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -103.7 104.57 14.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.866 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.6 t0 53.05 38.74 28.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.902 0.858 . . . . 0.0 110.051 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.64 7.46 78.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -111.84 101.22 50.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.146 -1.208 . . . . 0.0 109.308 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.0 139.99 69.92 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.628 2.218 . . . . 0.0 112.061 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 48' ' ' LEU . 94.2 t -89.43 121.73 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.009 . . . . 0.0 109.54 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 48' ' ' LEU . 49.4 mt -109.4 23.69 14.12 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' H ' HG12 ' A' ' 46' ' ' VAL . 4.3 mm? -100.01 126.27 46.17 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.437 1.113 . . . . 0.0 109.913 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.18 -41.92 92.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.642 0.734 . . . . 0.0 109.525 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.6 t0 -61.14 -34.67 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 109.801 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.6 -11.25 49.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.828 -1.17 . . . . 0.0 109.23 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.97 146.64 26.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.97 . . . . 0.0 110.049 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -112.96 140.6 47.63 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.921 0.867 . . . . 0.0 109.792 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -87.32 153.96 53.97 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.67 -0.644 . . . . 0.0 109.366 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.53 144.07 89.33 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.803 2.335 . . . . 0.0 112.749 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 C--N 1.3 -1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.059 179.53 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.51 138.98 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.99 1.793 . . . . 0.0 112.798 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.14 -35.34 0.08 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.2 -2.39 55.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 108.952 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.09 140.77 55.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.21 -29.46 8.81 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.2 mp -94.8 121.48 36.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 9' ' ' GLU . 70.0 mt -83.28 -76.65 0.27 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' LEU . 74.6 mm-40 43.87 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.811 0.815 . . . . 0.0 109.968 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.04 146.28 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.723 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.3 mp -79.58 137.16 37.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.434 -0.791 . . . . 0.0 109.611 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.27 122.08 8.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.4 p -68.81 152.37 96.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.3 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 16' ' ' CYS . 39.6 Cg_endo -66.3 145.23 77.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.561 2.174 . . . . 0.0 111.818 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 66.75 -61.17 0.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.575 -0.703 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -89.79 -173.57 3.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.273 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -136.61 109.96 7.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.463 -0.773 . . . . 0.0 109.61 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.85 176.42 0.48 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 7.5 Cg_exo -70.47 159.38 53.08 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.844 2.363 . . . . 0.0 112.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.77 143.94 45.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.46 118.37 30.92 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -80.36 128.65 33.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.504 -0.748 . . . . 0.0 109.206 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -130.68 123.6 29.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.483 -0.761 . . . . 0.0 109.202 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 52.82 -96.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.318 0.58 . . . . 0.0 109.69 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.97 30.08 3.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.28 155.17 46.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.845 . . . . 0.0 109.738 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.3 mt -104.54 128.57 52.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.26 131.34 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.454 0.645 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 1.7 t -72.13 123.99 24.05 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 -178.75 4.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.041 -1.037 . . . . 0.0 109.685 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.48 148.68 6.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 24.3 mp0 -75.14 -10.86 59.86 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -1.006 . . . . 0.0 108.831 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.87 -3.53 54.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.32 -150.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.259 -0.901 . . . . 0.0 109.791 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 145.5 2.74 0.66 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.16 160.32 32.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -1.142 . . . . 0.0 110.039 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.19 137.75 54.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.664 -0.647 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -121.35 107.96 36.38 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.26 150.5 22.65 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.95 1.767 . . . . 0.0 112.44 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.55 132.82 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -117.59 127.63 54.16 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 55.05 30.52 14.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 109.907 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.51 88.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mt -117.5 131.8 23.89 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.394 -1.062 . . . . 0.0 109.3 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.36 145.73 38.82 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.035 1.823 . . . . 0.0 111.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 48' ' ' LEU . 58.8 t -100.91 127.15 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.71 32.13 6.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 46' ' ' VAL . 72.7 mt -108.2 131.66 54.43 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.977 0.894 . . . . 0.0 109.767 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.93 -42.23 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.5 -19.28 46.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.91 -13.31 16.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.321 -0.862 . . . . 0.0 109.034 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.09 144.98 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.645 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -109.17 139.32 44.24 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -85.82 154.07 58.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . 59.3 Cg_exo -44.17 141.42 4.79 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.28 1.987 . . . . 0.0 112.899 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 55' ' ' PRO . 82.0 tt0 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.096 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.02 5.61 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.774 2.316 . . . . 0.0 111.435 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 5' ' ' ALA . 73.9 mt -72.73 -79.79 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.587 -0.695 . . . . 0.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 55.08 -82.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 3' ' ' LEU . . . -69.95 -9.52 55.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.19 -10.85 73.83 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.8 mt -74.92 -78.26 0.11 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -1.116 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.6 tp -89.06 128.37 35.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -55.32 -173.07 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.2 tp -91.65 124.04 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.433 -0.792 . . . . 0.0 109.185 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -118.93 124.27 46.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.02 147.66 46.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.815 . . . . 0.0 108.886 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.3 p -100.13 116.04 64.92 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.828 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.5 Cg_exo -51.36 146.88 23.35 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.762 1.642 . . . . 0.0 112.79 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 76.41 -35.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.558 -0.714 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -124.95 -166.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 109.137 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.657 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 50.4 p-80 -146.96 111.78 5.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.61 158.76 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.183 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' C ' ' OG1' ' A' ' 30' ' ' THR . 32.1 Cg_exo -56.97 177.41 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.362 2.041 . . . . 0.0 112.829 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt -120.1 141.7 49.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.395 -0.816 . . . . 0.0 109.28 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -122.64 134.23 54.5 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.933 0.873 . . . . 0.0 109.743 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.73 138.76 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.645 -0.66 . . . . 0.0 109.531 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -137.76 122.68 18.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.562 -0.711 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.0 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.413 0.625 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.91 28.12 3.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -139.16 160.95 38.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.342 -0.849 . . . . 0.0 109.564 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.0 mt -109.94 119.54 39.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.5 pt -107.8 144.43 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -0.884 . . . . 0.0 109.655 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 134.39 47.18 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.529 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' C ' ' A' ' 19' ' ' PRO . 6.3 m -73.63 145.9 45.01 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.304 -0.872 . . . . 0.0 109.935 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 140.44 9.57 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 26.7 mp0 -66.17 -45.61 80.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.624 -0.927 . . . . 0.0 109.692 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 57.8 t0 -78.53 -6.73 56.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -87.36 -46.92 9.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 41.78 -103.73 0.04 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.1 mt 41.2 111.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.229 1.014 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.46 127.63 53.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -0.768 . . . . 0.0 109.674 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -114.79 104.34 54.27 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.56 168.83 19.26 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.093 1.862 . . . . 0.0 111.61 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.39 131.5 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.945 . . . . 0.0 109.375 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 43' ' ' GLY . 62.8 ttm-85 -114.19 130.53 56.62 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 56.78 5.66 0.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.403 -0.81 . . . . 0.0 109.888 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ARG . . . 108.39 -7.68 34.7 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.28 135.0 20.62 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.344 -1.092 . . . . 0.0 109.645 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.36 144.0 32.57 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 112.544 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.93 111.74 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 109.177 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.5 mt -97.47 16.03 21.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.837 . . . . 0.0 108.933 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 48' ' ' LEU . 4.1 mm? -94.22 126.33 39.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 109.588 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.28 -42.36 90.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.635 -0.666 . . . . 0.0 109.753 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.55 -38.04 83.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.2 -6.99 56.47 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.23 -0.919 . . . . 0.0 109.358 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.18 39.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.649 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.72 142.03 33.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.452 -0.78 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -88.2 150.63 47.57 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 109.552 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.13 147.36 79.13 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.658 2.239 . . . . 0.0 112.702 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.708 179.7 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.19 -14.04 35.71 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.849 2.366 . . . . 0.0 111.738 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.3 mt -79.71 -1.39 38.24 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.598 -0.689 . . . . 0.0 109.255 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -142.19 -28.69 0.61 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.56 143.83 57.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -0.804 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 7' ' ' LEU . . . 42.93 -157.03 0.1 OUTLIER Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 6' ' ' GLY . 1.8 tt 76.86 -59.82 0.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.803 -0.822 . . . . 0.0 109.405 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.7 mm? 44.73 -107.55 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.571 -0.705 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.13 148.54 47.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.665 0.745 . . . . 0.0 110.395 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -77.58 93.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.38 155.96 33.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.629 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.95 136.61 54.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -78.79 153.79 78.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.625 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 38.1 Cg_endo -66.7 143.24 67.04 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.619 2.213 . . . . 0.0 111.779 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 68.92 -53.56 0.57 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.642 -0.661 . . . . 0.0 109.866 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.74 -173.36 2.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 54.6 t-80 -134.47 109.79 8.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.759 -0.588 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 173.6 155.39 0.28 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.0 Cg_exo -53.78 153.51 19.29 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.906 1.737 . . . . 0.0 112.647 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 mt -105.26 134.53 48.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -111.54 132.59 54.41 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' OE1' ' CD2' ' A' ' 27' ' ' LEU . 40.2 mm-40 -89.9 127.87 36.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' ALA . 60.6 ttt85 -125.71 108.72 11.8 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.62 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.55 27.27 2.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.478 -0.764 . . . . 0.0 109.286 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -135.22 155.96 49.79 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.425 0.631 . . . . 0.0 109.544 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' CD2' ' OE1' ' A' ' 22' ' ' GLU . 45.4 mt -106.83 130.62 54.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.594 -0.691 . . . . 0.0 109.662 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.55 130.55 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.374 0.607 . . . . 0.0 109.866 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.8 m -64.46 145.87 55.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.297 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -57.25 -19.39 21.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 108.978 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.65 8.62 87.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -62.66 -43.68 98.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.947 . . . . 0.0 108.958 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -126.77 -9.14 6.12 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.8 p -141.01 -112.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.773 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.49 19.72 0.51 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.61 157.61 33.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.497 -1.002 . . . . 0.0 109.954 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 38' ' ' TYR . . . -129.59 149.64 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.5 0.667 . . . . 0.0 109.91 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 15.7 m-85 -135.48 127.82 17.88 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.57 167.19 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.119 1.879 . . . . 0.0 111.852 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.82 131.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.508 -0.745 . . . . 0.0 109.048 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -103.4 107.41 18.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.387 -0.821 . . . . 0.0 109.68 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.4 t0 53.18 40.83 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.28 90.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.52 104.47 54.35 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.486 -1.008 . . . . 0.0 109.143 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.82 137.79 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.187 1.925 . . . . 0.0 112.396 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.54 101.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.725 . . . . 0.0 109.326 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 mt -93.71 35.28 1.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.745 0.783 . . . . 0.0 109.724 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.65 -43.46 93.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.583 -0.698 . . . . 0.0 109.745 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 6.5 p-10 -60.62 -33.19 72.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.52 -0.738 . . . . 0.0 109.851 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -92.35 10.83 28.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 109.039 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 145.46 54.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.579 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -111.11 137.26 48.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -87.38 151.62 51.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.578 -0.702 . . . . 0.0 109.327 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.69 145.73 82.16 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.691 2.26 . . . . 0.0 112.463 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.953 -1.023 . . . . 0.0 108.906 179.501 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.95 146.59 93.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.919 2.413 . . . . 0.0 112.518 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 4' ' ' GLU . 62.6 mt -70.7 117.94 12.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.451 -0.781 . . . . 0.0 109.841 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 3' ' ' LEU . 95.4 mt-10 40.77 -123.74 0.47 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.197 0.522 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.47 70.66 0.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.74 . . . . 0.0 109.242 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 73.78 26.78 68.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' GLY . 51.6 tp 56.31 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.89 . . . . 0.0 109.969 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 7' ' ' LEU . 1.7 tp 38.52 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.771 0.796 . . . . 0.0 111.118 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 42.82 79.04 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.455 0.645 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.8 tp -92.02 129.76 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.438 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.2 mt -104.51 131.78 51.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.664 -0.647 . . . . 0.0 109.315 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.73 145.46 26.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.166 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.7 t -93.74 140.02 22.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.25 33.0 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.001 1.801 . . . . 0.0 111.619 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -153.52 -75.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 109.157 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' C ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -87.57 7.04 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.6 m80 54.59 12.0 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 16' ' ' CYS . . . -73.9 151.7 88.7 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.167 -0.958 . . . . 0.0 109.721 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.68 163.2 33.94 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.707 2.271 . . . . 0.0 112.305 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -108.71 148.18 30.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -112.73 134.67 54.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.27 125.92 32.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 28' ' ' ILE . 42.6 ttm180 -132.22 117.44 18.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.533 -0.729 . . . . 0.0 109.194 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 52.47 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.247 0.546 . . . . 0.0 110.14 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -136.92 29.43 2.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.12 160.12 41.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.409 -0.807 . . . . 0.0 109.883 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.59 134.5 51.85 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 23' ' ' ARG . 96.8 mt -115.0 130.6 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.404 0.621 . . . . 0.0 109.657 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.5 t -66.97 131.7 46.4 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 110.224 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -77.09 -1.12 27.47 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.279 -0.888 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 129.47 19.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.81 -39.65 79.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.588 -0.948 . . . . 0.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -84.88 -5.45 59.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.171 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -94.03 -70.28 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.0 109.27 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.82 15.13 54.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 34' ' ' CYS . 91.1 mt -76.67 149.06 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -1.169 . . . . 0.0 110.256 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.97 144.37 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -129.84 115.29 17.9 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 156.95 32.23 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.269 1.979 . . . . 0.0 112.755 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.93 129.89 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -127.49 131.76 50.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 54.05 27.85 8.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.251 0.548 . . . . 0.0 110.256 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.33 -3.46 79.55 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 tt -138.84 135.42 17.69 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.268 -1.136 . . . . 0.0 109.919 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.03 155.77 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.272 1.982 . . . . 0.0 112.261 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 48' ' ' LEU . 21.8 t -87.49 130.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.527 -0.733 . . . . 0.0 109.415 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.35 34.2 2.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.608 -0.682 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' H ' HG12 ' A' ' 46' ' ' VAL . 68.7 mt -111.39 137.75 48.76 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.818 0.818 . . . . 0.0 109.595 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.47 -42.43 93.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.558 -0.714 . . . . 0.0 109.797 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 1.7 p-10 -60.28 -33.86 72.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -92.42 -7.92 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 108.807 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 149.6 49.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 110.044 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -101.76 138.52 38.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.454 -0.779 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -96.37 160.97 28.48 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.09 140.54 40.24 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.291 1.994 . . . . 0.0 112.695 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.794 -1.098 . . . . 0.0 109.04 179.657 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.64 144.33 97.7 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.739 2.293 . . . . 0.0 112.395 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.93 144.05 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.16 0.981 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 47.67 78.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.823 0.82 . . . . 0.0 109.888 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.19 145.0 55.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.644 0.735 . . . . 0.0 110.119 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.2 -83.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -84.45 -1.89 56.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -1.057 . . . . 0.0 109.433 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -89.16 113.56 24.76 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.737 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.546 ' N ' HD13 ' A' ' 8' ' ' LEU . 78.0 tt0 58.95 68.11 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.618 0.723 . . . . 0.0 109.57 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 10' ' ' ILE . 19.4 tt -109.0 129.21 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.596 -0.69 . . . . 0.0 109.708 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.78 125.01 49.94 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.724 0.773 . . . . 0.0 109.791 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.46 148.39 22.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.678 0.751 . . . . 0.0 109.317 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.8 t -85.54 125.37 69.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.556 -0.715 . . . . 0.0 109.403 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.15 -21.93 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.963 1.775 . . . . 0.0 111.466 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . . . -91.63 -25.07 19.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' CYS . 6.9 p -160.55 162.84 33.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.16 1.5 11.09 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 108.931 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.32 123.55 35.96 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.046 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.36 163.25 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 0.0 112.615 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -112.0 139.17 47.73 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.636 0.732 . . . . 0.0 109.896 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -113.62 122.69 47.95 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.848 0.833 . . . . 0.0 109.012 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.6 122.71 25.66 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.552 0.691 . . . . 0.0 109.99 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -127.98 117.11 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.638 0.732 . . . . 0.0 109.175 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 52.07 -109.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.479 0.656 . . . . 0.0 110.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.53 26.46 9.86 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -141.74 161.31 38.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.0 mt -111.35 130.3 55.73 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.04 129.84 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.818 0.818 . . . . 0.0 109.791 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.3 131.78 43.94 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.9 p -79.81 2.7 22.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.42 133.42 28.08 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.55 -46.42 76.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.676 -0.896 . . . . 0.0 109.974 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -85.48 -5.16 59.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -95.4 -69.22 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.07 19.2 2.44 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 34' ' ' CYS . 87.9 mt -73.21 151.03 41.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.316 -1.108 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.44 130.53 53.17 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 109.262 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.85 127.36 27.06 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 161.36 28.28 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.9 2.4 . . . . 0.0 112.41 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.87 131.61 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -103.88 104.27 14.23 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.961 0.886 . . . . 0.0 109.797 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 t0 52.82 39.68 29.32 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.878 0.847 . . . . 0.0 110.454 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.17 7.58 79.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mm -111.56 100.37 47.73 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.314 -1.11 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.19 139.7 72.01 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.798 2.332 . . . . 0.0 112.02 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 48' ' ' LEU . 60.4 t -97.26 120.74 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.083 -1.011 . . . . 0.0 109.547 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.4 mt -103.61 34.67 2.88 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HG12 ' A' ' 46' ' ' VAL . 75.1 mt -109.33 128.72 55.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.113 0.959 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.92 -40.29 87.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.646 0.736 . . . . 0.0 109.586 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.83 -39.67 81.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.568 -0.708 . . . . 0.0 110.166 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.59 -8.07 53.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.955 -1.091 . . . . 0.0 109.198 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 145.78 54.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -103.61 136.64 42.94 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.851 0.834 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 156.82 37.86 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.47 137.31 19.67 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.787 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 9.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 1' ' ' MET . 30.4 Cg_endo -64.11 147.85 91.43 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.516 2.144 . . . . 0.0 112.061 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -89.5 152.55 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.61 0.719 . . . . 0.0 109.611 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -84.43 16.68 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.432 -0.793 . . . . 0.0 109.135 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 139.65 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.443 -0.786 . . . . 0.0 109.894 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 8' ' ' LEU . . . 156.45 123.32 0.78 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 7' ' ' LEU . 8.6 mp 54.09 3.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.396 -1.061 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 8' ' ' LEU . 2.9 tt -63.4 -45.57 90.42 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.115 -0.991 . . . . 0.0 109.219 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -117.19 -52.96 2.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.835 . . . . 0.0 110.169 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.2 122.57 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -0.966 . . . . 0.0 109.552 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.44 153.73 26.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.548 -0.72 . . . . 0.0 109.693 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.41 141.28 41.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.501 -0.749 . . . . 0.0 109.085 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -76.19 170.49 15.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.46 -0.775 . . . . 0.0 109.642 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 72.2 Cg_endo -80.23 -86.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.581 2.187 . . . . 0.0 111.772 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -46.36 81.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 24.7 p -93.11 55.03 2.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 108.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 13' ' ' CYS . 86.8 m-70 -41.24 108.94 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 110.763 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.07 177.36 0.67 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.586 -0.697 . . . . 0.0 109.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.597 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 14.5 Cg_exo -68.66 147.79 70.61 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.812 2.341 . . . . 0.0 112.557 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.8 152.15 51.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -122.82 133.99 54.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.8 126.34 32.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.813 -0.554 . . . . 0.0 109.768 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -171.68 157.16 4.57 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.691 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 48.1 t0 56.21 24.27 7.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.618 -0.676 . . . . 0.0 109.344 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 72.28 15.22 5.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.984 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -142.01 165.61 26.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.8 mt -101.51 119.61 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.7 mt -97.4 131.61 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 m -75.61 143.12 42.48 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.457 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 106.82 4.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.322 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.48 17.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.48 -54.18 43.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.164 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 30.0 p-10 -112.72 7.64 18.67 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -86.28 163.89 17.45 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.715 0.769 . . . . 0.0 110.124 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.15 -20.09 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.81 178.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -1.087 . . . . 0.0 110.249 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 139.0 40.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.484 -0.76 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -121.52 120.49 28.81 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.46 164.92 28.07 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.084 1.856 . . . . 0.0 111.852 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.92 132.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -104.61 108.17 19.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 109.538 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.16 38.2 26.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.61 4.39 85.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.2 mt -108.41 104.42 54.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -1.115 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.12 142.11 55.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.092 1.861 . . . . 0.0 112.247 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 48' ' ' LEU . 69.0 t -95.23 131.64 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.4 -0.812 . . . . 0.0 109.395 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.67 35.38 4.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HG12 ' A' ' 46' ' ' VAL . 67.4 mt -106.33 131.41 53.58 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.76 0.79 . . . . 0.0 109.424 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.51 -43.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.994 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.54 -38.23 86.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 110.179 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -88.12 -6.45 57.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.057 -1.027 . . . . 0.0 109.242 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.01 46.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.681 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.85 161.2 15.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -90.43 177.1 2.51 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.552 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.8 144.92 99.37 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.17 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.641 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 96.1 mmm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 1' ' ' MET . 51.7 Cg_endo -67.74 145.22 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.704 2.27 . . . . 0.0 112.481 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' GLU . 69.7 mt -98.07 129.4 44.91 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.735 0.779 . . . . 0.0 110.005 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 3' ' ' LEU . 84.7 tt0 51.95 103.8 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.778 0.799 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.42 141.94 58.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.819 0.818 . . . . 0.0 110.105 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.21 42.31 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 ' CD2' ' H ' ' A' ' 7' ' ' LEU . 1.3 pt? -77.56 -1.17 29.34 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.655 -0.909 . . . . 0.0 109.503 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' LEU . 76.5 mt 41.35 91.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.606 0.717 . . . . 0.0 110.406 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.12 138.24 58.49 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.08 0.943 . . . . 0.0 109.762 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.699 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -77.67 149.85 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.974 0.892 . . . . 0.0 110.331 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.5 mt -72.72 150.83 42.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.779 0.8 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -128.88 126.66 40.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.215 1.007 . . . . 0.0 109.852 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -60.39 159.7 21.95 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-O 121.361 0.601 . . . . 0.0 109.731 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.84 -79.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.614 2.21 . . . . 0.0 111.847 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.7 85.97 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -104.89 164.94 11.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 109.422 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 49.3 p-80 -115.88 105.58 12.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.868 0.842 . . . . 0.0 110.1 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.26 176.51 0.57 Allowed Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 109.428 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 9.9 Cg_exo -70.1 155.69 64.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.957 2.438 . . . . 0.0 113.013 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.88 139.22 49.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.79 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -111.62 126.73 55.32 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.188 0.994 . . . . 0.0 109.399 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.5 mp0 -79.42 141.95 36.38 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.652 0.739 . . . . 0.0 110.558 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.9 tpt180 -143.93 161.46 38.66 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.863 0.84 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . 67.2 t0 -42.6 116.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.586 0.708 . . . . 0.0 110.604 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 24' ' ' ASP . . . 37.0 35.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.763 0.792 . . . . 0.0 110.047 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' CD ' ' NH2' ' A' ' 53' ' ' ARG . 68.9 tt0 -159.81 157.1 28.65 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.058 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.6 mt -126.32 127.59 45.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.573 0.701 . . . . 0.0 109.405 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 98.4 mt -106.8 125.77 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-O 121.923 0.868 . . . . 0.0 109.745 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -73.51 120.17 18.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.781 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -81.7 170.88 15.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.807 0.813 . . . . 0.0 110.184 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 148.71 21.98 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.34 -36.61 68.86 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.781 -0.834 . . . . 0.0 109.351 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.92 -5.23 47.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.739 . . . . 0.0 109.242 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 81.9 m -102.18 -117.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.3 -7.88 62.24 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.8 mt -68.4 149.71 49.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.987 . . . . 0.0 110.321 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.48 145.42 49.54 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 52' ' ' ALA . 80.2 m-85 -130.46 115.82 17.3 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.33 164.58 26.43 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.587 2.192 . . . . 0.0 111.941 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -103.32 132.11 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.715 0.769 . . . . 0.0 109.814 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -121.61 129.46 52.84 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.689 0.757 . . . . 0.0 109.638 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 57.33 30.82 19.14 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.511 0.672 . . . . 0.0 109.351 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.84 85.43 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.08 130.32 24.01 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.763 -0.845 . . . . 0.0 109.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.02 141.58 40.44 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.579 2.186 . . . . 0.0 112.09 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 48' ' ' LEU . 89.8 t -90.07 128.18 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.71 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.402 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.2 mt -117.79 30.17 7.42 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' H ' HG12 ' A' ' 46' ' ' VAL . 11.2 mp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.297 1.046 . . . . 0.0 109.575 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.11 -42.94 95.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.722 -0.611 . . . . 0.0 109.691 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.89 -17.13 64.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.518 -0.739 . . . . 0.0 109.4 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.63 -12.61 18.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.36 -0.838 . . . . 0.0 108.772 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . -57.14 142.73 41.52 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' NH2' ' CD ' ' A' ' 26' ' ' GLU . 89.2 mtm180 -105.87 146.43 29.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.706 0.765 . . . . 0.0 109.728 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 11.4 mpt_? -83.14 151.76 63.83 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.944 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.11 149.78 76.84 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.759 2.306 . . . . 0.0 112.665 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.523 179.33 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.15 140.21 92.13 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.732 2.288 . . . . 0.0 112.102 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.64 123.29 48.72 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.421 0.629 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 58.2 mp0 -92.23 123.86 35.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.648 -0.657 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 7' ' ' LEU . . . -170.47 131.04 0.9 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.42 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.93 6.85 6.07 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.4 mp -83.13 -10.22 58.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 0.0 109.109 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.99 147.02 49.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.538 -0.726 . . . . 0.0 110.455 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -57.66 139.28 54.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.762 -0.586 . . . . 0.0 109.741 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -135.37 132.68 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.475 0.655 . . . . 0.0 109.944 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.33 148.2 47.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.732 -0.605 . . . . 0.0 109.898 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.73 133.53 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.637 -0.664 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -90.1 153.72 46.98 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.684 -0.635 . . . . 0.0 110.266 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -65.28 141.91 70.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.663 2.242 . . . . 0.0 111.99 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 70.45 -12.59 0.51 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.603 -0.686 . . . . 0.0 109.243 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -136.54 -167.76 2.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 108.948 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 17' ' ' HIS . 56.5 t-80 -140.95 24.97 2.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.652 -0.655 . . . . 0.0 109.285 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -99.89 171.8 5.24 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.516 -0.74 . . . . 0.0 109.819 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.4 Cg_endo -77.99 178.12 7.97 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.238 1.959 . . . . 0.0 112.852 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 13' ' ' CYS . 92.2 mt -115.0 144.09 44.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.635 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -111.41 111.65 22.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.8 pt-20 -74.75 132.29 41.5 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.179 0.514 . . . . 0.0 110.014 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -141.53 124.91 16.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.5 -111.6 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.83 -0.544 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.4 34.69 4.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -152.47 155.69 37.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.0 109.827 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 131.29 56.38 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.27 130.33 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.46 0.648 . . . . 0.0 109.84 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 t -63.13 114.93 4.04 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.7 m -68.49 144.33 54.67 Favored 'General case' 0 C--O 1.209 -1.061 0 O-C-N 121.158 -0.964 . . . . 0.0 110.328 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.59 145.9 8.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -65.57 -41.39 92.95 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -86.9 -1.09 57.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 30' ' ' THR . 2.2 m -89.35 -79.24 0.33 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.626 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 64.37 -93.38 0.14 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.626 ' O ' ' O ' ' A' ' 35' ' ' GLY . 3.3 mm? 24.74 111.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.069 0.938 . . . . 0.0 111.708 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.27 123.74 44.87 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.52 -0.738 . . . . 0.0 109.335 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -108.0 104.62 54.09 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.67 160.81 28.02 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.288 1.992 . . . . 0.0 112.246 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.76 131.06 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -121.69 127.16 50.45 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.362 0.601 . . . . 0.0 109.584 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 51.7 t0 58.08 26.4 13.57 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.47 0.652 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.66 5.4 89.49 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.63 130.02 23.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.928 . . . . 0.0 109.834 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.32 143.18 47.39 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.367 2.045 . . . . 0.0 112.633 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.69 112.44 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -102.97 18.79 20.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.5 mt -107.88 128.74 54.89 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.638 0.732 . . . . 0.0 109.521 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.7 -41.37 92.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.341 0.591 . . . . 0.0 109.668 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.14 -42.66 81.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.921 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -89.06 -4.84 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.62 156.74 37.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.949 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.5 138.64 39.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.504 -0.748 . . . . 0.0 109.97 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -89.9 155.05 47.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.555 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -45.7 139.69 10.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.377 2.051 . . . . 0.0 112.797 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.989 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 4.4 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 1' ' ' MET . 30.8 Cg_endo -60.86 146.66 97.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.323 2.015 . . . . 0.0 112.317 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -77.41 146.91 36.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.424 -0.797 . . . . 0.0 109.45 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 58.6 mp0 -68.43 128.69 37.52 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.584 0.707 . . . . 0.0 110.154 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.14 -9.11 58.83 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.522 -0.736 . . . . 0.0 109.121 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . -152.48 -134.81 2.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.0 mp 56.06 111.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.68 -0.894 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' LEU . 62.2 mt 46.0 99.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.775 0.798 . . . . 0.0 110.022 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.18 -12.11 47.88 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.13 128.17 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.946 . . . . 0.0 109.637 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.3 mt -107.13 130.0 54.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.643 0.735 . . . . 0.0 109.356 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.98 158.03 16.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -67.36 153.61 94.49 Favored Pre-proline 0 C--N 1.296 -1.758 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.954 -178.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.72 -45.92 37.49 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.92 -61.89 1.67 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.625 . . . . 0.0 109.728 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.39 162.21 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 61.1 t-80 -107.62 103.54 12.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.525 -0.734 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . 176.92 158.12 0.46 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.104 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 27.3 Cg_endo -64.54 154.47 71.79 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.725 2.284 . . . . 0.0 112.604 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -106.75 148.44 28.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -106.57 127.38 53.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -75.72 130.81 39.27 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.5 tpt85 -139.03 165.38 27.27 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 23' ' ' ARG . 67.5 t0 -38.79 103.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.465 0.65 . . . . 0.0 110.411 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 40.6 38.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.428 0.632 . . . . 0.0 110.042 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -157.75 154.28 27.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.935 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -118.94 133.28 55.93 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.25 125.58 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.779 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.69 129.48 41.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -101.62 29.24 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.266 -0.896 . . . . 0.0 108.698 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 34' ' ' CYS . . . -97.95 144.81 17.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.7 -33.46 73.99 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.601 -0.94 . . . . 0.0 109.21 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.66 -3.63 52.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.201 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 11.0 p -144.16 128.52 17.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.71 27.54 2.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.11 157.79 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.451 -1.029 . . . . 0.0 109.89 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.74 141.32 51.93 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.393 0.616 . . . . 0.0 109.723 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-85 -125.02 122.96 25.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.73 161.25 30.75 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.314 2.009 . . . . 0.0 112.487 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -95.77 132.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.126 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -137.21 146.66 45.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.655 -0.653 . . . . 0.0 109.964 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.95 27.28 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.449 0.642 . . . . 0.0 109.675 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.88 7.05 83.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 pt -131.35 149.37 73.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.432 -1.04 . . . . 0.0 109.69 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.33 143.04 51.57 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.624 2.216 . . . . 0.0 112.668 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.25 93.07 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.008 . . . . 0.0 109.005 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 42.49 0.71 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.85 120.19 36.6 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.639 0.733 . . . . 0.0 109.405 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' VAL . 6.2 m -65.85 -30.34 49.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 0.0 109.348 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.19 -40.36 97.29 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.32 -6.55 52.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 157.26 27.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 110.011 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -129.48 168.72 15.92 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.813 0.816 . . . . 0.0 109.949 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -76.58 153.52 83.57 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.641 -0.662 . . . . 0.0 109.564 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.16 145.86 89.73 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.721 2.281 . . . . 0.0 112.463 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.129 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.38 -165.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.786 2.324 . . . . 0.0 112.719 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt 58.49 41.69 22.22 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.675 0.75 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -163.52 40.58 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.03 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.0 -10.07 59.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.112 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 92.98 -57.21 2.51 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 6' ' ' GLY . 43.3 tp 58.67 145.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.904 0.859 . . . . 0.0 110.406 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.2 tp -70.0 133.2 47.0 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.468 -0.77 . . . . 0.0 110.179 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.0 137.88 57.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.7 0.762 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 10' ' ' ILE . 96.1 mt -84.07 -4.43 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.46 128.51 47.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.853 . . . . 0.0 109.519 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.8 134.36 24.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.431 -0.793 . . . . 0.0 109.484 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -60.07 156.82 35.44 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.627 -0.671 . . . . 0.0 109.534 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.92 -8.11 22.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.436 2.091 . . . . 0.0 111.22 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.52 -47.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.34 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -69.11 -24.53 64.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 18' ' ' ALA . 36.2 t-80 69.9 -26.65 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.733 -0.604 . . . . 0.0 109.865 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -48.9 -178.71 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.445 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.678 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 38.1 Cg_endo -86.14 163.38 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.846 2.364 . . . . 0.0 112.606 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.72 151.3 32.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.178 -0.951 . . . . 0.0 109.359 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -122.24 133.65 54.7 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.544 0.688 . . . . 0.0 109.223 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.09 127.67 33.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.879 -0.513 . . . . 0.0 109.774 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -132.66 116.57 16.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.543 -0.723 . . . . 0.0 109.279 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 51.17 -110.76 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.74 -0.6 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 40' ' ' VAL . . . -115.77 26.31 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.83 161.25 38.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -109.96 129.32 55.68 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.13 131.67 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.543 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -69.49 119.67 14.1 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.528 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 2.8 m -89.99 165.17 14.21 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.53 -176.97 18.9 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.98 -57.35 4.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.533 -0.98 . . . . 0.0 110.103 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -114.01 28.07 9.04 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -78.11 -80.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 62.85 -114.86 7.3 Favored Glycine 0 C--O 1.202 -1.853 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 ' O ' ' O ' ' A' ' 35' ' ' GLY . 75.1 mt 41.98 121.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.58 1.181 . . . . 0.0 111.453 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.99 133.34 51.79 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.19 -0.944 . . . . 0.0 109.793 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.42 108.68 45.05 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.335 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.99 161.52 23.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.564 2.176 . . . . 0.0 112.352 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 25' ' ' ALA . 90.7 t -95.26 132.84 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.806 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -105.83 108.16 19.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.24 36.95 28.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.584 0.707 . . . . 0.0 109.658 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.26 87.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -110.18 105.02 56.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.534 -0.98 . . . . 0.0 109.715 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.35 134.08 50.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.0 98.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.78 31.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.368 -0.833 . . . . 0.0 109.422 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.45 126.57 55.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.094 0.949 . . . . 0.0 109.592 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -64.6 -39.93 87.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.602 0.715 . . . . 0.0 109.618 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.5 t0 -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -91.04 -9.73 44.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.272 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.71 38.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 109.948 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -111.76 139.45 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.789 0.804 . . . . 0.0 110.05 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -79.9 158.75 72.39 Favored Pre-proline 0 C--N 1.303 -1.42 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.402 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.75 139.41 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 112.655 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.901 -179.789 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.16 -6.38 17.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.672 2.248 . . . . 0.0 110.812 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.71 135.83 54.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.727 0.775 . . . . 0.0 110.067 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.54 133.78 56.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.803 0.811 . . . . 0.0 110.314 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 6' ' ' GLY . . . -81.03 -6.62 59.01 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . . . -41.88 123.13 3.02 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt -69.1 -9.71 54.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -1.0 . . . . 0.0 109.071 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 8' ' ' LEU . 4.0 mm? -65.36 -31.86 73.2 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.48 -0.762 . . . . 0.0 109.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.78 -25.23 67.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 pt -108.12 38.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.37 -0.832 . . . . 0.0 109.211 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -107.68 119.88 40.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.499 -0.751 . . . . 0.0 109.185 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.621 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -122.09 130.84 53.61 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 109.413 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.1 p -58.46 114.93 9.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.689 -0.632 . . . . 0.0 109.723 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -50.26 -9.64 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.237 1.958 . . . . 0.0 111.515 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -100.95 -72.98 0.66 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.225 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -13.64 51.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.374 -0.829 . . . . 0.0 109.277 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 85.9 t60 55.07 88.68 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.847 0.832 . . . . 0.0 109.835 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.643 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -173.01 170.22 2.12 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.421 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 35.8 Cg_exo -60.53 153.78 58.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.06 2.506 . . . . 0.0 112.632 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD11 HD12 ' A' ' 11' ' ' LEU . 67.6 mt -114.27 149.19 36.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.0 109.805 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -117.74 135.09 54.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.37 124.14 36.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.271 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 25' ' ' ALA . 69.0 ttp85 -122.8 112.66 18.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 53.98 -87.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.0 110.192 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -139.56 28.62 2.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 108.848 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' C ' HD22 ' A' ' 27' ' ' LEU . 98.1 mt-10 -137.62 154.87 49.67 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.705 0.764 . . . . 0.0 109.907 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.436 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.8 mm? -105.11 134.68 47.8 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.794 0.807 . . . . 0.0 110.002 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.77 129.35 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.673 0.749 . . . . 0.0 110.012 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 125.37 25.03 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.03 127.22 55.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.533 -0.729 . . . . 0.0 109.847 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.97 -172.47 39.0 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -73.1 -57.4 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.558 -0.966 . . . . 0.0 110.032 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -89.58 5.8 44.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.073 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -80.14 168.97 18.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.959 0.885 . . . . 0.0 110.074 -179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 -10.29 0.18 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -70.54 157.73 37.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 0.0 110.602 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.84 146.51 50.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.07 129.63 22.56 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.93 164.68 31.26 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.326 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -108.11 132.42 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.522 0.677 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -122.72 128.36 50.44 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.911 0.863 . . . . 0.0 110.04 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 57.52 28.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.72 0.771 . . . . 0.0 109.918 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 3.99 90.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.54 131.41 23.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.5 -1.0 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.06 145.14 54.52 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.592 2.195 . . . . 0.0 112.583 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 48' ' ' LEU . 83.5 t -89.38 123.91 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.546 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.58 32.26 5.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' H ' HG12 ' A' ' 46' ' ' VAL . 77.2 mt -102.53 132.51 48.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.32 -41.1 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.613 0.721 . . . . 0.0 109.764 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.5 -40.13 86.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.945 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.77 7.96 16.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.99 -1.069 . . . . 0.0 109.247 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.13 58.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.691 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.93 120.43 41.89 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.716 0.77 . . . . 0.0 109.159 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -84.61 151.23 58.26 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 56' ' ' GLU . 54.1 Cg_endo -67.14 146.26 75.82 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.764 2.309 . . . . 0.0 112.801 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 55' ' ' PRO . 80.4 mm-40 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.899 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 2' ' ' PRO . 9.9 mmt . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -14.65 -111.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 123.907 3.071 . . . . 0.0 114.992 -176.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.5 mt -75.74 123.66 25.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 118.993 -2.317 . . . . 0.0 112.35 -177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -97.44 -13.74 21.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.11 -25.89 68.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 109.06 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.3 -24.08 63.05 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.59 -40.32 96.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 109.367 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.15 145.5 46.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.989 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.42 97.71 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.44 137.21 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.534 -0.729 . . . . 0.0 109.27 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt -68.74 150.44 47.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.21 150.44 36.13 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.559 0.695 . . . . 0.0 109.881 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.69 163.58 53.55 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.23 -83.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.389 2.059 . . . . 0.0 112.057 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.8 77.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.091 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 30.1 p -97.19 66.34 2.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -41.58 119.13 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -176.99 159.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.464 -0.772 . . . . 0.0 109.187 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.94 137.34 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.962 1.775 . . . . 0.0 112.802 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' SG ' ' A' ' 13' ' ' CYS . 73.4 mt -112.65 148.59 34.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.53 -0.731 . . . . 0.0 110.087 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -113.54 117.66 32.28 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -98.8 123.45 43.05 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.554 -0.716 . . . . 0.0 109.596 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' ALA . 10.3 ptp180 -128.85 125.95 38.76 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.633 -0.667 . . . . 0.0 109.36 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.88 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.316 0.579 . . . . 0.0 109.593 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.43 28.71 1.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -135.48 139.52 44.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.6 -0.687 . . . . 0.0 109.253 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.9 mp -109.73 135.78 50.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.622 -0.674 . . . . 0.0 109.555 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.7 132.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.433 0.635 . . . . 0.0 110.121 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.3 m -58.08 123.88 17.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.64 -20.17 17.82 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.05 -1.031 . . . . 0.0 108.62 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -66.33 137.48 35.36 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.73 -14.5 52.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.238 -1.154 . . . . 0.0 108.882 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -80.11 -4.22 51.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.355 -0.841 . . . . 0.0 109.138 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -157.02 165.81 35.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.65 17.01 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.64 159.44 34.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.486 -1.008 . . . . 0.0 109.996 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.32 144.29 49.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.574 0.702 . . . . 0.0 110.275 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 12.1 m-85 -129.86 127.18 22.76 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.15 158.31 30.19 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.168 1.912 . . . . 0.0 111.916 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.72 131.21 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -104.36 108.77 20.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.501 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 53.39 36.86 24.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.8 87.3 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mt -111.04 108.36 57.48 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.4 -1.059 . . . . 0.0 109.387 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.44 135.02 53.95 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.831 1.687 . . . . 0.0 112.121 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -92.81 95.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 108.966 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.1 mt -89.29 64.23 6.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.1 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -121.33 125.77 47.81 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.747 0.784 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.63 -43.51 98.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.72 -40.26 94.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.77 -4.68 59.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.002 -1.061 . . . . 0.0 109.49 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.21 142.57 30.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.135 -0.978 . . . . 0.0 109.601 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -106.04 141.73 36.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 0.0 109.281 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.55 150.63 49.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.0 109.295 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -38.43 136.31 0.63 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.505 2.137 . . . . 0.0 112.873 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.552 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 7.2 mtt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 18.1 Cg_endo -58.77 145.44 96.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.036 1.824 . . . . 0.0 111.963 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' GLY . 76.0 mt -74.82 141.41 44.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.664 0.745 . . . . 0.0 110.368 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 44.0 -127.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.585 -0.697 . . . . 0.0 110.14 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.75 -10.2 59.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.472 -0.768 . . . . 0.0 109.672 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 3' ' ' LEU . . . 82.4 72.6 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -78.52 134.34 37.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 109.606 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' GLU . 78.0 mt -75.91 144.46 41.1 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.595 0.712 . . . . 0.0 110.311 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 8' ' ' LEU . 49.1 tp10 51.14 99.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -104.99 -23.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.213 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.3 mp -86.86 141.48 28.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 109.333 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.79 147.27 27.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.511 -0.743 . . . . 0.0 109.182 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.8 m -59.41 151.07 61.65 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.56 -22.48 58.41 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.04 1.827 . . . . 0.0 111.672 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.93 -30.64 2.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.266 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.6 -168.1 1.63 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.399 -0.813 . . . . 0.0 109.141 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -125.15 19.51 8.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.549 -0.719 . . . . 0.0 109.537 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -95.42 -177.75 0.69 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.652 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 48.2 Cg_endo -86.73 167.04 8.64 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 113.36 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -112.13 150.04 31.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.135 -0.978 . . . . 0.0 109.647 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -128.46 121.03 28.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.75 135.43 37.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ALA . 78.6 ttt-85 -128.87 104.61 7.71 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 99.0 m-20 -22.28 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 O-C-N 123.59 0.556 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . 155.38 -30.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -178.08 -174.15 0.41 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.706 0.765 . . . . 0.0 110.784 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -105.26 129.58 53.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 131.48 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.681 . . . . 0.0 109.271 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 t -74.87 122.79 23.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.2 m -84.46 157.4 21.36 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.05 -1.031 . . . . 0.0 109.342 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.11 167.67 13.82 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -75.91 -55.11 5.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 109.757 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -80.52 -2.93 48.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 57.1 m -81.25 -114.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.528 -0.733 . . . . 0.0 109.805 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 36' ' ' LEU . . . 86.68 -62.45 4.25 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' GLY . 66.8 mt -9.43 125.59 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.637 0.732 . . . . 0.0 111.932 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 130.84 55.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.316 -0.865 . . . . 0.0 109.522 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -113.04 119.85 41.7 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.87 164.92 22.53 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.163 1.909 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.24 131.15 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -119.82 126.32 50.7 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.528 0.68 . . . . 0.0 109.697 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.0 t0 56.23 28.39 13.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.68 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -0.08 89.7 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mm -107.1 131.02 22.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -1.188 . . . . 0.0 109.139 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.32 142.74 27.28 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.306 2.004 . . . . 0.0 112.132 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.63 94.75 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 109.087 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -85.27 39.88 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.346 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.2 mt -111.61 128.0 55.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.784 0.802 . . . . 0.0 109.788 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.75 -41.67 90.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -57.98 -41.21 82.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -90.27 -5.86 55.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.009 -1.057 . . . . 0.0 109.516 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.83 48.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -104.32 143.48 32.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.454 0.645 . . . . 0.0 109.674 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -95.27 113.85 62.49 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.701 -0.624 . . . . 0.0 109.435 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -52.57 143.29 46.42 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.864 1.709 . . . . 0.0 112.805 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.518 179.219 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.34 -46.67 30.76 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.42 2.08 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 4' ' ' GLU . 3.4 tt -170.51 114.65 0.46 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.808 . . . . 0.0 108.992 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.553 ' N ' HD23 ' A' ' 3' ' ' LEU . 11.7 pt-20 -64.33 137.53 57.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.08 46.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.68 . . . . 0.0 110.272 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.82 -78.66 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 7' ' ' LEU . 9.8 mp -73.63 146.3 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.1 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.551 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.9 mm? -69.38 133.81 48.26 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.554 0.693 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.89 -8.14 38.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 10' ' ' ILE . 21.2 tt -47.07 129.07 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 109.707 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -77.51 146.5 36.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.617 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.16 141.24 22.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.98 159.02 58.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.397 -0.814 . . . . 0.0 109.813 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.804 2.336 . . . . 0.0 112.012 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.52 -48.25 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.911 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -99.58 159.89 14.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.286 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.656 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 47.3 p-80 -108.58 112.09 24.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.546 -0.721 . . . . 0.0 109.9 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.82 156.78 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.01 163.31 39.7 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.688 2.259 . . . . 0.0 111.985 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.4 147.75 45.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.638 -0.664 . . . . 0.0 109.292 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.59 126.82 52.58 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.97 122.75 31.95 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.214 0.53 . . . . 0.0 109.845 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.92 161.26 4.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 98.2 m-20 52.95 31.48 10.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.35 22.64 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 110.281 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.76 159.47 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.518 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 27' ' ' LEU . 8.2 mp -106.84 125.32 50.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.6 mt -101.82 128.85 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 129.57 38.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.561 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 70.2 p -84.59 170.9 12.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 110.172 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 145.8 16.14 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -68.32 -53.74 22.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.618 -0.931 . . . . 0.0 109.7 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.87 -5.52 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -0.791 . . . . 0.0 109.709 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.3 t -116.96 87.47 2.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.32 -141.07 9.14 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt 74.45 160.6 0.23 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.849 0.833 . . . . 0.0 109.759 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.81 150.73 35.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.838 . . . . 0.0 109.54 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.3 m-85 -115.56 134.08 22.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.99 161.5 41.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.044 1.829 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.37 131.85 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -112.44 120.69 42.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.632 -0.668 . . . . 0.0 109.601 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.9 t0 57.16 22.67 7.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.11 -2.28 71.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.87 124.12 39.85 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.396 -1.061 . . . . 0.0 109.151 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.44 142.12 40.06 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.044 1.829 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 48' ' ' LEU . 25.9 t -88.98 118.93 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.074 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.6 mt -100.33 32.22 3.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.477 -0.764 . . . . 0.0 109.317 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' H ' HG12 ' A' ' 46' ' ' VAL . 76.9 mt -107.09 129.07 54.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.942 0.877 . . . . 0.0 109.471 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.74 -42.15 94.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.63 -20.08 53.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.495 -0.753 . . . . 0.0 110.162 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -102.19 2.62 37.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 0.0 108.986 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 145.97 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.812 . . . . 0.0 109.645 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -119.22 141.72 48.65 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.55 0.69 . . . . 0.0 109.347 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 3.0 mtp180 -89.77 177.55 2.38 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' GLU . 36.5 Cg_exo -59.61 145.86 96.89 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.657 2.238 . . . . 0.0 112.508 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' PRO . 10.1 tm-20 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.675 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.35 113.18 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.028 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.03 -41.08 99.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.19 140.8 0.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.784 0.802 . . . . 0.0 109.928 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.02 88.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.79 0.805 . . . . 0.0 109.84 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.4 156.11 52.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.47 128.2 34.66 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.805 0.812 . . . . 0.0 110.047 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 8' ' ' LEU . 1.4 tt -64.33 -42.47 96.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 59.55 106.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.696 0.76 . . . . 0.0 110.099 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.21 149.22 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.785 0.802 . . . . 0.0 110.158 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.5 mt -68.85 135.26 50.84 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.864 0.84 . . . . 0.0 110.099 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.42 153.95 29.7 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.832 0.825 . . . . 0.0 109.912 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -74.64 150.39 86.59 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.841 -0.537 . . . . 0.0 110.117 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.56 -11.34 26.2 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.766 2.311 . . . . 0.0 111.321 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.0 -53.25 0.98 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.636 -0.665 . . . . 0.0 109.452 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.47 -29.29 69.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.463 -0.773 . . . . 0.0 109.26 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 63.31 -1.44 0.55 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.797 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -79.38 169.33 20.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.543 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.712 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.7 Cg_endo -69.2 153.12 71.99 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.362 2.042 . . . . 0.0 112.439 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD21 ' SG ' ' A' ' 13' ' ' CYS . 50.2 mt -111.75 152.69 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.725 0.774 . . . . 0.0 109.703 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' CG ' ' OG1' ' A' ' 30' ' ' THR . 68.3 mm-40 -127.44 139.42 52.83 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.951 0.882 . . . . 0.0 109.734 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.29 128.39 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.57 0.7 . . . . 0.0 109.961 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' ' 24' ' ' ASP . 76.3 ttt180 -124.52 156.92 36.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 23' ' ' ARG . 35.0 t0 17.17 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.637 0.732 . . . . 0.0 110.705 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.6 29.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.637 -0.665 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 54.7 mp0 -144.56 167.27 22.92 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 0.0 110.053 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -97.16 134.56 40.32 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.345 0.593 . . . . 0.0 109.856 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.51 131.38 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.924 0.868 . . . . 0.0 110.183 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.515 ' SG ' ' OH ' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -70.07 127.71 33.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.447 ' OG1' ' CG ' ' A' ' 21' ' ' GLU . 89.1 m -120.24 125.27 47.72 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.818 0.818 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.23 -163.84 37.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.07 -58.14 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.651 -0.911 . . . . 0.0 109.732 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -96.86 15.06 23.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -90.51 163.54 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.906 0.86 . . . . 0.0 110.014 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.56 -11.31 0.1 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.24 162.37 14.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 110.169 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.67 142.17 48.96 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.657 0.742 . . . . 0.0 109.684 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -127.94 128.13 23.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.92 166.61 26.58 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.391 2.061 . . . . 0.0 112.379 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -94.04 128.71 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.8 0.809 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -137.89 141.8 40.65 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.63 27.31 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.545 0.688 . . . . 0.0 109.636 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.91 10.84 85.01 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.81 149.55 64.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.466 -1.02 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.18 147.52 54.03 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.371 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 48' ' ' LEU . 97.7 t -84.16 96.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.749 0.785 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.86 38.3 0.45 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 46' ' ' VAL . 53.4 mt -115.71 119.27 35.51 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.155 0.978 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 m -66.04 -29.86 48.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.586 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.98 -43.56 95.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.729 -0.607 . . . . 0.0 109.938 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.7 mp0 -92.05 -4.09 54.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.08 151.42 47.06 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.533 0.682 . . . . 0.0 110.092 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -103.84 143.11 33.26 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.931 0.872 . . . . 0.0 110.024 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 155.92 37.21 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' GLU . 51.0 Cg_exo -47.55 138.96 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.478 2.119 . . . . 0.0 112.949 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' PRO . 80.8 tt0 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.769 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 61.7 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 1' ' ' MET . 55.2 Cg_endo -69.72 147.8 63.91 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.674 2.25 . . . . 0.0 112.499 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 4' ' ' GLU . 63.0 mt 54.94 -176.13 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.779 0.8 . . . . 0.0 110.313 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' LEU . 71.4 mm-40 55.09 163.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.848 0.832 . . . . 0.0 110.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -169.05 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.69 158.5 21.88 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.2 143.05 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.684 -0.892 . . . . 0.0 110.003 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.51 144.27 46.23 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.973 0.892 . . . . 0.0 110.118 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 57.8 mp0 -84.49 -108.4 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.344 0.592 . . . . 0.0 110.071 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.9 pt -92.85 141.44 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.985 0.898 . . . . 0.0 110.36 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -89.96 153.06 20.89 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.917 0.865 . . . . 0.0 109.918 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.66 147.86 30.44 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.932 0.872 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.696 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -59.36 159.52 15.94 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-O 121.45 0.643 . . . . 0.0 109.771 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.81 -79.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.607 2.204 . . . . 0.0 112.363 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.78 98.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.456 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.942 0.877 . . . . 0.0 109.951 -179.487 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.78 104.45 15.23 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.676 0.751 . . . . 0.0 109.495 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 30' ' ' THR . . . -177.86 155.49 1.05 Allowed Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 164.05 35.23 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.706 2.27 . . . . 0.0 113.001 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.21 151.21 33.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.588 0.708 . . . . 0.0 109.596 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -124.89 120.75 32.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.002 0.906 . . . . 0.0 109.604 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -81.13 135.9 35.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.967 0.889 . . . . 0.0 110.211 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -167.59 143.86 4.16 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.846 0.831 . . . . 0.0 109.973 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.1 t70 54.0 36.42 24.45 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.254 0.549 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.36 18.6 11.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.806 -0.559 . . . . 0.0 109.562 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 53' ' ' ARG . 94.3 mt-10 -132.67 159.63 39.04 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.719 0.771 . . . . 0.0 109.679 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.46 126.3 48.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.7 . . . . 0.0 109.909 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.3 mt -108.58 127.3 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.734 0.778 . . . . 0.0 109.686 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.52 119.87 13.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.729 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 25.1 m -105.82 113.13 26.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.659 0.742 . . . . 0.0 109.652 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.53 169.26 42.21 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.62 -50.51 62.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.726 -0.867 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.3 -0.41 49.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.465 -0.772 . . . . 0.0 108.982 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 94.1 m -81.58 -171.35 3.27 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.721 0.772 . . . . 0.0 110.149 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.99 -9.07 0.96 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.85 160.59 22.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.328 -1.101 . . . . 0.0 110.5 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.88 138.8 48.56 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.58 0.705 . . . . 0.0 109.407 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -124.31 125.07 25.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.28 166.22 24.7 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.412 2.075 . . . . 0.0 112.348 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.16 131.14 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.568 0.699 . . . . 0.0 109.438 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -118.88 120.17 36.52 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.889 0.852 . . . . 0.0 109.76 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 56.87 33.55 23.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.451 0.643 . . . . 0.0 109.797 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.46 -2.36 82.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -99.86 122.85 49.52 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.521 -0.988 . . . . 0.0 109.575 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.17 144.94 27.06 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.676 2.251 . . . . 0.0 112.825 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 48' ' ' LEU . 81.6 t -88.5 128.05 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.607 0.718 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.4 mt -118.4 25.33 10.37 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -100.12 130.48 46.27 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.316 1.055 . . . . 0.0 109.481 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.85 -42.29 94.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.645 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.19 -38.38 88.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.499 -0.75 . . . . 0.0 109.68 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.0 -8.0 58.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.127 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 146.22 54.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.731 0.777 . . . . 0.0 109.971 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 26' ' ' GLU . 90.9 mtm180 -102.13 139.34 37.88 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.721 0.772 . . . . 0.0 110.008 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -89.61 151.9 46.45 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.94 145.42 90.08 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.532 2.155 . . . . 0.0 112.689 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 C--N 1.3 -1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.3 179.468 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.593 0.711 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.02 162.45 7.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.363 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -59.81 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.442 2.095 . . . . 0.0 112.239 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -51.24 2.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.452 -0.78 . . . . 0.0 109.469 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.0 p -73.11 65.0 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' CYS . 53.9 t-80 -37.89 112.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.004 0.907 . . . . 0.0 110.497 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.45 168.72 1.93 Allowed Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.965 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 32.8 Cg_exo -56.01 145.93 71.94 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.883 2.389 . . . . 0.0 112.759 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 13' ' ' CYS . 76.6 mt -121.15 145.15 48.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.0 109.547 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -121.87 121.15 36.5 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.836 0.827 . . . . 0.0 109.081 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.93 137.53 34.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.74 -0.6 . . . . 0.0 109.977 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -139.3 115.02 10.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.027 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.8 -112.93 0.66 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.501 0.667 . . . . 0.0 110.602 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.73 27.03 10.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 108.901 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 41.3 mp0 -141.28 154.7 45.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.135 -0.978 . . . . 0.0 109.355 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.25 134.66 54.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.93 132.95 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.551 0.691 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.36 132.97 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.462 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.426 ' HG1' ' C ' ' A' ' 19' ' ' PRO . 11.7 p -124.2 136.85 54.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.76 -161.31 32.21 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.61 -57.51 3.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -1.053 . . . . 0.0 110.056 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -95.41 4.57 53.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.184 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -74.56 178.06 5.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.38 -5.13 1.83 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -74.7 155.75 37.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -1.084 . . . . 0.0 110.419 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.8 139.2 53.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-85 -127.33 109.74 21.25 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 157.06 28.58 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -91.75 132.21 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -0.959 . . . . 0.0 109.698 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -118.11 126.32 52.01 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.463 0.649 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 56.3 29.23 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.803 0.811 . . . . 0.0 110.085 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.31 5.34 90.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.0 mt -112.7 131.25 22.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.417 -1.049 . . . . 0.0 109.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 154.33 49.04 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.538 2.158 . . . . 0.0 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.34 122.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.44 ' C ' HD22 ' A' ' 48' ' ' LEU . 89.3 mt -113.09 21.39 15.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' C ' ' A' ' 47' ' ' LEU . 4.2 mm? -100.19 129.19 46.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.493 1.139 . . . . 0.0 109.924 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.46 -42.28 94.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -62.22 -37.92 87.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.658 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 -9.36 58.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.768 -1.207 . . . . 0.0 109.159 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.16 145.17 37.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -106.83 147.0 30.25 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.807 0.813 . . . . 0.0 109.966 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 9.9 mpt_? -86.17 156.07 57.43 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.696 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo . . . . . 0 N--CA 1.491 1.327 0 C-N-CA 122.344 2.03 . . . . 0.0 112.774 179.244 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.807 0.813 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.581 ' H ' ' HA ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -126.58 168.55 14.09 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-O 122.062 0.934 . . . . 0.0 109.749 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' CYS . 23.8 Cg_exo -63.3 141.59 82.49 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.44 2.094 . . . . 0.0 113.045 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.27 15.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.321 0.582 . . . . 0.0 109.56 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . 29.5 p -172.86 123.4 0.43 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.444 0.64 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.581 ' HA ' ' H ' ' A' ' 13' ' ' CYS . 51.7 p-80 -111.38 115.95 30.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.806 0.813 . . . . 0.0 110.057 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -176.27 173.14 0.87 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-O 121.365 0.602 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 43.2 Cg_exo -54.43 147.26 47.93 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.751 2.301 . . . . 0.0 112.664 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.577 HD21 ' SG ' ' A' ' 13' ' ' CYS . 83.4 mt -120.66 141.08 50.71 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.032 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -127.06 135.61 51.03 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.86 0.838 . . . . 0.0 109.687 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -83.4 137.12 34.07 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.669 0.747 . . . . 0.0 110.184 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -173.02 153.87 2.66 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.81 0.814 . . . . 0.0 110.128 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 96.8 m-20 54.52 33.25 18.52 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.304 0.573 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.52 19.02 11.66 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -142.16 175.29 9.86 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.635 0.731 . . . . 0.0 110.052 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.71 124.43 48.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.543 0.687 . . . . 0.0 109.548 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.61 137.4 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.914 0.864 . . . . 0.0 110.179 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.7 m -73.27 124.82 26.42 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 m -114.49 108.17 16.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.729 0.776 . . . . 0.0 109.957 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.44 48.41 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.5 -54.8 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.727 -0.866 . . . . 0.0 109.405 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.47 -2.26 31.17 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -93.61 113.71 25.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.516 -0.74 . . . . 0.0 109.553 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 9.79 0.89 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.84 156.49 38.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.42 131.52 56.74 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.754 0.788 . . . . 0.0 109.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.94 117.82 35.12 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.42 165.39 29.26 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.522 2.148 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.04 134.47 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.675 0.75 . . . . 0.0 110.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -101.48 103.81 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.732 0.777 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 54.33 36.4 25.2 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.423 0.63 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.61 72.09 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.17 98.93 44.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 122.018 -0.696 . . . . 0.0 109.285 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.23 134.6 64.72 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.647 2.232 . . . . 0.0 112.189 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.45 96.73 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.592 0.71 . . . . 0.0 109.413 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.0 mt -77.24 45.58 0.46 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.38 133.03 53.56 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.187 0.994 . . . . 0.0 109.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.14 -36.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.9 -39.85 90.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.595 -0.691 . . . . 0.0 109.358 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 51.0 mp0 -90.92 -6.02 54.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.44 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.98 147.19 50.45 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.489 0.662 . . . . 0.0 109.881 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -117.75 141.08 48.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.011 0.91 . . . . 0.0 110.064 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -94.87 150.95 38.6 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.777 2.318 . . . . 0.0 112.427 179.735 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.677 0.751 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.709 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -79.81 119.19 75.93 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-O 121.212 0.53 . . . . 0.0 109.754 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 52.6 Cg_exo -50.93 144.06 28.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.369 2.046 . . . . 0.0 112.649 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 79.87 -36.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.7 -169.09 1.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.834 0.826 . . . . 0.0 109.792 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -135.89 97.55 3.67 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.739 0.78 . . . . 0.0 109.633 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.07 171.2 1.12 Allowed Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 2.8 Cg_exo -74.79 172.25 16.65 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.9 2.4 . . . . 0.0 112.652 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.8 mt -114.48 134.26 55.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.699 -0.626 . . . . 0.0 109.618 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 30' ' ' THR . 6.1 pt-20 -111.21 135.48 51.68 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.853 0.835 . . . . 0.0 109.299 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -97.6 133.98 41.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.535 0.684 . . . . 0.0 110.451 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 124.85 27.79 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.85 0.833 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 49.74 -113.68 0.65 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.286 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.51 23.36 13.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.593 -0.692 . . . . 0.0 109.2 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.71 162.0 36.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.705 . . . . 0.0 110.064 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.74 148.13 38.76 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.895 0.855 . . . . 0.0 109.726 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.48 152.1 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.27 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -68.19 131.24 45.04 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.086 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 21' ' ' GLU . 3.1 m -91.65 166.91 12.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.092 0.948 . . . . 0.0 110.109 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 30' ' ' THR . . . 85.26 147.86 9.73 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.641 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 1.8 pm0 -75.5 -10.33 59.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.755 -0.85 . . . . 0.0 108.781 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.8 -4.73 55.68 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 34.9 m -129.46 -145.09 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.572 0.701 . . . . 0.0 109.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 148.41 -15.07 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -49.52 149.07 2.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.773 -0.839 . . . . 0.0 110.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . . . -113.66 135.4 53.96 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.659 0.742 . . . . 0.0 109.662 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -124.59 105.88 30.07 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.99 173.3 12.9 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.232 1.955 . . . . 0.0 111.977 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.17 132.34 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.507 0.67 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -124.94 126.4 45.44 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.933 0.873 . . . . 0.0 109.847 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.5 t0 57.54 27.68 14.44 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.446 0.641 . . . . 0.0 109.772 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.06 6.26 89.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.92 130.3 24.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.849 -0.795 . . . . 0.0 109.698 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.92 150.5 61.25 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.681 2.254 . . . . 0.0 112.676 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.1 t -91.79 106.68 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 46' ' ' VAL . 4.2 mm? -103.08 14.99 30.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.76 133.17 49.2 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.865 0.84 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.45 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.318 0.58 . . . . 0.0 109.63 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -59.44 -39.75 84.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 0.0 109.842 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.85 -5.49 53.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.091 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 154.46 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.493 0.663 . . . . 0.0 110.169 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.599 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 89.1 mtm180 -100.07 137.58 38.33 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.943 0.878 . . . . 0.0 110.096 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -49.21 167.51 0.21 Allowed Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.903 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo . . . . . 0 C--N 1.311 -1.438 0 C-N-CA 122.127 1.884 . . . . 0.0 112.765 179.911 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -88.36 142.88 31.75 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.269 -0.894 . . . . 0.0 110.171 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 72.4 Cg_endo -72.89 152.64 52.4 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.188 . . . . 0.0 112.988 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 69.41 -69.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.636 0.732 . . . . 0.0 110.777 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -29.41 68.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 0.0 109.489 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 52.63 88.82 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.005 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -171.37 172.05 2.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 24.6 Cg_exo -60.0 148.07 90.45 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.471 2.114 . . . . 0.0 112.588 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.84 142.36 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.927 0.87 . . . . 0.0 110.082 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -110.09 116.84 32.27 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.34 127.71 36.89 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.377 0.608 . . . . 0.0 110.02 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' ASP . 95.6 mtt180 -134.82 132.54 38.78 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 25' ' ' ALA . 5.6 p-10 40.2 -116.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.369 0.604 . . . . 0.0 110.55 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 24' ' ' ASP . . . -111.24 42.07 1.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 109.044 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -153.31 149.54 27.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.2 mp -116.19 134.67 54.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.553 0.692 . . . . 0.0 109.429 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.23 132.04 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.616 0.722 . . . . 0.0 109.966 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -70.72 125.64 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.23 127.78 56.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.571 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.88 -161.18 34.86 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.27 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -79.43 -58.01 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.495 -1.003 . . . . 0.0 109.514 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -95.05 7.67 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.051 -1.03 . . . . 0.0 108.72 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 171.0 15.74 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.41 -6.81 0.34 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.4 154.71 41.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.146 -1.208 . . . . 0.0 110.291 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.97 139.3 54.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 m-85 -124.01 121.26 26.34 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.81 161.86 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.26 131.6 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -103.7 104.57 14.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.866 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.6 t0 53.05 38.74 28.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.902 0.858 . . . . 0.0 110.051 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.64 7.46 78.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -111.84 101.22 50.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.146 -1.208 . . . . 0.0 109.308 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.0 139.99 69.92 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.628 2.218 . . . . 0.0 112.061 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 48' ' ' LEU . 94.2 t -89.43 121.73 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.009 . . . . 0.0 109.54 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 48' ' ' LEU . 49.4 mt -109.4 23.69 14.12 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' H ' HG12 ' A' ' 46' ' ' VAL . 4.3 mm? -100.01 126.27 46.17 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.437 1.113 . . . . 0.0 109.913 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.18 -41.92 92.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.642 0.734 . . . . 0.0 109.525 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.6 t0 -61.14 -34.67 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 109.801 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.6 -11.25 49.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.828 -1.17 . . . . 0.0 109.23 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.97 146.64 26.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.97 . . . . 0.0 110.049 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -112.96 140.6 47.63 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.921 0.867 . . . . 0.0 109.792 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -87.32 153.96 53.97 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.67 -0.644 . . . . 0.0 109.366 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.803 2.335 . . . . 0.0 112.749 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.4 p -68.81 152.37 96.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.3 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 16' ' ' CYS . 39.6 Cg_endo -66.3 145.23 77.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.561 2.174 . . . . 0.0 111.818 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 66.75 -61.17 0.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.575 -0.703 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -89.79 -173.57 3.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.273 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -136.61 109.96 7.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.463 -0.773 . . . . 0.0 109.61 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.85 176.42 0.48 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 7.5 Cg_exo -70.47 159.38 53.08 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.844 2.363 . . . . 0.0 112.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.77 143.94 45.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.46 118.37 30.92 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -80.36 128.65 33.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.504 -0.748 . . . . 0.0 109.206 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -130.68 123.6 29.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.483 -0.761 . . . . 0.0 109.202 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 52.82 -96.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.318 0.58 . . . . 0.0 109.69 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.97 30.08 3.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.28 155.17 46.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.845 . . . . 0.0 109.738 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.3 mt -104.54 128.57 52.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.26 131.34 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.454 0.645 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 34' ' ' CYS . 1.7 t -72.13 123.99 24.05 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 -178.75 4.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.041 -1.037 . . . . 0.0 109.685 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.48 148.68 6.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 24.3 mp0 -75.14 -10.86 59.86 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -1.006 . . . . 0.0 108.831 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.87 -3.53 54.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -142.32 -150.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.259 -0.901 . . . . 0.0 109.791 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 145.5 2.74 0.66 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.16 160.32 32.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -1.142 . . . . 0.0 110.039 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.19 137.75 54.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.664 -0.647 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -121.35 107.96 36.38 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.26 150.5 22.65 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.95 1.767 . . . . 0.0 112.44 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.55 132.82 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -117.59 127.63 54.16 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 55.05 30.52 14.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 109.907 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.51 88.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mt -117.5 131.8 23.89 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.394 -1.062 . . . . 0.0 109.3 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.36 145.73 38.82 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.035 1.823 . . . . 0.0 111.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 48' ' ' LEU . 58.8 t -100.91 127.15 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.71 32.13 6.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 46' ' ' VAL . 72.7 mt -108.2 131.66 54.43 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.977 0.894 . . . . 0.0 109.767 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.93 -42.23 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.5 -19.28 46.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.91 -13.31 16.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.321 -0.862 . . . . 0.0 109.034 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.09 144.98 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.645 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -109.17 139.32 44.24 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -85.82 154.07 58.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.28 1.987 . . . . 0.0 112.899 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.3 p -100.13 116.04 64.92 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.828 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.5 Cg_exo -51.36 146.88 23.35 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.762 1.642 . . . . 0.0 112.79 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 76.41 -35.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.558 -0.714 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -124.95 -166.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 109.137 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.657 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 50.4 p-80 -146.96 111.78 5.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.61 158.76 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.183 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' C ' ' OG1' ' A' ' 30' ' ' THR . 32.1 Cg_exo -56.97 177.41 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.362 2.041 . . . . 0.0 112.829 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt -120.1 141.7 49.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.395 -0.816 . . . . 0.0 109.28 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -122.64 134.23 54.5 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.933 0.873 . . . . 0.0 109.743 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.73 138.76 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.645 -0.66 . . . . 0.0 109.531 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -137.76 122.68 18.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.562 -0.711 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.0 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.413 0.625 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.91 28.12 3.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -139.16 160.95 38.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.342 -0.849 . . . . 0.0 109.564 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.0 mt -109.94 119.54 39.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.5 pt -107.8 144.43 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -0.884 . . . . 0.0 109.655 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -70.93 134.39 47.18 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.529 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' C ' ' A' ' 19' ' ' PRO . 6.3 m -73.63 145.9 45.01 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.304 -0.872 . . . . 0.0 109.935 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 140.44 9.57 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 26.7 mp0 -66.17 -45.61 80.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.624 -0.927 . . . . 0.0 109.692 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 57.8 t0 -78.53 -6.73 56.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -87.36 -46.92 9.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 41.78 -103.73 0.04 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.1 mt 41.2 111.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.229 1.014 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.46 127.63 53.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -0.768 . . . . 0.0 109.674 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -114.79 104.34 54.27 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.56 168.83 19.26 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.093 1.862 . . . . 0.0 111.61 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.39 131.5 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.945 . . . . 0.0 109.375 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 43' ' ' GLY . 62.8 ttm-85 -114.19 130.53 56.62 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 56.78 5.66 0.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.403 -0.81 . . . . 0.0 109.888 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ARG . . . 108.39 -7.68 34.7 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.28 135.0 20.62 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.344 -1.092 . . . . 0.0 109.645 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.36 144.0 32.57 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 112.544 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.93 111.74 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 109.177 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.5 mt -97.47 16.03 21.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.837 . . . . 0.0 108.933 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 48' ' ' LEU . 4.1 mm? -94.22 126.33 39.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 109.588 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.28 -42.36 90.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.635 -0.666 . . . . 0.0 109.753 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.55 -38.04 83.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.2 -6.99 56.47 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.23 -0.919 . . . . 0.0 109.358 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.18 39.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.649 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.72 142.03 33.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.452 -0.78 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -88.2 150.63 47.57 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 109.552 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.498 1.759 0 C-N-CA 122.658 2.239 . . . . 0.0 112.702 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -78.79 153.79 78.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.625 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 38.1 Cg_endo -66.7 143.24 67.04 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.619 2.213 . . . . 0.0 111.779 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 68.92 -53.56 0.57 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.642 -0.661 . . . . 0.0 109.866 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.74 -173.36 2.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 54.6 t-80 -134.47 109.79 8.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.759 -0.588 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 173.6 155.39 0.28 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.0 Cg_exo -53.78 153.51 19.29 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.906 1.737 . . . . 0.0 112.647 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 mt -105.26 134.53 48.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -111.54 132.59 54.41 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' OE1' ' CD2' ' A' ' 27' ' ' LEU . 40.2 mm-40 -89.9 127.87 36.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' ALA . 60.6 ttt85 -125.71 108.72 11.8 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.62 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.55 27.27 2.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.478 -0.764 . . . . 0.0 109.286 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -135.22 155.96 49.79 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.425 0.631 . . . . 0.0 109.544 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' CD2' ' OE1' ' A' ' 22' ' ' GLU . 45.4 mt -106.83 130.62 54.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.594 -0.691 . . . . 0.0 109.662 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.55 130.55 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.374 0.607 . . . . 0.0 109.866 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.8 m -64.46 145.87 55.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.297 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -57.25 -19.39 21.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 108.978 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.65 8.62 87.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -62.66 -43.68 98.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.947 . . . . 0.0 108.958 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -126.77 -9.14 6.12 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.8 p -141.01 -112.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.773 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.49 19.72 0.51 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.61 157.61 33.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.497 -1.002 . . . . 0.0 109.954 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 38' ' ' TYR . . . -129.59 149.64 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.5 0.667 . . . . 0.0 109.91 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 15.7 m-85 -135.48 127.82 17.88 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.57 167.19 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.119 1.879 . . . . 0.0 111.852 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.82 131.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.508 -0.745 . . . . 0.0 109.048 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -103.4 107.41 18.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.387 -0.821 . . . . 0.0 109.68 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.4 t0 53.18 40.83 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.28 90.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.52 104.47 54.35 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.486 -1.008 . . . . 0.0 109.143 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.82 137.79 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.187 1.925 . . . . 0.0 112.396 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.54 101.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.725 . . . . 0.0 109.326 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 mt -93.71 35.28 1.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.745 0.783 . . . . 0.0 109.724 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.65 -43.46 93.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.583 -0.698 . . . . 0.0 109.745 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 6.5 p-10 -60.62 -33.19 72.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.52 -0.738 . . . . 0.0 109.851 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -92.35 10.83 28.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 109.039 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 145.46 54.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.579 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -111.11 137.26 48.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -87.38 151.62 51.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.578 -0.702 . . . . 0.0 109.327 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.496 1.619 0 C-N-CA 122.691 2.26 . . . . 0.0 112.463 179.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.7 t -93.74 140.02 22.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.25 33.0 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.001 1.801 . . . . 0.0 111.619 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -153.52 -75.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 109.157 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' C ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -87.57 7.04 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.6 m80 54.59 12.0 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 16' ' ' CYS . . . -73.9 151.7 88.7 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.167 -0.958 . . . . 0.0 109.721 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.68 163.2 33.94 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.707 2.271 . . . . 0.0 112.305 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -108.71 148.18 30.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -112.73 134.67 54.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.27 125.92 32.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 28' ' ' ILE . 42.6 ttm180 -132.22 117.44 18.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.533 -0.729 . . . . 0.0 109.194 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 52.47 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.247 0.546 . . . . 0.0 110.14 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -136.92 29.43 2.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.12 160.12 41.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.409 -0.807 . . . . 0.0 109.883 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.59 134.5 51.85 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 23' ' ' ARG . 96.8 mt -115.0 130.6 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.404 0.621 . . . . 0.0 109.657 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.5 t -66.97 131.7 46.4 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 110.224 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -77.09 -1.12 27.47 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.279 -0.888 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 129.47 19.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.81 -39.65 79.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.588 -0.948 . . . . 0.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -84.88 -5.45 59.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.171 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -94.03 -70.28 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.0 109.27 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.82 15.13 54.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 34' ' ' CYS . 91.1 mt -76.67 149.06 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -1.169 . . . . 0.0 110.256 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.97 144.37 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -129.84 115.29 17.9 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 156.95 32.23 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.269 1.979 . . . . 0.0 112.755 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.93 129.89 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -127.49 131.76 50.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 54.05 27.85 8.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.251 0.548 . . . . 0.0 110.256 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.33 -3.46 79.55 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 tt -138.84 135.42 17.69 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.268 -1.136 . . . . 0.0 109.919 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.03 155.77 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.272 1.982 . . . . 0.0 112.261 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 48' ' ' LEU . 21.8 t -87.49 130.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.527 -0.733 . . . . 0.0 109.415 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.35 34.2 2.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.608 -0.682 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' H ' HG12 ' A' ' 46' ' ' VAL . 68.7 mt -111.39 137.75 48.76 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.818 0.818 . . . . 0.0 109.595 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.47 -42.43 93.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.558 -0.714 . . . . 0.0 109.797 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 1.7 p-10 -60.28 -33.86 72.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -92.42 -7.92 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 108.807 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 149.6 49.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 110.044 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -101.76 138.52 38.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.454 -0.779 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -96.37 160.97 28.48 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.496 1.649 0 C-N-CA 122.291 1.994 . . . . 0.0 112.695 178.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.678 0.751 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.8 t -85.54 125.37 69.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.556 -0.715 . . . . 0.0 109.403 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.15 -21.93 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.963 1.775 . . . . 0.0 111.466 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . . . -91.63 -25.07 19.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' CYS . 6.9 p -160.55 162.84 33.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.16 1.5 11.09 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 108.931 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.32 123.55 35.96 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.046 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.36 163.25 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 0.0 112.615 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -112.0 139.17 47.73 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.636 0.732 . . . . 0.0 109.896 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -113.62 122.69 47.95 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.848 0.833 . . . . 0.0 109.012 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.6 122.71 25.66 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.552 0.691 . . . . 0.0 109.99 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -127.98 117.11 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.638 0.732 . . . . 0.0 109.175 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 52.07 -109.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.479 0.656 . . . . 0.0 110.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.53 26.46 9.86 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -141.74 161.31 38.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.0 mt -111.35 130.3 55.73 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.04 129.84 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.818 0.818 . . . . 0.0 109.791 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.3 131.78 43.94 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.9 p -79.81 2.7 22.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.42 133.42 28.08 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.55 -46.42 76.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.676 -0.896 . . . . 0.0 109.974 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -85.48 -5.16 59.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -95.4 -69.22 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.07 19.2 2.44 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 34' ' ' CYS . 87.9 mt -73.21 151.03 41.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.316 -1.108 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.44 130.53 53.17 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 109.262 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.85 127.36 27.06 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 161.36 28.28 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.9 2.4 . . . . 0.0 112.41 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.87 131.61 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -103.88 104.27 14.23 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.961 0.886 . . . . 0.0 109.797 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 t0 52.82 39.68 29.32 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.878 0.847 . . . . 0.0 110.454 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.17 7.58 79.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mm -111.56 100.37 47.73 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.314 -1.11 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.19 139.7 72.01 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.798 2.332 . . . . 0.0 112.02 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 48' ' ' LEU . 60.4 t -97.26 120.74 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.083 -1.011 . . . . 0.0 109.547 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.4 mt -103.61 34.67 2.88 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HG12 ' A' ' 46' ' ' VAL . 75.1 mt -109.33 128.72 55.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.113 0.959 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.92 -40.29 87.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.646 0.736 . . . . 0.0 109.586 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.83 -39.67 81.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.568 -0.708 . . . . 0.0 110.166 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.59 -8.07 53.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.955 -1.091 . . . . 0.0 109.198 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 145.78 54.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -103.61 136.64 42.94 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.851 0.834 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 156.82 37.86 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -76.19 170.49 15.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.46 -0.775 . . . . 0.0 109.642 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 72.2 Cg_endo -80.23 -86.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.581 2.187 . . . . 0.0 111.772 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -46.36 81.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 24.7 p -93.11 55.03 2.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 108.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 13' ' ' CYS . 86.8 m-70 -41.24 108.94 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 110.763 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.07 177.36 0.67 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.586 -0.697 . . . . 0.0 109.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.597 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 14.5 Cg_exo -68.66 147.79 70.61 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.812 2.341 . . . . 0.0 112.557 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.8 152.15 51.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -122.82 133.99 54.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.8 126.34 32.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.813 -0.554 . . . . 0.0 109.768 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -171.68 157.16 4.57 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.691 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 48.1 t0 56.21 24.27 7.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.618 -0.676 . . . . 0.0 109.344 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 72.28 15.22 5.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.984 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -142.01 165.61 26.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.8 mt -101.51 119.61 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.7 mt -97.4 131.61 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 m -75.61 143.12 42.48 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.457 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 106.82 4.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.322 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.48 17.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.48 -54.18 43.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.164 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 30.0 p-10 -112.72 7.64 18.67 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -86.28 163.89 17.45 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.715 0.769 . . . . 0.0 110.124 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.15 -20.09 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.81 178.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -1.087 . . . . 0.0 110.249 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 139.0 40.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.484 -0.76 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -121.52 120.49 28.81 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.46 164.92 28.07 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.084 1.856 . . . . 0.0 111.852 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.92 132.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -104.61 108.17 19.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 109.538 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.16 38.2 26.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.61 4.39 85.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.2 mt -108.41 104.42 54.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -1.115 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.12 142.11 55.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.092 1.861 . . . . 0.0 112.247 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 48' ' ' LEU . 69.0 t -95.23 131.64 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.4 -0.812 . . . . 0.0 109.395 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.67 35.38 4.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HG12 ' A' ' 46' ' ' VAL . 67.4 mt -106.33 131.41 53.58 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.76 0.79 . . . . 0.0 109.424 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.51 -43.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.994 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.54 -38.23 86.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 110.179 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -88.12 -6.45 57.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.057 -1.027 . . . . 0.0 109.242 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.01 46.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.681 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.85 161.2 15.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -90.43 177.1 2.51 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.552 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 N--CA 1.498 1.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.17 -179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 122.215 1.007 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -60.39 159.7 21.95 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-O 121.361 0.601 . . . . 0.0 109.731 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.84 -79.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.614 2.21 . . . . 0.0 111.847 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.7 85.97 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -104.89 164.94 11.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 109.422 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 49.3 p-80 -115.88 105.58 12.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.868 0.842 . . . . 0.0 110.1 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.26 176.51 0.57 Allowed Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 109.428 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 9.9 Cg_exo -70.1 155.69 64.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.957 2.438 . . . . 0.0 113.013 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.88 139.22 49.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.79 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -111.62 126.73 55.32 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.188 0.994 . . . . 0.0 109.399 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.5 mp0 -79.42 141.95 36.38 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.652 0.739 . . . . 0.0 110.558 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.9 tpt180 -143.93 161.46 38.66 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.863 0.84 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . 67.2 t0 -42.6 116.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.586 0.708 . . . . 0.0 110.604 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 24' ' ' ASP . . . 37.0 35.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.763 0.792 . . . . 0.0 110.047 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' CD ' ' NH2' ' A' ' 53' ' ' ARG . 68.9 tt0 -159.81 157.1 28.65 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.058 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.6 mt -126.32 127.59 45.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.573 0.701 . . . . 0.0 109.405 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 98.4 mt -106.8 125.77 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-O 121.923 0.868 . . . . 0.0 109.745 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -73.51 120.17 18.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.781 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -81.7 170.88 15.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.807 0.813 . . . . 0.0 110.184 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 148.71 21.98 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.34 -36.61 68.86 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.781 -0.834 . . . . 0.0 109.351 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.92 -5.23 47.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.739 . . . . 0.0 109.242 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 81.9 m -102.18 -117.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.3 -7.88 62.24 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.8 mt -68.4 149.71 49.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.987 . . . . 0.0 110.321 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.48 145.42 49.54 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 52' ' ' ALA . 80.2 m-85 -130.46 115.82 17.3 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.33 164.58 26.43 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.587 2.192 . . . . 0.0 111.941 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -103.32 132.11 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.715 0.769 . . . . 0.0 109.814 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -121.61 129.46 52.84 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.689 0.757 . . . . 0.0 109.638 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 57.33 30.82 19.14 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.511 0.672 . . . . 0.0 109.351 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.84 85.43 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.08 130.32 24.01 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.763 -0.845 . . . . 0.0 109.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.02 141.58 40.44 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.579 2.186 . . . . 0.0 112.09 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 48' ' ' LEU . 89.8 t -90.07 128.18 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.71 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.402 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.2 mt -117.79 30.17 7.42 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' H ' HG12 ' A' ' 46' ' ' VAL . 11.2 mp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.297 1.046 . . . . 0.0 109.575 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.11 -42.94 95.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.722 -0.611 . . . . 0.0 109.691 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.89 -17.13 64.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.518 -0.739 . . . . 0.0 109.4 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.63 -12.61 18.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.36 -0.838 . . . . 0.0 108.772 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . -57.14 142.73 41.52 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' NH2' ' CD ' ' A' ' 26' ' ' GLU . 89.2 mtm180 -105.87 146.43 29.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.706 0.765 . . . . 0.0 109.728 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 11.4 mpt_? -83.14 151.76 63.83 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.944 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 C--N 1.308 -1.595 0 C-N-CA 122.759 2.306 . . . . 0.0 112.665 179.893 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -90.1 153.72 46.98 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.684 -0.635 . . . . 0.0 110.266 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -65.28 141.91 70.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.663 2.242 . . . . 0.0 111.99 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 70.45 -12.59 0.51 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.603 -0.686 . . . . 0.0 109.243 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -136.54 -167.76 2.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 108.948 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 17' ' ' HIS . 56.5 t-80 -140.95 24.97 2.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.652 -0.655 . . . . 0.0 109.285 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -99.89 171.8 5.24 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.516 -0.74 . . . . 0.0 109.819 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.4 Cg_endo -77.99 178.12 7.97 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.238 1.959 . . . . 0.0 112.852 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 13' ' ' CYS . 92.2 mt -115.0 144.09 44.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.635 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -111.41 111.65 22.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.8 pt-20 -74.75 132.29 41.5 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.179 0.514 . . . . 0.0 110.014 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -141.53 124.91 16.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.5 -111.6 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.83 -0.544 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.4 34.69 4.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -152.47 155.69 37.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.0 109.827 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 131.29 56.38 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.27 130.33 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.46 0.648 . . . . 0.0 109.84 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 t -63.13 114.93 4.04 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.7 m -68.49 144.33 54.67 Favored 'General case' 0 C--O 1.209 -1.061 0 O-C-N 121.158 -0.964 . . . . 0.0 110.328 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.59 145.9 8.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -65.57 -41.39 92.95 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -86.9 -1.09 57.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 30' ' ' THR . 2.2 m -89.35 -79.24 0.33 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.626 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 64.37 -93.38 0.14 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.626 ' O ' ' O ' ' A' ' 35' ' ' GLY . 3.3 mm? 24.74 111.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.069 0.938 . . . . 0.0 111.708 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.27 123.74 44.87 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.52 -0.738 . . . . 0.0 109.335 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -108.0 104.62 54.09 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.67 160.81 28.02 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.288 1.992 . . . . 0.0 112.246 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.76 131.06 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -121.69 127.16 50.45 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.362 0.601 . . . . 0.0 109.584 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 51.7 t0 58.08 26.4 13.57 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.47 0.652 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.66 5.4 89.49 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.63 130.02 23.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.928 . . . . 0.0 109.834 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.32 143.18 47.39 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.367 2.045 . . . . 0.0 112.633 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.69 112.44 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -102.97 18.79 20.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.5 mt -107.88 128.74 54.89 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.638 0.732 . . . . 0.0 109.521 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.7 -41.37 92.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.341 0.591 . . . . 0.0 109.668 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.14 -42.66 81.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.921 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -89.06 -4.84 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.62 156.74 37.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.949 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.5 138.64 39.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.504 -0.748 . . . . 0.0 109.97 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -89.9 155.05 47.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.555 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 N--CA 1.493 1.467 0 C-N-CA 122.377 2.051 . . . . 0.0 112.797 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -67.36 153.61 94.49 Favored Pre-proline 0 C--N 1.296 -1.758 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.954 -178.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.72 -45.92 37.49 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.92 -61.89 1.67 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.625 . . . . 0.0 109.728 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.39 162.21 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 61.1 t-80 -107.62 103.54 12.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.525 -0.734 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . 176.92 158.12 0.46 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.104 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 27.3 Cg_endo -64.54 154.47 71.79 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.725 2.284 . . . . 0.0 112.604 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -106.75 148.44 28.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -106.57 127.38 53.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -75.72 130.81 39.27 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.5 tpt85 -139.03 165.38 27.27 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 23' ' ' ARG . 67.5 t0 -38.79 103.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.465 0.65 . . . . 0.0 110.411 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 40.6 38.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.428 0.632 . . . . 0.0 110.042 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -157.75 154.28 27.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.935 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -118.94 133.28 55.93 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.25 125.58 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.779 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.69 129.48 41.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -101.62 29.24 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.266 -0.896 . . . . 0.0 108.698 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 34' ' ' CYS . . . -97.95 144.81 17.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.7 -33.46 73.99 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.601 -0.94 . . . . 0.0 109.21 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.66 -3.63 52.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.201 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 11.0 p -144.16 128.52 17.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.71 27.54 2.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.11 157.79 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.451 -1.029 . . . . 0.0 109.89 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.74 141.32 51.93 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.393 0.616 . . . . 0.0 109.723 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-85 -125.02 122.96 25.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.73 161.25 30.75 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.314 2.009 . . . . 0.0 112.487 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -95.77 132.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.126 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -137.21 146.66 45.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.655 -0.653 . . . . 0.0 109.964 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.95 27.28 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.449 0.642 . . . . 0.0 109.675 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.88 7.05 83.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 pt -131.35 149.37 73.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.432 -1.04 . . . . 0.0 109.69 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.33 143.04 51.57 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.624 2.216 . . . . 0.0 112.668 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.25 93.07 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.008 . . . . 0.0 109.005 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 42.49 0.71 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.85 120.19 36.6 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.639 0.733 . . . . 0.0 109.405 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' VAL . 6.2 m -65.85 -30.34 49.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 0.0 109.348 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.19 -40.36 97.29 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.32 -6.55 52.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 157.26 27.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 110.011 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -129.48 168.72 15.92 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.813 0.816 . . . . 0.0 109.949 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -76.58 153.52 83.57 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.641 -0.662 . . . . 0.0 109.564 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.495 1.571 0 C-N-CA 122.721 2.281 . . . . 0.0 112.463 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.436 0.636 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -60.07 156.82 35.44 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.627 -0.671 . . . . 0.0 109.534 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.92 -8.11 22.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.436 2.091 . . . . 0.0 111.22 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.52 -47.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.34 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -69.11 -24.53 64.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 18' ' ' ALA . 36.2 t-80 69.9 -26.65 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.733 -0.604 . . . . 0.0 109.865 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -48.9 -178.71 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.445 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.678 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 38.1 Cg_endo -86.14 163.38 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.846 2.364 . . . . 0.0 112.606 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.72 151.3 32.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.178 -0.951 . . . . 0.0 109.359 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -122.24 133.65 54.7 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.544 0.688 . . . . 0.0 109.223 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.09 127.67 33.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.879 -0.513 . . . . 0.0 109.774 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -132.66 116.57 16.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.543 -0.723 . . . . 0.0 109.279 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 51.17 -110.76 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.74 -0.6 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 40' ' ' VAL . . . -115.77 26.31 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.83 161.25 38.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -109.96 129.32 55.68 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.13 131.67 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.543 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -69.49 119.67 14.1 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.528 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 2.8 m -89.99 165.17 14.21 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.53 -176.97 18.9 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.98 -57.35 4.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.533 -0.98 . . . . 0.0 110.103 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -114.01 28.07 9.04 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -78.11 -80.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 62.85 -114.86 7.3 Favored Glycine 0 C--O 1.202 -1.853 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 ' O ' ' O ' ' A' ' 35' ' ' GLY . 75.1 mt 41.98 121.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.58 1.181 . . . . 0.0 111.453 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.99 133.34 51.79 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.19 -0.944 . . . . 0.0 109.793 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.42 108.68 45.05 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.335 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.99 161.52 23.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.564 2.176 . . . . 0.0 112.352 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 25' ' ' ALA . 90.7 t -95.26 132.84 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.806 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -105.83 108.16 19.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.24 36.95 28.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.584 0.707 . . . . 0.0 109.658 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.26 87.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -110.18 105.02 56.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.534 -0.98 . . . . 0.0 109.715 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.35 134.08 50.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.0 98.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.78 31.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.368 -0.833 . . . . 0.0 109.422 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.45 126.57 55.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.094 0.949 . . . . 0.0 109.592 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -64.6 -39.93 87.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.602 0.715 . . . . 0.0 109.618 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.5 t0 -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -91.04 -9.73 44.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.272 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.71 38.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 109.948 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -111.76 139.45 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.789 0.804 . . . . 0.0 110.05 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -79.9 158.75 72.39 Favored Pre-proline 0 C--N 1.303 -1.42 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.402 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 112.655 179.169 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.1 p -58.46 114.93 9.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.689 -0.632 . . . . 0.0 109.723 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -50.26 -9.64 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.237 1.958 . . . . 0.0 111.515 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -100.95 -72.98 0.66 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.225 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -13.64 51.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.374 -0.829 . . . . 0.0 109.277 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 85.9 t60 55.07 88.68 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.847 0.832 . . . . 0.0 109.835 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.643 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -173.01 170.22 2.12 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.421 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 35.8 Cg_exo -60.53 153.78 58.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.06 2.506 . . . . 0.0 112.632 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.27 149.19 36.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.0 109.805 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -117.74 135.09 54.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.37 124.14 36.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.271 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 25' ' ' ALA . 69.0 ttp85 -122.8 112.66 18.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 53.98 -87.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.0 110.192 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -139.56 28.62 2.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 108.848 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' C ' HD22 ' A' ' 27' ' ' LEU . 98.1 mt-10 -137.62 154.87 49.67 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.705 0.764 . . . . 0.0 109.907 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.436 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.8 mm? -105.11 134.68 47.8 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.794 0.807 . . . . 0.0 110.002 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.77 129.35 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.673 0.749 . . . . 0.0 110.012 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 125.37 25.03 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.03 127.22 55.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.533 -0.729 . . . . 0.0 109.847 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.97 -172.47 39.0 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -73.1 -57.4 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.558 -0.966 . . . . 0.0 110.032 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -89.58 5.8 44.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.073 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -80.14 168.97 18.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.959 0.885 . . . . 0.0 110.074 -179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 -10.29 0.18 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -70.54 157.73 37.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 0.0 110.602 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.84 146.51 50.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.07 129.63 22.56 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.93 164.68 31.26 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.326 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -108.11 132.42 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.522 0.677 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -122.72 128.36 50.44 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.911 0.863 . . . . 0.0 110.04 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 57.52 28.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.72 0.771 . . . . 0.0 109.918 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 3.99 90.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.54 131.41 23.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.5 -1.0 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.06 145.14 54.52 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.592 2.195 . . . . 0.0 112.583 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 48' ' ' LEU . 83.5 t -89.38 123.91 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.546 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.58 32.26 5.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' H ' HG12 ' A' ' 46' ' ' VAL . 77.2 mt -102.53 132.51 48.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.32 -41.1 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.613 0.721 . . . . 0.0 109.764 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.5 -40.13 86.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.945 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.77 7.96 16.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.99 -1.069 . . . . 0.0 109.247 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.13 58.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.691 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.93 120.43 41.89 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.716 0.77 . . . . 0.0 109.159 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -84.61 151.23 58.26 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.764 2.309 . . . . 0.0 112.801 179.707 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.559 0.695 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.69 163.58 53.55 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.23 -83.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.389 2.059 . . . . 0.0 112.057 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.8 77.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.091 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 30.1 p -97.19 66.34 2.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -41.58 119.13 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -176.99 159.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.464 -0.772 . . . . 0.0 109.187 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.94 137.34 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.962 1.775 . . . . 0.0 112.802 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' SG ' ' A' ' 13' ' ' CYS . 73.4 mt -112.65 148.59 34.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.53 -0.731 . . . . 0.0 110.087 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -113.54 117.66 32.28 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -98.8 123.45 43.05 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.554 -0.716 . . . . 0.0 109.596 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' ALA . 10.3 ptp180 -128.85 125.95 38.76 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.633 -0.667 . . . . 0.0 109.36 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.88 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.316 0.579 . . . . 0.0 109.593 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.43 28.71 1.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -135.48 139.52 44.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.6 -0.687 . . . . 0.0 109.253 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.9 mp -109.73 135.78 50.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.622 -0.674 . . . . 0.0 109.555 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.7 132.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.433 0.635 . . . . 0.0 110.121 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.3 m -58.08 123.88 17.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.64 -20.17 17.82 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.05 -1.031 . . . . 0.0 108.62 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -66.33 137.48 35.36 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.73 -14.5 52.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.238 -1.154 . . . . 0.0 108.882 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -80.11 -4.22 51.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.355 -0.841 . . . . 0.0 109.138 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -157.02 165.81 35.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.65 17.01 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.64 159.44 34.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.486 -1.008 . . . . 0.0 109.996 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.32 144.29 49.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.574 0.702 . . . . 0.0 110.275 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 12.1 m-85 -129.86 127.18 22.76 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.15 158.31 30.19 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.168 1.912 . . . . 0.0 111.916 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.72 131.21 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -104.36 108.77 20.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.501 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 53.39 36.86 24.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.8 87.3 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mt -111.04 108.36 57.48 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.4 -1.059 . . . . 0.0 109.387 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.44 135.02 53.95 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.831 1.687 . . . . 0.0 112.121 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -92.81 95.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 108.966 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.1 mt -89.29 64.23 6.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.1 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -121.33 125.77 47.81 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.747 0.784 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.63 -43.51 98.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.72 -40.26 94.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.77 -4.68 59.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.002 -1.061 . . . . 0.0 109.49 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.21 142.57 30.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.135 -0.978 . . . . 0.0 109.601 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -106.04 141.73 36.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 0.0 109.281 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.55 150.63 49.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.0 109.295 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo . . . . . 0 N--CA 1.49 1.294 0 C-N-CA 122.505 2.137 . . . . 0.0 112.873 179.824 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.8 m -59.41 151.07 61.65 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.56 -22.48 58.41 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.04 1.827 . . . . 0.0 111.672 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.93 -30.64 2.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.266 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.6 -168.1 1.63 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.399 -0.813 . . . . 0.0 109.141 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -125.15 19.51 8.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.549 -0.719 . . . . 0.0 109.537 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -95.42 -177.75 0.69 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.652 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 48.2 Cg_endo -86.73 167.04 8.64 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 113.36 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -112.13 150.04 31.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.135 -0.978 . . . . 0.0 109.647 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -128.46 121.03 28.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.75 135.43 37.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ALA . 78.6 ttt-85 -128.87 104.61 7.71 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 99.0 m-20 -22.28 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 O-C-N 123.59 0.556 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . 155.38 -30.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -178.08 -174.15 0.41 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.706 0.765 . . . . 0.0 110.784 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -105.26 129.58 53.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 131.48 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.681 . . . . 0.0 109.271 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 t -74.87 122.79 23.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.2 m -84.46 157.4 21.36 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.05 -1.031 . . . . 0.0 109.342 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.11 167.67 13.82 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -75.91 -55.11 5.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 109.757 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -80.52 -2.93 48.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 57.1 m -81.25 -114.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.528 -0.733 . . . . 0.0 109.805 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 36' ' ' LEU . . . 86.68 -62.45 4.25 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' GLY . 66.8 mt -9.43 125.59 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.637 0.732 . . . . 0.0 111.932 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 130.84 55.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.316 -0.865 . . . . 0.0 109.522 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -113.04 119.85 41.7 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.87 164.92 22.53 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.163 1.909 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.24 131.15 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -119.82 126.32 50.7 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.528 0.68 . . . . 0.0 109.697 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.0 t0 56.23 28.39 13.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.68 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -0.08 89.7 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mm -107.1 131.02 22.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -1.188 . . . . 0.0 109.139 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.32 142.74 27.28 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.306 2.004 . . . . 0.0 112.132 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.63 94.75 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 109.087 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -85.27 39.88 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.346 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.2 mt -111.61 128.0 55.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.784 0.802 . . . . 0.0 109.788 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.75 -41.67 90.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -57.98 -41.21 82.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -90.27 -5.86 55.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.009 -1.057 . . . . 0.0 109.516 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.83 48.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -104.32 143.48 32.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.454 0.645 . . . . 0.0 109.674 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -95.27 113.85 62.49 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.701 -0.624 . . . . 0.0 109.435 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo . . . . . 0 N--CA 1.496 1.658 0 C-N-CA 121.864 1.709 . . . . 0.0 112.805 179.206 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.98 159.02 58.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.397 -0.814 . . . . 0.0 109.813 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.804 2.336 . . . . 0.0 112.012 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.52 -48.25 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.911 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -99.58 159.89 14.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.286 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.656 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 47.3 p-80 -108.58 112.09 24.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.546 -0.721 . . . . 0.0 109.9 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.82 156.78 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.01 163.31 39.7 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.688 2.259 . . . . 0.0 111.985 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.4 147.75 45.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.638 -0.664 . . . . 0.0 109.292 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.59 126.82 52.58 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.97 122.75 31.95 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.214 0.53 . . . . 0.0 109.845 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.92 161.26 4.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 98.2 m-20 52.95 31.48 10.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.35 22.64 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 110.281 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.76 159.47 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.518 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 27' ' ' LEU . 8.2 mp -106.84 125.32 50.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.6 mt -101.82 128.85 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 129.57 38.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.561 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.2 p -84.59 170.9 12.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 145.8 16.14 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -68.32 -53.74 22.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.618 -0.931 . . . . 0.0 109.7 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.87 -5.52 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -0.791 . . . . 0.0 109.709 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 1.3 t -116.96 87.47 2.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.32 -141.07 9.14 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt 74.45 160.6 0.23 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.849 0.833 . . . . 0.0 109.759 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.81 150.73 35.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.838 . . . . 0.0 109.54 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.3 m-85 -115.56 134.08 22.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.99 161.5 41.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.044 1.829 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.37 131.85 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -112.44 120.69 42.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.632 -0.668 . . . . 0.0 109.601 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.9 t0 57.16 22.67 7.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.11 -2.28 71.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.87 124.12 39.85 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.396 -1.061 . . . . 0.0 109.151 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.44 142.12 40.06 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.044 1.829 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 48' ' ' LEU . 25.9 t -88.98 118.93 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.074 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.6 mt -100.33 32.22 3.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.477 -0.764 . . . . 0.0 109.317 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' H ' HG12 ' A' ' 46' ' ' VAL . 76.9 mt -107.09 129.07 54.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.942 0.877 . . . . 0.0 109.471 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.74 -42.15 94.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.63 -20.08 53.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.495 -0.753 . . . . 0.0 110.162 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -102.19 2.62 37.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 0.0 108.986 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 145.97 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.812 . . . . 0.0 109.645 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -119.22 141.72 48.65 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.55 0.69 . . . . 0.0 109.347 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 3.0 mtp180 -89.77 177.55 2.38 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 54' ' ' ARG . 36.5 Cg_exo . . . . . 0 N--CA 1.496 1.663 0 C-N-CA 122.657 2.238 . . . . 0.0 112.508 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.832 0.825 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -74.64 150.39 86.59 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.841 -0.537 . . . . 0.0 110.117 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.56 -11.34 26.2 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.766 2.311 . . . . 0.0 111.321 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.0 -53.25 0.98 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.636 -0.665 . . . . 0.0 109.452 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.47 -29.29 69.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.463 -0.773 . . . . 0.0 109.26 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 63.31 -1.44 0.55 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.797 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -79.38 169.33 20.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.543 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.712 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.7 Cg_endo -69.2 153.12 71.99 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.362 2.042 . . . . 0.0 112.439 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD21 ' SG ' ' A' ' 13' ' ' CYS . 50.2 mt -111.75 152.69 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.725 0.774 . . . . 0.0 109.703 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' CG ' ' OG1' ' A' ' 30' ' ' THR . 68.3 mm-40 -127.44 139.42 52.83 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.951 0.882 . . . . 0.0 109.734 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.29 128.39 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.57 0.7 . . . . 0.0 109.961 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' ' 24' ' ' ASP . 76.3 ttt180 -124.52 156.92 36.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 23' ' ' ARG . 35.0 t0 17.17 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.637 0.732 . . . . 0.0 110.705 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.6 29.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.637 -0.665 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 54.7 mp0 -144.56 167.27 22.92 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 0.0 110.053 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -97.16 134.56 40.32 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.345 0.593 . . . . 0.0 109.856 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.51 131.38 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.924 0.868 . . . . 0.0 110.183 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.07 127.71 33.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.447 ' OG1' ' CG ' ' A' ' 21' ' ' GLU . 89.1 m -120.24 125.27 47.72 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.818 0.818 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.23 -163.84 37.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.07 -58.14 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.651 -0.911 . . . . 0.0 109.732 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -96.86 15.06 23.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -90.51 163.54 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.906 0.86 . . . . 0.0 110.014 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.56 -11.31 0.1 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.24 162.37 14.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 110.169 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.67 142.17 48.96 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.657 0.742 . . . . 0.0 109.684 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -127.94 128.13 23.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.92 166.61 26.58 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.391 2.061 . . . . 0.0 112.379 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -94.04 128.71 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.8 0.809 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -137.89 141.8 40.65 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.63 27.31 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.545 0.688 . . . . 0.0 109.636 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.91 10.84 85.01 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.81 149.55 64.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.466 -1.02 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.18 147.52 54.03 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.371 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 48' ' ' LEU . 97.7 t -84.16 96.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.749 0.785 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.86 38.3 0.45 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 46' ' ' VAL . 53.4 mt -115.71 119.27 35.51 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.155 0.978 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 m -66.04 -29.86 48.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.586 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.98 -43.56 95.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.729 -0.607 . . . . 0.0 109.938 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.7 mp0 -92.05 -4.09 54.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.08 151.42 47.06 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.533 0.682 . . . . 0.0 110.092 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -103.84 143.11 33.26 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.931 0.872 . . . . 0.0 110.024 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 155.92 37.21 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.478 2.119 . . . . 0.0 112.949 179.191 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.932 0.872 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.696 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -59.36 159.52 15.94 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-O 121.45 0.643 . . . . 0.0 109.771 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.81 -79.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.607 2.204 . . . . 0.0 112.363 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.78 98.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.456 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.942 0.877 . . . . 0.0 109.951 -179.487 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.78 104.45 15.23 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.676 0.751 . . . . 0.0 109.495 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 30' ' ' THR . . . -177.86 155.49 1.05 Allowed Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 164.05 35.23 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.706 2.27 . . . . 0.0 113.001 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.21 151.21 33.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.588 0.708 . . . . 0.0 109.596 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -124.89 120.75 32.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.002 0.906 . . . . 0.0 109.604 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -81.13 135.9 35.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.967 0.889 . . . . 0.0 110.211 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -167.59 143.86 4.16 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.846 0.831 . . . . 0.0 109.973 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.1 t70 54.0 36.42 24.45 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.254 0.549 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.36 18.6 11.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.806 -0.559 . . . . 0.0 109.562 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 53' ' ' ARG . 94.3 mt-10 -132.67 159.63 39.04 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.719 0.771 . . . . 0.0 109.679 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.46 126.3 48.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.7 . . . . 0.0 109.909 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.3 mt -108.58 127.3 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.734 0.778 . . . . 0.0 109.686 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.52 119.87 13.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.729 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 25.1 m -105.82 113.13 26.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.659 0.742 . . . . 0.0 109.652 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.53 169.26 42.21 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.62 -50.51 62.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.726 -0.867 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.3 -0.41 49.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.465 -0.772 . . . . 0.0 108.982 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 94.1 m -81.58 -171.35 3.27 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.721 0.772 . . . . 0.0 110.149 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.99 -9.07 0.96 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.85 160.59 22.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.328 -1.101 . . . . 0.0 110.5 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.88 138.8 48.56 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.58 0.705 . . . . 0.0 109.407 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -124.31 125.07 25.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.28 166.22 24.7 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.412 2.075 . . . . 0.0 112.348 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.16 131.14 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.568 0.699 . . . . 0.0 109.438 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -118.88 120.17 36.52 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.889 0.852 . . . . 0.0 109.76 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 56.87 33.55 23.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.451 0.643 . . . . 0.0 109.797 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.46 -2.36 82.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -99.86 122.85 49.52 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.521 -0.988 . . . . 0.0 109.575 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.17 144.94 27.06 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.676 2.251 . . . . 0.0 112.825 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 48' ' ' LEU . 81.6 t -88.5 128.05 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.607 0.718 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.4 mt -118.4 25.33 10.37 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -100.12 130.48 46.27 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.316 1.055 . . . . 0.0 109.481 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.85 -42.29 94.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.645 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.19 -38.38 88.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.499 -0.75 . . . . 0.0 109.68 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.0 -8.0 58.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.127 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 146.22 54.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.731 0.777 . . . . 0.0 109.971 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 26' ' ' GLU . 90.9 mtm180 -102.13 139.34 37.88 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.721 0.772 . . . . 0.0 110.008 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -89.61 151.9 46.45 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.532 2.155 . . . . 0.0 112.689 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 52.8 mmm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 1' ' ' MET . 29.7 Cg_endo -63.86 147.79 92.05 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.84 2.36 . . . . 0.0 112.519 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.9 146.15 42.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -65.69 139.81 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.508 0.67 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.13 -65.88 1.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 62.34 58.52 12.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.3 mp 55.01 111.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.26 1.029 . . . . 0.0 110.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.739 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.0 pt? -73.33 -3.76 29.1 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.038 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.17 -6.4 59.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 108.889 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 7' ' ' LEU . 21.4 tt -73.12 132.37 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.372 -0.83 . . . . 0.0 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.89 125.27 34.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.35 137.88 15.96 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.299 -0.875 . . . . 0.0 109.204 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.02 162.45 7.22 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.363 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -59.81 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.442 2.095 . . . . 0.0 112.239 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -51.24 2.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.452 -0.78 . . . . 0.0 109.469 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.0 p -73.11 65.0 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.221 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' CYS . 53.9 t-80 -37.89 112.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.004 0.907 . . . . 0.0 110.497 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.45 168.72 1.93 Allowed Pre-proline 0 C--N 1.292 -1.925 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.965 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 32.8 Cg_exo -56.01 145.93 71.94 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.883 2.389 . . . . 0.0 112.759 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 13' ' ' CYS . 76.6 mt -121.15 145.15 48.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.376 -0.827 . . . . 0.0 109.547 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -121.87 121.15 36.5 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.836 0.827 . . . . 0.0 109.081 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.93 137.53 34.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.74 -0.6 . . . . 0.0 109.977 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -139.3 115.02 10.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.027 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.8 -112.93 0.66 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.501 0.667 . . . . 0.0 110.602 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.73 27.03 10.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 108.901 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 41.3 mp0 -141.28 154.7 45.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.135 -0.978 . . . . 0.0 109.355 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.25 134.66 54.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.675 -0.641 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.93 132.95 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.551 0.691 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.36 132.97 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.462 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.426 ' HG1' ' C ' ' A' ' 19' ' ' PRO . 11.7 p -124.2 136.85 54.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.76 -161.31 32.21 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.61 -57.51 3.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -1.053 . . . . 0.0 110.056 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -95.41 4.57 53.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.184 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -74.56 178.06 5.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.38 -5.13 1.83 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -74.7 155.75 37.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -1.084 . . . . 0.0 110.419 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.8 139.2 53.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-85 -127.33 109.74 21.25 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 157.06 28.58 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -91.75 132.21 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.165 -0.959 . . . . 0.0 109.698 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -118.11 126.32 52.01 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.463 0.649 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 56.3 29.23 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.803 0.811 . . . . 0.0 110.085 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.31 5.34 90.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.0 mt -112.7 131.25 22.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.417 -1.049 . . . . 0.0 109.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 154.33 49.04 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.538 2.158 . . . . 0.0 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.34 122.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.44 ' C ' HD22 ' A' ' 48' ' ' LEU . 89.3 mt -113.09 21.39 15.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' C ' ' A' ' 47' ' ' LEU . 4.2 mm? -100.19 129.19 46.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.493 1.139 . . . . 0.0 109.924 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.46 -42.28 94.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -62.22 -37.92 87.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.658 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 -9.36 58.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.768 -1.207 . . . . 0.0 109.159 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.16 145.17 37.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -106.83 147.0 30.25 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.807 0.813 . . . . 0.0 109.966 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 9.9 mpt_? -86.17 156.07 57.43 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.696 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -46.13 141.35 9.74 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.344 2.03 . . . . 0.0 112.774 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.859 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 mtp . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.36 -18.11 39.05 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.492 2.128 . . . . 0.0 111.412 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -94.95 -10.54 30.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.686 . . . . 0.0 109.214 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -113.94 -53.44 2.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.97 -61.25 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.56 -131.99 47.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 1.8 tp -80.99 -167.69 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.813 -0.816 . . . . 0.0 110.448 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' GLU . 90.8 mt -63.7 -42.12 98.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' ILE . 50.8 mt-10 49.07 99.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.516 0.674 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' GLU . 96.3 mt 54.63 111.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 121.774 0.797 . . . . 0.0 110.261 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.2 mp -77.74 148.0 35.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.491 0.663 . . . . 0.0 109.849 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.79 150.93 37.5 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.807 0.813 . . . . 0.0 109.872 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.581 ' H ' ' HA ' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -126.58 168.55 14.09 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-O 122.062 0.934 . . . . 0.0 109.749 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' CYS . 23.8 Cg_exo -63.3 141.59 82.49 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.44 2.094 . . . . 0.0 113.045 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.27 15.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.321 0.582 . . . . 0.0 109.56 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' O ' ' A' ' 14' ' ' PRO . 29.5 p -172.86 123.4 0.43 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.444 0.64 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.581 ' HA ' ' H ' ' A' ' 13' ' ' CYS . 51.7 p-80 -111.38 115.95 30.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.806 0.813 . . . . 0.0 110.057 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -176.27 173.14 0.87 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-O 121.365 0.602 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 43.2 Cg_exo -54.43 147.26 47.93 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.751 2.301 . . . . 0.0 112.664 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.577 HD21 ' SG ' ' A' ' 13' ' ' CYS . 83.4 mt -120.66 141.08 50.71 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.032 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -127.06 135.61 51.03 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.86 0.838 . . . . 0.0 109.687 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -83.4 137.12 34.07 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.669 0.747 . . . . 0.0 110.184 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -173.02 153.87 2.66 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.81 0.814 . . . . 0.0 110.128 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 96.8 m-20 54.52 33.25 18.52 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.304 0.573 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.52 19.02 11.66 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -142.16 175.29 9.86 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.635 0.731 . . . . 0.0 110.052 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.1 mt -103.71 124.43 48.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.543 0.687 . . . . 0.0 109.548 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.1 mm -109.61 137.4 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.914 0.864 . . . . 0.0 110.179 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.7 m -73.27 124.82 26.42 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 m -114.49 108.17 16.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.729 0.776 . . . . 0.0 109.957 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.44 48.41 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.5 -54.8 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.727 -0.866 . . . . 0.0 109.405 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.47 -2.26 31.17 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -93.61 113.71 25.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.516 -0.74 . . . . 0.0 109.553 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 9.79 0.89 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.84 156.49 38.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.42 131.52 56.74 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.754 0.788 . . . . 0.0 109.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.94 117.82 35.12 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.42 165.39 29.26 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.522 2.148 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.04 134.47 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.675 0.75 . . . . 0.0 110.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -101.48 103.81 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.732 0.777 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 54.33 36.4 25.2 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.423 0.63 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.61 72.09 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.17 98.93 44.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 122.018 -0.696 . . . . 0.0 109.285 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.23 134.6 64.72 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.647 2.232 . . . . 0.0 112.189 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.45 96.73 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.592 0.71 . . . . 0.0 109.413 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.0 mt -77.24 45.58 0.46 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.38 133.03 53.56 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.187 0.994 . . . . 0.0 109.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.14 -36.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.9 -39.85 90.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.595 -0.691 . . . . 0.0 109.358 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 51.0 mp0 -90.92 -6.02 54.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.44 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.98 147.19 50.45 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.489 0.662 . . . . 0.0 109.881 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 56' ' ' GLU . 79.6 ttt-85 -117.75 141.08 48.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.011 0.91 . . . . 0.0 110.064 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -94.87 150.95 38.6 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.0 147.19 84.26 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.777 2.318 . . . . 0.0 112.427 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 53' ' ' ARG . 80.2 mm-40 . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.4 tpt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 1' ' ' MET . 37.4 Cg_endo -67.34 152.51 79.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.9 mm? -86.5 -4.59 59.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.777 -0.577 . . . . 0.0 109.458 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 80.2 mm-40 -84.83 -88.1 0.11 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.391 0.615 . . . . 0.0 109.736 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' GLU . . . 57.07 156.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.779 0.8 . . . . 0.0 110.434 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 164.36 54.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.13 130.77 42.97 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.725 0.774 . . . . 0.0 110.081 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -100.11 -22.37 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 109.214 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -57.88 121.49 10.65 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.626 0.727 . . . . 0.0 110.045 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 4.0 mp -106.62 -19.81 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.09 148.43 44.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.539 0.685 . . . . 0.0 110.153 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.44 136.08 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.677 0.751 . . . . 0.0 109.871 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.709 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -79.81 119.19 75.93 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-O 121.212 0.53 . . . . 0.0 109.754 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 52.6 Cg_exo -50.93 144.06 28.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.369 2.046 . . . . 0.0 112.649 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 79.87 -36.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.7 -169.09 1.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.834 0.826 . . . . 0.0 109.792 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -135.89 97.55 3.67 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.739 0.78 . . . . 0.0 109.633 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.07 171.2 1.12 Allowed Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 2.8 Cg_exo -74.79 172.25 16.65 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.9 2.4 . . . . 0.0 112.652 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.8 mt -114.48 134.26 55.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.699 -0.626 . . . . 0.0 109.618 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' OG1' ' A' ' 30' ' ' THR . 6.1 pt-20 -111.21 135.48 51.68 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.853 0.835 . . . . 0.0 109.299 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -97.6 133.98 41.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.535 0.684 . . . . 0.0 110.451 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 124.85 27.79 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.85 0.833 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 49.74 -113.68 0.65 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.286 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.51 23.36 13.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.593 -0.692 . . . . 0.0 109.2 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.71 162.0 36.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.705 . . . . 0.0 110.064 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.74 148.13 38.76 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.895 0.855 . . . . 0.0 109.726 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.9 mt -136.48 152.1 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.27 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -68.19 131.24 45.04 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.086 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 21' ' ' GLU . 3.1 m -91.65 166.91 12.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.092 0.948 . . . . 0.0 110.109 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 30' ' ' THR . . . 85.26 147.86 9.73 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.641 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 1.8 pm0 -75.5 -10.33 59.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.755 -0.85 . . . . 0.0 108.781 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.8 -4.73 55.68 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 34.9 m -129.46 -145.09 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.572 0.701 . . . . 0.0 109.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 148.41 -15.07 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -49.52 149.07 2.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.773 -0.839 . . . . 0.0 110.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . . . -113.66 135.4 53.96 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.659 0.742 . . . . 0.0 109.662 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -124.59 105.88 30.07 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.99 173.3 12.9 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.232 1.955 . . . . 0.0 111.977 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.17 132.34 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.507 0.67 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -124.94 126.4 45.44 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.933 0.873 . . . . 0.0 109.847 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.5 t0 57.54 27.68 14.44 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.446 0.641 . . . . 0.0 109.772 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.06 6.26 89.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.92 130.3 24.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.849 -0.795 . . . . 0.0 109.698 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.92 150.5 61.25 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.681 2.254 . . . . 0.0 112.676 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.1 t -91.79 106.68 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 46' ' ' VAL . 4.2 mm? -103.08 14.99 30.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.76 133.17 49.2 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.865 0.84 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.45 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.318 0.58 . . . . 0.0 109.63 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -59.44 -39.75 84.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 0.0 109.842 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.85 -5.49 53.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.091 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 154.46 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.493 0.663 . . . . 0.0 110.169 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.599 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 89.1 mtm180 -100.07 137.58 38.33 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.943 0.878 . . . . 0.0 110.096 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -49.21 167.51 0.21 Allowed Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.903 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' OXT' ' A' ' 56' ' ' GLU . 65.5 Cg_exo -48.69 135.06 27.86 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.127 1.884 . . . . 0.0 112.765 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' OXT' ' O ' ' A' ' 55' ' ' PRO . 82.6 tt0 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.847 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.8 ttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 1' ' ' MET . 27.0 Cg_endo -63.8 146.69 92.17 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.732 2.288 . . . . 0.0 112.399 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' PRO . 51.9 mt 59.01 123.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.066 0.936 . . . . 0.0 110.051 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.38 -5.19 59.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.955 . . . . 0.0 108.84 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.98 139.19 58.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . -90.31 116.85 4.91 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.3 mp 50.13 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.218 1.008 . . . . 0.0 110.242 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.25 139.85 57.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.67 138.98 56.74 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.733 0.778 . . . . 0.0 110.008 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.2 pt -109.81 -164.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.871 0.843 . . . . 0.0 110.154 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.15 155.26 39.83 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.021 0.915 . . . . 0.0 110.603 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.67 39.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.476 -0.765 . . . . 0.0 109.038 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -88.36 142.88 31.75 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.269 -0.894 . . . . 0.0 110.171 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 72.4 Cg_endo -72.89 152.64 52.4 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.188 . . . . 0.0 112.988 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 69.41 -69.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.636 0.732 . . . . 0.0 110.777 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -29.41 68.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 0.0 109.489 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 52.63 88.82 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.005 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -171.37 172.05 2.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 24.6 Cg_exo -60.0 148.07 90.45 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.471 2.114 . . . . 0.0 112.588 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.84 142.36 46.67 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.927 0.87 . . . . 0.0 110.082 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -110.09 116.84 32.27 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.34 127.71 36.89 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.377 0.608 . . . . 0.0 110.02 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' ASP . 95.6 mtt180 -134.82 132.54 38.78 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 25' ' ' ALA . 5.6 p-10 40.2 -116.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.369 0.604 . . . . 0.0 110.55 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 24' ' ' ASP . . . -111.24 42.07 1.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 109.044 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -153.31 149.54 27.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.2 mp -116.19 134.67 54.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.553 0.692 . . . . 0.0 109.429 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.23 132.04 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.616 0.722 . . . . 0.0 109.966 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 125.64 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.23 127.78 56.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.571 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.88 -161.18 34.86 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.27 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -79.43 -58.01 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.495 -1.003 . . . . 0.0 109.514 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -95.05 7.67 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.051 -1.03 . . . . 0.0 108.72 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.45 171.0 15.74 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.41 -6.81 0.34 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.4 154.71 41.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.146 -1.208 . . . . 0.0 110.291 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.97 139.3 54.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 m-85 -124.01 121.26 26.34 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.81 161.86 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.26 131.6 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 109.297 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -103.7 104.57 14.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.866 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.6 t0 53.05 38.74 28.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.902 0.858 . . . . 0.0 110.051 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.64 7.46 78.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.2 mt -111.84 101.22 50.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.146 -1.208 . . . . 0.0 109.308 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.0 139.99 69.92 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.628 2.218 . . . . 0.0 112.061 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 48' ' ' LEU . 94.2 t -89.43 121.73 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.009 . . . . 0.0 109.54 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 48' ' ' LEU . 49.4 mt -109.4 23.69 14.12 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' H ' HG12 ' A' ' 46' ' ' VAL . 4.3 mm? -100.01 126.27 46.17 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.437 1.113 . . . . 0.0 109.913 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.18 -41.92 92.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.642 0.734 . . . . 0.0 109.525 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 67.6 t0 -61.14 -34.67 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 109.801 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -87.6 -11.25 49.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.828 -1.17 . . . . 0.0 109.23 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.97 146.64 26.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.97 . . . . 0.0 110.049 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -112.96 140.6 47.63 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.921 0.867 . . . . 0.0 109.792 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -87.32 153.96 53.97 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.67 -0.644 . . . . 0.0 109.366 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.53 144.07 89.33 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.803 2.335 . . . . 0.0 112.749 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 C--N 1.3 -1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.059 179.53 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.51 138.98 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.99 1.793 . . . . 0.0 112.798 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.14 -35.34 0.08 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.2 -2.39 55.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 108.952 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.09 140.77 55.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.21 -29.46 8.81 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.2 mp -94.8 121.48 36.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 9' ' ' GLU . 70.0 mt -83.28 -76.65 0.27 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' LEU . 74.6 mm-40 43.87 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.811 0.815 . . . . 0.0 109.968 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.04 146.28 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.723 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.3 mp -79.58 137.16 37.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.434 -0.791 . . . . 0.0 109.611 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.27 122.08 8.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.4 p -68.81 152.37 96.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.3 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 16' ' ' CYS . 39.6 Cg_endo -66.3 145.23 77.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.561 2.174 . . . . 0.0 111.818 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 66.75 -61.17 0.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.575 -0.703 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -89.79 -173.57 3.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.273 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -136.61 109.96 7.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.463 -0.773 . . . . 0.0 109.61 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -177.85 176.42 0.48 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 7.5 Cg_exo -70.47 159.38 53.08 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.844 2.363 . . . . 0.0 112.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.77 143.94 45.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.46 118.37 30.92 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -80.36 128.65 33.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.504 -0.748 . . . . 0.0 109.206 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -130.68 123.6 29.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.483 -0.761 . . . . 0.0 109.202 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 52.82 -96.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.318 0.58 . . . . 0.0 109.69 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.97 30.08 3.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.28 155.17 46.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.845 . . . . 0.0 109.738 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.3 mt -104.54 128.57 52.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.26 131.34 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.454 0.645 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 1.7 t -72.13 123.99 24.05 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 -178.75 4.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.041 -1.037 . . . . 0.0 109.685 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.48 148.68 6.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 24.3 mp0 -75.14 -10.86 59.86 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -1.006 . . . . 0.0 108.831 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.87 -3.53 54.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.32 -150.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.259 -0.901 . . . . 0.0 109.791 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 29' ' ' CYS . . . 145.5 2.74 0.66 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.16 160.32 32.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.259 -1.142 . . . . 0.0 110.039 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.19 137.75 54.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.664 -0.647 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -121.35 107.96 36.38 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.26 150.5 22.65 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.95 1.767 . . . . 0.0 112.44 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.55 132.82 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -117.59 127.63 54.16 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.513 -0.742 . . . . 0.0 109.672 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 55.05 30.52 14.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 109.907 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.51 88.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mt -117.5 131.8 23.89 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.394 -1.062 . . . . 0.0 109.3 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.36 145.73 38.82 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.035 1.823 . . . . 0.0 111.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 48' ' ' LEU . 58.8 t -100.91 127.15 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.5 mt -113.71 32.13 6.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 46' ' ' VAL . 72.7 mt -108.2 131.66 54.43 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.977 0.894 . . . . 0.0 109.767 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.93 -42.23 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.5 -19.28 46.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.91 -13.31 16.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.321 -0.862 . . . . 0.0 109.034 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.09 144.98 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.645 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -109.17 139.32 44.24 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -85.82 154.07 58.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . 59.3 Cg_exo -44.17 141.42 4.79 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.28 1.987 . . . . 0.0 112.899 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 55' ' ' PRO . 82.0 tt0 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.096 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.02 5.61 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.774 2.316 . . . . 0.0 111.435 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 5' ' ' ALA . 73.9 mt -72.73 -79.79 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.587 -0.695 . . . . 0.0 109.565 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 55.08 -82.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.769 . . . . 0.0 109.567 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 3' ' ' LEU . . . -69.95 -9.52 55.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.19 -10.85 73.83 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.8 mt -74.92 -78.26 0.11 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -1.116 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.6 tp -89.06 128.37 35.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -55.32 -173.07 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.2 tp -91.65 124.04 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.433 -0.792 . . . . 0.0 109.185 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -118.93 124.27 46.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.02 147.66 46.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.395 -0.815 . . . . 0.0 108.886 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.3 p -100.13 116.04 64.92 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.828 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.5 Cg_exo -51.36 146.88 23.35 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.762 1.642 . . . . 0.0 112.79 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 76.41 -35.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.558 -0.714 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -124.95 -166.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.746 . . . . 0.0 109.137 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.657 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 50.4 p-80 -146.96 111.78 5.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.61 158.76 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.183 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' C ' ' OG1' ' A' ' 30' ' ' THR . 32.1 Cg_exo -56.97 177.41 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.362 2.041 . . . . 0.0 112.829 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt -120.1 141.7 49.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.395 -0.816 . . . . 0.0 109.28 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -122.64 134.23 54.5 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.933 0.873 . . . . 0.0 109.743 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.73 138.76 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.645 -0.66 . . . . 0.0 109.531 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -137.76 122.68 18.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.562 -0.711 . . . . 0.0 109.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.0 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.413 0.625 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.91 28.12 3.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -139.16 160.95 38.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.342 -0.849 . . . . 0.0 109.564 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.0 mt -109.94 119.54 39.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.5 pt -107.8 144.43 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -0.884 . . . . 0.0 109.655 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 134.39 47.18 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.529 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' C ' ' A' ' 19' ' ' PRO . 6.3 m -73.63 145.9 45.01 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.304 -0.872 . . . . 0.0 109.935 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 140.44 9.57 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 26.7 mp0 -66.17 -45.61 80.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.624 -0.927 . . . . 0.0 109.692 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 57.8 t0 -78.53 -6.73 56.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -87.36 -46.92 9.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 41.78 -103.73 0.04 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.1 mt 41.2 111.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.229 1.014 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.46 127.63 53.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -0.768 . . . . 0.0 109.674 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -114.79 104.34 54.27 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.56 168.83 19.26 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.093 1.862 . . . . 0.0 111.61 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.39 131.5 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.945 . . . . 0.0 109.375 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 43' ' ' GLY . 62.8 ttm-85 -114.19 130.53 56.62 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 56.78 5.66 0.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.403 -0.81 . . . . 0.0 109.888 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ARG . . . 108.39 -7.68 34.7 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.28 135.0 20.62 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.344 -1.092 . . . . 0.0 109.645 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.36 144.0 32.57 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 112.544 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.93 111.74 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 109.177 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.5 mt -97.47 16.03 21.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.837 . . . . 0.0 108.933 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 48' ' ' LEU . 4.1 mm? -94.22 126.33 39.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 109.588 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.28 -42.36 90.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.635 -0.666 . . . . 0.0 109.753 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.55 -38.04 83.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.2 -6.99 56.47 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.23 -0.919 . . . . 0.0 109.358 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.18 39.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.649 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.72 142.03 33.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.452 -0.78 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -88.2 150.63 47.57 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 109.552 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.13 147.36 79.13 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.658 2.239 . . . . 0.0 112.702 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.708 179.7 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.19 -14.04 35.71 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.849 2.366 . . . . 0.0 111.738 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.3 mt -79.71 -1.39 38.24 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.598 -0.689 . . . . 0.0 109.255 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -142.19 -28.69 0.61 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.56 143.83 57.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -0.804 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 7' ' ' LEU . . . 42.93 -157.03 0.1 OUTLIER Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 6' ' ' GLY . 1.8 tt 76.86 -59.82 0.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.803 -0.822 . . . . 0.0 109.405 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.7 mm? 44.73 -107.55 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.571 -0.705 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.13 148.54 47.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.665 0.745 . . . . 0.0 110.395 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -77.58 93.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.38 155.96 33.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.629 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.95 136.61 54.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -78.79 153.79 78.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.625 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 38.1 Cg_endo -66.7 143.24 67.04 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.619 2.213 . . . . 0.0 111.779 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 68.92 -53.56 0.57 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.642 -0.661 . . . . 0.0 109.866 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.74 -173.36 2.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 54.6 t-80 -134.47 109.79 8.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.759 -0.588 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 173.6 155.39 0.28 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.0 Cg_exo -53.78 153.51 19.29 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.906 1.737 . . . . 0.0 112.647 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 mt -105.26 134.53 48.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.322 0.582 . . . . 0.0 109.713 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -111.54 132.59 54.41 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' OE1' ' CD2' ' A' ' 27' ' ' LEU . 40.2 mm-40 -89.9 127.87 36.09 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' ALA . 60.6 ttt85 -125.71 108.72 11.8 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.62 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.55 27.27 2.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.478 -0.764 . . . . 0.0 109.286 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -135.22 155.96 49.79 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.425 0.631 . . . . 0.0 109.544 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' CD2' ' OE1' ' A' ' 22' ' ' GLU . 45.4 mt -106.83 130.62 54.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.594 -0.691 . . . . 0.0 109.662 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.55 130.55 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.374 0.607 . . . . 0.0 109.866 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.8 m -64.46 145.87 55.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.297 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -57.25 -19.39 21.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 108.978 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.65 8.62 87.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -62.66 -43.68 98.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.947 . . . . 0.0 108.958 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -126.77 -9.14 6.12 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.8 p -141.01 -112.85 0.14 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.773 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.49 19.72 0.51 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.61 157.61 33.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.497 -1.002 . . . . 0.0 109.954 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 38' ' ' TYR . . . -129.59 149.64 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.5 0.667 . . . . 0.0 109.91 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 15.7 m-85 -135.48 127.82 17.88 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.57 167.19 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.119 1.879 . . . . 0.0 111.852 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.82 131.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.508 -0.745 . . . . 0.0 109.048 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -103.4 107.41 18.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.387 -0.821 . . . . 0.0 109.68 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.4 t0 53.18 40.83 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.28 90.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.52 104.47 54.35 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.486 -1.008 . . . . 0.0 109.143 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.82 137.79 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.187 1.925 . . . . 0.0 112.396 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.54 101.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.725 . . . . 0.0 109.326 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 mt -93.71 35.28 1.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.745 0.783 . . . . 0.0 109.724 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.65 -43.46 93.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.583 -0.698 . . . . 0.0 109.745 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 6.5 p-10 -60.62 -33.19 72.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.52 -0.738 . . . . 0.0 109.851 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -92.35 10.83 28.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 109.039 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 145.46 54.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.579 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -111.11 137.26 48.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -87.38 151.62 51.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.578 -0.702 . . . . 0.0 109.327 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.69 145.73 82.16 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.691 2.26 . . . . 0.0 112.463 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.953 -1.023 . . . . 0.0 108.906 179.501 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.95 146.59 93.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.919 2.413 . . . . 0.0 112.518 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 4' ' ' GLU . 62.6 mt -70.7 117.94 12.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.451 -0.781 . . . . 0.0 109.841 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 3' ' ' LEU . 95.4 mt-10 40.77 -123.74 0.47 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.197 0.522 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.47 70.66 0.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.74 . . . . 0.0 109.242 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 73.78 26.78 68.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' GLY . 51.6 tp 56.31 116.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.89 . . . . 0.0 109.969 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 7' ' ' LEU . 1.7 tp 38.52 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.771 0.796 . . . . 0.0 111.118 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 42.82 79.04 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.455 0.645 . . . . 0.0 109.531 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.8 tp -92.02 129.76 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.438 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.2 mt -104.51 131.78 51.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.664 -0.647 . . . . 0.0 109.315 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.73 145.46 26.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.166 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' A' ' 15' ' ' ALA . 2.7 t -93.74 140.02 22.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.25 33.0 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.001 1.801 . . . . 0.0 111.619 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -153.52 -75.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 109.157 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' C ' ' N ' ' A' ' 18' ' ' ALA . 1.6 p -87.57 7.04 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.6 m80 54.59 12.0 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 16' ' ' CYS . . . -73.9 151.7 88.7 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.167 -0.958 . . . . 0.0 109.721 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.68 163.2 33.94 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.707 2.271 . . . . 0.0 112.305 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -108.71 148.18 30.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -112.73 134.67 54.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.27 125.92 32.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 28' ' ' ILE . 42.6 ttm180 -132.22 117.44 18.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.533 -0.729 . . . . 0.0 109.194 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 52.47 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.247 0.546 . . . . 0.0 110.14 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -136.92 29.43 2.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.12 160.12 41.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.409 -0.807 . . . . 0.0 109.883 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.2 mt -109.59 134.5 51.85 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 23' ' ' ARG . 96.8 mt -115.0 130.6 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.404 0.621 . . . . 0.0 109.657 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.5 t -66.97 131.7 46.4 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 110.224 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -77.09 -1.12 27.47 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.279 -0.888 . . . . 0.0 109.03 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 129.47 19.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.81 -39.65 79.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.588 -0.948 . . . . 0.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -84.88 -5.45 59.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.171 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -94.03 -70.28 0.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.0 109.27 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.82 15.13 54.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 34' ' ' CYS . 91.1 mt -76.67 149.06 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -1.169 . . . . 0.0 110.256 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.97 144.37 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -129.84 115.29 17.9 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 156.95 32.23 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.269 1.979 . . . . 0.0 112.755 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.93 129.89 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -127.49 131.76 50.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 54.05 27.85 8.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.251 0.548 . . . . 0.0 110.256 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.33 -3.46 79.55 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 tt -138.84 135.42 17.69 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.268 -1.136 . . . . 0.0 109.919 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.03 155.77 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.272 1.982 . . . . 0.0 112.261 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 48' ' ' LEU . 21.8 t -87.49 130.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.527 -0.733 . . . . 0.0 109.415 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.35 34.2 2.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.608 -0.682 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' H ' HG12 ' A' ' 46' ' ' VAL . 68.7 mt -111.39 137.75 48.76 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.818 0.818 . . . . 0.0 109.595 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.47 -42.43 93.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.558 -0.714 . . . . 0.0 109.797 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 1.7 p-10 -60.28 -33.86 72.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -92.42 -7.92 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 108.807 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 149.6 49.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 110.044 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -101.76 138.52 38.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.454 -0.779 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -96.37 160.97 28.48 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.09 140.54 40.24 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.291 1.994 . . . . 0.0 112.695 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.794 -1.098 . . . . 0.0 109.04 179.657 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.64 144.33 97.7 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.739 2.293 . . . . 0.0 112.395 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.93 144.05 45.47 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.16 0.981 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 47.67 78.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.823 0.82 . . . . 0.0 109.888 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.19 145.0 55.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.644 0.735 . . . . 0.0 110.119 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.2 -83.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -84.45 -1.89 56.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -1.057 . . . . 0.0 109.433 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -89.16 113.56 24.76 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.737 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.546 ' N ' HD13 ' A' ' 8' ' ' LEU . 78.0 tt0 58.95 68.11 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.618 0.723 . . . . 0.0 109.57 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 10' ' ' ILE . 19.4 tt -109.0 129.21 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.596 -0.69 . . . . 0.0 109.708 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.78 125.01 49.94 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.724 0.773 . . . . 0.0 109.791 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.46 148.39 22.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.678 0.751 . . . . 0.0 109.317 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.8 t -85.54 125.37 69.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.556 -0.715 . . . . 0.0 109.403 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.15 -21.93 3.3 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.963 1.775 . . . . 0.0 111.466 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . . . -91.63 -25.07 19.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' CYS . 6.9 p -160.55 162.84 33.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.16 1.5 11.09 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 108.931 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.32 123.55 35.96 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.046 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.36 163.25 0.42 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 0.0 112.615 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -112.0 139.17 47.73 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.636 0.732 . . . . 0.0 109.896 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -113.62 122.69 47.95 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.848 0.833 . . . . 0.0 109.012 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.6 122.71 25.66 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.552 0.691 . . . . 0.0 109.99 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -127.98 117.11 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.638 0.732 . . . . 0.0 109.175 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 52.07 -109.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.479 0.656 . . . . 0.0 110.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.53 26.46 9.86 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -141.74 161.31 38.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.01 -1.056 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.0 mt -111.35 130.3 55.73 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 mm -109.04 129.84 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.818 0.818 . . . . 0.0 109.791 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.3 131.78 43.94 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.9 p -79.81 2.7 22.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.42 133.42 28.08 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.55 -46.42 76.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.676 -0.896 . . . . 0.0 109.974 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -85.48 -5.16 59.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -95.4 -69.22 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 50.07 19.2 2.44 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 34' ' ' CYS . 87.9 mt -73.21 151.03 41.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.316 -1.108 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.44 130.53 53.17 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 109.262 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.85 127.36 27.06 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 161.36 28.28 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.9 2.4 . . . . 0.0 112.41 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.87 131.61 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -103.88 104.27 14.23 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.961 0.886 . . . . 0.0 109.797 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 t0 52.82 39.68 29.32 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.878 0.847 . . . . 0.0 110.454 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.17 7.58 79.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mm -111.56 100.37 47.73 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.314 -1.11 . . . . 0.0 109.79 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.19 139.7 72.01 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.798 2.332 . . . . 0.0 112.02 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 48' ' ' LEU . 60.4 t -97.26 120.74 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.083 -1.011 . . . . 0.0 109.547 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.4 mt -103.61 34.67 2.88 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HG12 ' A' ' 46' ' ' VAL . 75.1 mt -109.33 128.72 55.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.113 0.959 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.92 -40.29 87.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.646 0.736 . . . . 0.0 109.586 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.83 -39.67 81.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.568 -0.708 . . . . 0.0 110.166 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.59 -8.07 53.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.955 -1.091 . . . . 0.0 109.198 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.12 145.78 54.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -103.61 136.64 42.94 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.851 0.834 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 156.82 37.86 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.47 137.31 19.67 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.787 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 9.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 1' ' ' MET . 30.4 Cg_endo -64.11 147.85 91.43 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.516 2.144 . . . . 0.0 112.061 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -89.5 152.55 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.61 0.719 . . . . 0.0 109.611 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -84.43 16.68 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.432 -0.793 . . . . 0.0 109.135 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 139.65 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.443 -0.786 . . . . 0.0 109.894 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 8' ' ' LEU . . . 156.45 123.32 0.78 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 7' ' ' LEU . 8.6 mp 54.09 3.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.396 -1.061 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 8' ' ' LEU . 2.9 tt -63.4 -45.57 90.42 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.115 -0.991 . . . . 0.0 109.219 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -117.19 -52.96 2.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.365 -0.835 . . . . 0.0 110.169 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.2 122.57 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -0.966 . . . . 0.0 109.552 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.44 153.73 26.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.548 -0.72 . . . . 0.0 109.693 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.41 141.28 41.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.501 -0.749 . . . . 0.0 109.085 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -76.19 170.49 15.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.46 -0.775 . . . . 0.0 109.642 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' CD2' ' A' ' 17' ' ' HIS . 72.2 Cg_endo -80.23 -86.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.581 2.187 . . . . 0.0 111.772 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -46.36 81.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 24.7 p -93.11 55.03 2.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 108.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 13' ' ' CYS . 86.8 m-70 -41.24 108.94 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 110.763 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.809 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -174.07 177.36 0.67 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.586 -0.697 . . . . 0.0 109.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.597 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 14.5 Cg_exo -68.66 147.79 70.61 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.812 2.341 . . . . 0.0 112.557 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.8 152.15 51.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -122.82 133.99 54.42 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.8 126.34 32.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.813 -0.554 . . . . 0.0 109.768 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -171.68 157.16 4.57 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.691 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 48.1 t0 56.21 24.27 7.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.618 -0.676 . . . . 0.0 109.344 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 72.28 15.22 5.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.984 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -142.01 165.61 26.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.8 mt -101.51 119.61 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.7 mt -97.4 131.61 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 m -75.61 143.12 42.48 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.457 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 106.82 4.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.322 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.48 17.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.48 -54.18 43.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.164 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 30.0 p-10 -112.72 7.64 18.67 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -86.28 163.89 17.45 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.715 0.769 . . . . 0.0 110.124 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.15 -20.09 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.81 178.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -1.087 . . . . 0.0 110.249 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 139.0 40.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.484 -0.76 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -121.52 120.49 28.81 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.46 164.92 28.07 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.084 1.856 . . . . 0.0 111.852 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.92 132.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -104.61 108.17 19.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.421 -0.8 . . . . 0.0 109.538 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.16 38.2 26.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.61 4.39 85.49 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.2 mt -108.41 104.42 54.0 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -1.115 . . . . 0.0 109.286 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.12 142.11 55.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.092 1.861 . . . . 0.0 112.247 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 48' ' ' LEU . 69.0 t -95.23 131.64 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.4 -0.812 . . . . 0.0 109.395 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.67 35.38 4.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HG12 ' A' ' 46' ' ' VAL . 67.4 mt -106.33 131.41 53.58 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.76 0.79 . . . . 0.0 109.424 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.51 -43.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.994 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.54 -38.23 86.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 110.179 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -88.12 -6.45 57.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.057 -1.027 . . . . 0.0 109.242 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.01 46.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.681 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.85 161.2 15.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -90.43 177.1 2.51 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.552 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.8 144.92 99.37 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.511 2.14 . . . . 0.0 112.17 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.641 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 96.1 mmm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 1' ' ' MET . 51.7 Cg_endo -67.74 145.22 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.704 2.27 . . . . 0.0 112.481 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' GLU . 69.7 mt -98.07 129.4 44.91 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.735 0.779 . . . . 0.0 110.005 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 3' ' ' LEU . 84.7 tt0 51.95 103.8 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.778 0.799 . . . . 0.0 110.043 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.42 141.94 58.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.819 0.818 . . . . 0.0 110.105 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 171.42 -169.21 42.31 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 ' CD2' ' H ' ' A' ' 7' ' ' LEU . 1.3 pt? -77.56 -1.17 29.34 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.655 -0.909 . . . . 0.0 109.503 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' LEU . 76.5 mt 41.35 91.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.606 0.717 . . . . 0.0 110.406 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.12 138.24 58.49 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.08 0.943 . . . . 0.0 109.762 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.699 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -77.67 149.85 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.974 0.892 . . . . 0.0 110.331 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.5 mt -72.72 150.83 42.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.779 0.8 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -128.88 126.66 40.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.215 1.007 . . . . 0.0 109.852 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -60.39 159.7 21.95 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-O 121.361 0.601 . . . . 0.0 109.731 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.84 -79.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.614 2.21 . . . . 0.0 111.847 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.7 85.97 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -104.89 164.94 11.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 109.422 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 17' ' ' HIS . 49.3 p-80 -115.88 105.58 12.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.868 0.842 . . . . 0.0 110.1 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -176.26 176.51 0.57 Allowed Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 109.428 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 9.9 Cg_exo -70.1 155.69 64.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.957 2.438 . . . . 0.0 113.013 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -113.88 139.22 49.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.79 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -111.62 126.73 55.32 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.188 0.994 . . . . 0.0 109.399 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.5 mp0 -79.42 141.95 36.38 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.652 0.739 . . . . 0.0 110.558 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.9 tpt180 -143.93 161.46 38.66 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.863 0.84 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . 67.2 t0 -42.6 116.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.586 0.708 . . . . 0.0 110.604 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 24' ' ' ASP . . . 37.0 35.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.763 0.792 . . . . 0.0 110.047 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' CD ' ' NH2' ' A' ' 53' ' ' ARG . 68.9 tt0 -159.81 157.1 28.65 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.058 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.6 mt -126.32 127.59 45.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.573 0.701 . . . . 0.0 109.405 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 98.4 mt -106.8 125.77 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-O 121.923 0.868 . . . . 0.0 109.745 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -73.51 120.17 18.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.781 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -81.7 170.88 15.24 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-O 121.807 0.813 . . . . 0.0 110.184 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 148.71 21.98 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.34 -36.61 68.86 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.781 -0.834 . . . . 0.0 109.351 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.92 -5.23 47.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.739 . . . . 0.0 109.242 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 81.9 m -102.18 -117.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.441 -0.787 . . . . 0.0 109.501 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.3 -7.88 62.24 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.8 mt -68.4 149.71 49.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.987 . . . . 0.0 110.321 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.48 145.42 49.54 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 52' ' ' ALA . 80.2 m-85 -130.46 115.82 17.3 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.33 164.58 26.43 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.587 2.192 . . . . 0.0 111.941 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.1 t -103.32 132.11 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.715 0.769 . . . . 0.0 109.814 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -121.61 129.46 52.84 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.689 0.757 . . . . 0.0 109.638 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 57.33 30.82 19.14 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.511 0.672 . . . . 0.0 109.351 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.84 85.43 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.08 130.32 24.01 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.763 -0.845 . . . . 0.0 109.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.02 141.58 40.44 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.579 2.186 . . . . 0.0 112.09 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 48' ' ' LEU . 89.8 t -90.07 128.18 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.71 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.402 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.2 mt -117.79 30.17 7.42 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' H ' HG12 ' A' ' 46' ' ' VAL . 11.2 mp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.297 1.046 . . . . 0.0 109.575 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.11 -42.94 95.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.722 -0.611 . . . . 0.0 109.691 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.89 -17.13 64.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.518 -0.739 . . . . 0.0 109.4 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.63 -12.61 18.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.36 -0.838 . . . . 0.0 108.772 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . -57.14 142.73 41.52 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' NH2' ' CD ' ' A' ' 26' ' ' GLU . 89.2 mtm180 -105.87 146.43 29.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.706 0.765 . . . . 0.0 109.728 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' CD ' ' N ' ' A' ' 54' ' ' ARG . 11.4 mpt_? -83.14 151.76 63.83 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.944 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.11 149.78 76.84 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.759 2.306 . . . . 0.0 112.665 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.523 179.33 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.15 140.21 92.13 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.732 2.288 . . . . 0.0 112.102 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.64 123.29 48.72 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.421 0.629 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 58.2 mp0 -92.23 123.86 35.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.648 -0.657 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 7' ' ' LEU . . . -170.47 131.04 0.9 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.463 -0.773 . . . . 0.0 109.42 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.93 6.85 6.07 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.4 mp -83.13 -10.22 58.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.293 -1.122 . . . . 0.0 109.109 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.99 147.02 49.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.538 -0.726 . . . . 0.0 110.455 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -57.66 139.28 54.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.762 -0.586 . . . . 0.0 109.741 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -135.37 132.68 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.475 0.655 . . . . 0.0 109.944 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.33 148.2 47.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.732 -0.605 . . . . 0.0 109.898 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.73 133.53 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.637 -0.664 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -90.1 153.72 46.98 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.684 -0.635 . . . . 0.0 110.266 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.555 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -65.28 141.91 70.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.663 2.242 . . . . 0.0 111.99 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 14' ' ' PRO . . . 70.45 -12.59 0.51 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.603 -0.686 . . . . 0.0 109.243 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -136.54 -167.76 2.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 108.948 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 17' ' ' HIS . 56.5 t-80 -140.95 24.97 2.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.652 -0.655 . . . . 0.0 109.285 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -99.89 171.8 5.24 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.516 -0.74 . . . . 0.0 109.819 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.4 Cg_endo -77.99 178.12 7.97 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.238 1.959 . . . . 0.0 112.852 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 13' ' ' CYS . 92.2 mt -115.0 144.09 44.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.635 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -111.41 111.65 22.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 7.8 pt-20 -74.75 132.29 41.5 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.179 0.514 . . . . 0.0 110.014 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -141.53 124.91 16.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.5 -111.6 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.83 -0.544 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.4 34.69 4.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -152.47 155.69 37.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.0 109.827 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 131.29 56.38 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.27 130.33 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.46 0.648 . . . . 0.0 109.84 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.2 t -63.13 114.93 4.04 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.7 m -68.49 144.33 54.67 Favored 'General case' 0 C--O 1.209 -1.061 0 O-C-N 121.158 -0.964 . . . . 0.0 110.328 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.59 145.9 8.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -65.57 -41.39 92.95 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -86.9 -1.09 57.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 30' ' ' THR . 2.2 m -89.35 -79.24 0.33 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.626 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 64.37 -93.38 0.14 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.626 ' O ' ' O ' ' A' ' 35' ' ' GLY . 3.3 mm? 24.74 111.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.069 0.938 . . . . 0.0 111.708 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.27 123.74 44.87 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.52 -0.738 . . . . 0.0 109.335 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -108.0 104.62 54.09 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.67 160.81 28.02 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.288 1.992 . . . . 0.0 112.246 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.76 131.06 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -121.69 127.16 50.45 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.362 0.601 . . . . 0.0 109.584 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 51.7 t0 58.08 26.4 13.57 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.47 0.652 . . . . 0.0 109.555 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.66 5.4 89.49 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.63 130.02 23.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.928 . . . . 0.0 109.834 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.32 143.18 47.39 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.367 2.045 . . . . 0.0 112.633 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.69 112.44 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -102.97 18.79 20.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.5 mt -107.88 128.74 54.89 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.638 0.732 . . . . 0.0 109.521 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.7 -41.37 92.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.341 0.591 . . . . 0.0 109.668 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.14 -42.66 81.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.921 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -89.06 -4.84 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.62 156.74 37.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.949 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.5 138.64 39.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.504 -0.748 . . . . 0.0 109.97 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -89.9 155.05 47.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.555 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -45.7 139.69 10.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.377 2.051 . . . . 0.0 112.797 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.989 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 4.4 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 1' ' ' MET . 30.8 Cg_endo -60.86 146.66 97.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.323 2.015 . . . . 0.0 112.317 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -77.41 146.91 36.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.424 -0.797 . . . . 0.0 109.45 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 58.6 mp0 -68.43 128.69 37.52 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.584 0.707 . . . . 0.0 110.154 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.14 -9.11 58.83 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.522 -0.736 . . . . 0.0 109.121 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . -152.48 -134.81 2.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.0 mp 56.06 111.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.68 -0.894 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' LEU . 62.2 mt 46.0 99.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.775 0.798 . . . . 0.0 110.022 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.18 -12.11 47.88 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.13 128.17 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.946 . . . . 0.0 109.637 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.3 mt -107.13 130.0 54.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.643 0.735 . . . . 0.0 109.356 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.98 158.03 16.01 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -67.36 153.61 94.49 Favored Pre-proline 0 C--N 1.296 -1.758 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.954 -178.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.72 -45.92 37.49 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.92 -61.89 1.67 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.625 . . . . 0.0 109.728 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.39 162.21 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.836 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 61.1 t-80 -107.62 103.54 12.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.525 -0.734 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . . . 176.92 158.12 0.46 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.104 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 27.3 Cg_endo -64.54 154.47 71.79 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.725 2.284 . . . . 0.0 112.604 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -106.75 148.44 28.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -106.57 127.38 53.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -75.72 130.81 39.27 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 9.5 tpt85 -139.03 165.38 27.27 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 23' ' ' ARG . 67.5 t0 -38.79 103.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.465 0.65 . . . . 0.0 110.411 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 40.6 38.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.428 0.632 . . . . 0.0 110.042 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -157.75 154.28 27.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.935 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -118.94 133.28 55.93 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.25 125.58 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.779 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.69 129.48 41.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -101.62 29.24 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.266 -0.896 . . . . 0.0 108.698 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 34' ' ' CYS . . . -97.95 144.81 17.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.7 -33.46 73.99 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.601 -0.94 . . . . 0.0 109.21 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.66 -3.63 52.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.201 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 34' ' ' CYS . 11.0 p -144.16 128.52 17.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.71 27.54 2.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.11 157.79 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.451 -1.029 . . . . 0.0 109.89 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.74 141.32 51.93 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.393 0.616 . . . . 0.0 109.723 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-85 -125.02 122.96 25.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.73 161.25 30.75 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.314 2.009 . . . . 0.0 112.487 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -95.77 132.85 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.126 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -137.21 146.66 45.11 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.655 -0.653 . . . . 0.0 109.964 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.95 27.28 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.449 0.642 . . . . 0.0 109.675 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.88 7.05 83.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 pt -131.35 149.37 73.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.432 -1.04 . . . . 0.0 109.69 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.33 143.04 51.57 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.624 2.216 . . . . 0.0 112.668 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.25 93.07 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.008 . . . . 0.0 109.005 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 42.49 0.71 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.85 120.19 36.6 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.639 0.733 . . . . 0.0 109.405 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' VAL . 6.2 m -65.85 -30.34 49.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 0.0 109.348 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.19 -40.36 97.29 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.32 -6.55 52.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 157.26 27.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 110.011 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -129.48 168.72 15.92 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.813 0.816 . . . . 0.0 109.949 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -76.58 153.52 83.57 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.641 -0.662 . . . . 0.0 109.564 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.16 145.86 89.73 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.721 2.281 . . . . 0.0 112.463 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.129 -179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.38 -165.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.786 2.324 . . . . 0.0 112.719 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt 58.49 41.69 22.22 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.675 0.75 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -163.52 40.58 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.03 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.0 -10.07 59.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.112 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LEU . . . 92.98 -57.21 2.51 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 6' ' ' GLY . 43.3 tp 58.67 145.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.904 0.859 . . . . 0.0 110.406 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.2 tp -70.0 133.2 47.0 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.468 -0.77 . . . . 0.0 110.179 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.0 137.88 57.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.7 0.762 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 10' ' ' ILE . 96.1 mt -84.07 -4.43 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.46 128.51 47.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.853 . . . . 0.0 109.519 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.8 134.36 24.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.431 -0.793 . . . . 0.0 109.484 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -60.07 156.82 35.44 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.627 -0.671 . . . . 0.0 109.534 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.92 -8.11 22.78 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.436 2.091 . . . . 0.0 111.22 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.52 -47.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.34 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -69.11 -24.53 64.13 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 18' ' ' ALA . 36.2 t-80 69.9 -26.65 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.733 -0.604 . . . . 0.0 109.865 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -48.9 -178.71 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.444 -0.785 . . . . 0.0 110.445 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.678 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 38.1 Cg_endo -86.14 163.38 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.846 2.364 . . . . 0.0 112.606 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.72 151.3 32.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.178 -0.951 . . . . 0.0 109.359 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -122.24 133.65 54.7 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.544 0.688 . . . . 0.0 109.223 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.09 127.67 33.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.879 -0.513 . . . . 0.0 109.774 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -132.66 116.57 16.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.543 -0.723 . . . . 0.0 109.279 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 51.17 -110.76 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.74 -0.6 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 40' ' ' VAL . . . -115.77 26.31 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -141.83 161.25 38.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -109.96 129.32 55.68 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.13 131.67 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.543 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -69.49 119.67 14.1 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.528 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 2.8 m -89.99 165.17 14.21 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 121.032 -1.042 . . . . 0.0 109.616 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.53 -176.97 18.9 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -70.98 -57.35 4.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.533 -0.98 . . . . 0.0 110.103 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -114.01 28.07 9.04 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -78.11 -80.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' O ' ' O ' ' A' ' 36' ' ' LEU . . . 62.85 -114.86 7.3 Favored Glycine 0 C--O 1.202 -1.853 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 ' O ' ' O ' ' A' ' 35' ' ' GLY . 75.1 mt 41.98 121.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.58 1.181 . . . . 0.0 111.453 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.99 133.34 51.79 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.19 -0.944 . . . . 0.0 109.793 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.42 108.68 45.05 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.335 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.99 161.52 23.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.564 2.176 . . . . 0.0 112.352 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 25' ' ' ALA . 90.7 t -95.26 132.84 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.806 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -105.83 108.16 19.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.24 36.95 28.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.584 0.707 . . . . 0.0 109.658 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.26 87.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -110.18 105.02 56.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.534 -0.98 . . . . 0.0 109.715 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.35 134.08 50.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.0 98.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -91.78 31.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.368 -0.833 . . . . 0.0 109.422 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.45 126.57 55.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.094 0.949 . . . . 0.0 109.592 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -64.6 -39.93 87.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.602 0.715 . . . . 0.0 109.618 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 66.5 t0 -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -91.04 -9.73 44.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.272 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.71 38.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 109.948 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -111.76 139.45 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.789 0.804 . . . . 0.0 110.05 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -79.9 158.75 72.39 Favored Pre-proline 0 C--N 1.303 -1.42 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.402 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.75 139.41 31.84 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 112.655 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.901 -179.789 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.16 -6.38 17.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.672 2.248 . . . . 0.0 110.812 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.71 135.83 54.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.727 0.775 . . . . 0.0 110.067 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.54 133.78 56.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.803 0.811 . . . . 0.0 110.314 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 6' ' ' GLY . . . -81.03 -6.62 59.01 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . . . -41.88 123.13 3.02 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt -69.1 -9.71 54.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.5 -1.0 . . . . 0.0 109.071 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 8' ' ' LEU . 4.0 mm? -65.36 -31.86 73.2 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.48 -0.762 . . . . 0.0 109.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.78 -25.23 67.35 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 pt -108.12 38.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.37 -0.832 . . . . 0.0 109.211 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -107.68 119.88 40.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.499 -0.751 . . . . 0.0 109.185 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.621 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -122.09 130.84 53.61 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 109.413 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.1 p -58.46 114.93 9.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.689 -0.632 . . . . 0.0 109.723 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -50.26 -9.64 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.237 1.958 . . . . 0.0 111.515 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -100.95 -72.98 0.66 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 110.225 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -13.64 51.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.374 -0.829 . . . . 0.0 109.277 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.584 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 85.9 t60 55.07 88.68 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.847 0.832 . . . . 0.0 109.835 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.643 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . -173.01 170.22 2.12 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.421 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 35.8 Cg_exo -60.53 153.78 58.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.06 2.506 . . . . 0.0 112.632 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD11 HD12 ' A' ' 11' ' ' LEU . 67.6 mt -114.27 149.19 36.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.0 109.805 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -117.74 135.09 54.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.37 124.14 36.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.271 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 25' ' ' ALA . 69.0 ttp85 -122.8 112.66 18.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 53.98 -87.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.0 110.192 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -139.56 28.62 2.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 108.848 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' C ' HD22 ' A' ' 27' ' ' LEU . 98.1 mt-10 -137.62 154.87 49.67 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.705 0.764 . . . . 0.0 109.907 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.436 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.8 mm? -105.11 134.68 47.8 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.794 0.807 . . . . 0.0 110.002 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.77 129.35 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.673 0.749 . . . . 0.0 110.012 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 125.37 25.03 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.03 127.22 55.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.533 -0.729 . . . . 0.0 109.847 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.97 -172.47 39.0 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -73.1 -57.4 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.558 -0.966 . . . . 0.0 110.032 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -89.58 5.8 44.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.073 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -80.14 168.97 18.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.959 0.885 . . . . 0.0 110.074 -179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 -10.29 0.18 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -70.54 157.73 37.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 0.0 110.602 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.84 146.51 50.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.07 129.63 22.56 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.93 164.68 31.26 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.544 2.162 . . . . 0.0 112.326 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -108.11 132.42 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.522 0.677 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -122.72 128.36 50.44 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.911 0.863 . . . . 0.0 110.04 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 t0 57.52 28.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.72 0.771 . . . . 0.0 109.918 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 3.99 90.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.54 131.41 23.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.5 -1.0 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.06 145.14 54.52 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.592 2.195 . . . . 0.0 112.583 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 48' ' ' LEU . 83.5 t -89.38 123.91 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.546 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.58 32.26 5.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' H ' HG12 ' A' ' 46' ' ' VAL . 77.2 mt -102.53 132.51 48.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.32 -41.1 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.613 0.721 . . . . 0.0 109.764 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.5 -40.13 86.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.945 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.77 7.96 16.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.99 -1.069 . . . . 0.0 109.247 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.13 58.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.691 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.93 120.43 41.89 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.716 0.77 . . . . 0.0 109.159 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -84.61 151.23 58.26 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 56' ' ' GLU . 54.1 Cg_endo -67.14 146.26 75.82 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.764 2.309 . . . . 0.0 112.801 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 55' ' ' PRO . 80.4 mm-40 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.899 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 2' ' ' PRO . 9.9 mmt . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -14.65 -111.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 123.907 3.071 . . . . 0.0 114.992 -176.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.5 mt -75.74 123.66 25.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 118.993 -2.317 . . . . 0.0 112.35 -177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -97.44 -13.74 21.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.11 -25.89 68.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 109.06 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.3 -24.08 63.05 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.59 -40.32 96.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 109.367 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.15 145.5 46.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.989 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.42 97.71 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.44 137.21 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.534 -0.729 . . . . 0.0 109.27 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt -68.74 150.44 47.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.21 150.44 36.13 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.559 0.695 . . . . 0.0 109.881 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.69 163.58 53.55 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.46 -0.775 . . . . 0.0 109.706 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.23 -83.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.389 2.059 . . . . 0.0 112.057 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.8 77.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 110.091 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 30.1 p -97.19 66.34 2.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -41.58 119.13 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -176.99 159.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.464 -0.772 . . . . 0.0 109.187 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.94 137.34 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.962 1.775 . . . . 0.0 112.802 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' SG ' ' A' ' 13' ' ' CYS . 73.4 mt -112.65 148.59 34.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.53 -0.731 . . . . 0.0 110.087 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -113.54 117.66 32.28 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -98.8 123.45 43.05 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.554 -0.716 . . . . 0.0 109.596 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' ALA . 10.3 ptp180 -128.85 125.95 38.76 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.633 -0.667 . . . . 0.0 109.36 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.88 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.316 0.579 . . . . 0.0 109.593 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.43 28.71 1.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -135.48 139.52 44.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.6 -0.687 . . . . 0.0 109.253 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.9 mp -109.73 135.78 50.12 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.622 -0.674 . . . . 0.0 109.555 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.7 132.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.433 0.635 . . . . 0.0 110.121 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.3 m -58.08 123.88 17.45 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.64 -20.17 17.82 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.05 -1.031 . . . . 0.0 108.62 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -66.33 137.48 35.36 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.73 -14.5 52.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.238 -1.154 . . . . 0.0 108.882 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -80.11 -4.22 51.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.355 -0.841 . . . . 0.0 109.138 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -157.02 165.81 35.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.65 17.01 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.64 159.44 34.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.486 -1.008 . . . . 0.0 109.996 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.32 144.29 49.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.574 0.702 . . . . 0.0 110.275 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 12.1 m-85 -129.86 127.18 22.76 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.15 158.31 30.19 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.168 1.912 . . . . 0.0 111.916 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.72 131.21 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -104.36 108.77 20.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.501 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 53.39 36.86 24.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.39 2.8 87.3 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 mt -111.04 108.36 57.48 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.4 -1.059 . . . . 0.0 109.387 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.44 135.02 53.95 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.831 1.687 . . . . 0.0 112.121 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -92.81 95.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 108.966 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.1 mt -89.29 64.23 6.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.1 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -121.33 125.77 47.81 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.747 0.784 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.63 -43.51 98.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.72 -40.26 94.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.222 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.77 -4.68 59.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.002 -1.061 . . . . 0.0 109.49 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.21 142.57 30.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.135 -0.978 . . . . 0.0 109.601 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -106.04 141.73 36.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 0.0 109.281 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.55 150.63 49.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.0 109.295 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -38.43 136.31 0.63 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.505 2.137 . . . . 0.0 112.873 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.552 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 7.2 mtt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 18.1 Cg_endo -58.77 145.44 96.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.036 1.824 . . . . 0.0 111.963 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' GLY . 76.0 mt -74.82 141.41 44.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.664 0.745 . . . . 0.0 110.368 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 44.0 -127.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.585 -0.697 . . . . 0.0 110.14 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.75 -10.2 59.41 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.472 -0.768 . . . . 0.0 109.672 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 3' ' ' LEU . . . 82.4 72.6 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -78.52 134.34 37.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 109.606 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' GLU . 78.0 mt -75.91 144.46 41.1 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.595 0.712 . . . . 0.0 110.311 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 8' ' ' LEU . 49.1 tp10 51.14 99.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -104.99 -23.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.213 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.3 mp -86.86 141.48 28.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.518 -0.739 . . . . 0.0 109.333 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.79 147.27 27.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.511 -0.743 . . . . 0.0 109.182 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 1.8 m -59.41 151.07 61.65 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.56 -22.48 58.41 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.04 1.827 . . . . 0.0 111.672 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.93 -30.64 2.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.266 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.6 -168.1 1.63 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.399 -0.813 . . . . 0.0 109.141 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -125.15 19.51 8.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.549 -0.719 . . . . 0.0 109.537 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB1' ' CD ' ' A' ' 19' ' ' PRO . . . -95.42 -177.75 0.69 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.652 ' CD ' ' HB1' ' A' ' 18' ' ' ALA . 48.2 Cg_endo -86.73 167.04 8.64 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 113.36 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -112.13 150.04 31.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.135 -0.978 . . . . 0.0 109.647 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -128.46 121.03 28.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.75 135.43 37.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ALA . 78.6 ttt-85 -128.87 104.61 7.71 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 99.0 m-20 -22.28 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 O-C-N 123.59 0.556 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . 155.38 -30.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -178.08 -174.15 0.41 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.706 0.765 . . . . 0.0 110.784 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -105.26 129.58 53.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.6 mm -108.16 131.48 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.611 -0.681 . . . . 0.0 109.271 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 t -74.87 122.79 23.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.501 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.2 m -84.46 157.4 21.36 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.05 -1.031 . . . . 0.0 109.342 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.11 167.67 13.82 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -75.91 -55.11 5.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 109.757 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -80.52 -2.93 48.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 57.1 m -81.25 -114.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.528 -0.733 . . . . 0.0 109.805 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 36' ' ' LEU . . . 86.68 -62.45 4.25 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' GLY . 66.8 mt -9.43 125.59 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.637 0.732 . . . . 0.0 111.932 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 130.84 55.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.316 -0.865 . . . . 0.0 109.522 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -113.04 119.85 41.7 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.87 164.92 22.53 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.163 1.909 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.24 131.15 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -119.82 126.32 50.7 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.528 0.68 . . . . 0.0 109.697 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.0 t0 56.23 28.39 13.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.375 -0.828 . . . . 0.0 109.68 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -0.08 89.7 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.3 mm -107.1 131.02 22.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.18 -1.188 . . . . 0.0 109.139 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.32 142.74 27.28 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.306 2.004 . . . . 0.0 112.132 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.63 94.75 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 109.087 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -85.27 39.88 0.8 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.346 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.2 mt -111.61 128.0 55.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.784 0.802 . . . . 0.0 109.788 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.75 -41.67 90.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -57.98 -41.21 82.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -90.27 -5.86 55.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.009 -1.057 . . . . 0.0 109.516 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.83 48.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -104.32 143.48 32.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.454 0.645 . . . . 0.0 109.674 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -95.27 113.85 62.49 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.701 -0.624 . . . . 0.0 109.435 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -52.57 143.29 46.42 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.864 1.709 . . . . 0.0 112.805 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.518 179.219 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.34 -46.67 30.76 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.42 2.08 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 4' ' ' GLU . 3.4 tt -170.51 114.65 0.46 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.808 . . . . 0.0 108.992 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.553 ' N ' HD23 ' A' ' 3' ' ' LEU . 11.7 pt-20 -64.33 137.53 57.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.08 46.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.68 . . . . 0.0 110.272 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.82 -78.66 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 7' ' ' LEU . 9.8 mp -73.63 146.3 44.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.1 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.551 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.9 mm? -69.38 133.81 48.26 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.554 0.693 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.89 -8.14 38.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 10' ' ' ILE . 21.2 tt -47.07 129.07 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 109.707 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -77.51 146.5 36.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.636 -0.665 . . . . 0.0 109.617 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.16 141.24 22.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.98 159.02 58.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.397 -0.814 . . . . 0.0 109.813 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.804 2.336 . . . . 0.0 112.012 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.52 -48.25 79.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.911 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -99.58 159.89 14.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.286 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.656 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 47.3 p-80 -108.58 112.09 24.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.546 -0.721 . . . . 0.0 109.9 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 17' ' ' HIS . . . 164.82 156.78 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.01 163.31 39.7 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.688 2.259 . . . . 0.0 111.985 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.4 147.75 45.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.638 -0.664 . . . . 0.0 109.292 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.59 126.82 52.58 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.97 122.75 31.95 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.214 0.53 . . . . 0.0 109.845 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.92 161.26 4.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 98.2 m-20 52.95 31.48 10.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.35 22.64 12.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 110.281 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.76 159.47 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.518 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 27' ' ' LEU . 8.2 mp -106.84 125.32 50.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.6 mt -101.82 128.85 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 129.57 38.41 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.561 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 70.2 p -84.59 170.9 12.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.42 -0.8 . . . . 0.0 110.172 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 145.8 16.14 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -68.32 -53.74 22.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.618 -0.931 . . . . 0.0 109.7 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.87 -5.52 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.435 -0.791 . . . . 0.0 109.709 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 1.3 t -116.96 87.47 2.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.32 -141.07 9.14 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt 74.45 160.6 0.23 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.849 0.833 . . . . 0.0 109.759 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.81 150.73 35.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.838 . . . . 0.0 109.54 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 3.3 m-85 -115.56 134.08 22.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.99 161.5 41.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.044 1.829 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.37 131.85 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -112.44 120.69 42.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.632 -0.668 . . . . 0.0 109.601 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.9 t0 57.16 22.67 7.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.11 -2.28 71.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.87 124.12 39.85 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.396 -1.061 . . . . 0.0 109.151 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.44 142.12 40.06 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.044 1.829 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 48' ' ' LEU . 25.9 t -88.98 118.93 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.074 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.6 mt -100.33 32.22 3.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.477 -0.764 . . . . 0.0 109.317 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' H ' HG12 ' A' ' 46' ' ' VAL . 76.9 mt -107.09 129.07 54.88 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.942 0.877 . . . . 0.0 109.471 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.74 -42.15 94.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.636 -0.665 . . . . 0.0 110.064 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.63 -20.08 53.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.495 -0.753 . . . . 0.0 110.162 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -102.19 2.62 37.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 0.0 108.986 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 145.97 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.812 . . . . 0.0 109.645 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -119.22 141.72 48.65 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.55 0.69 . . . . 0.0 109.347 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 3.0 mtp180 -89.77 177.55 2.38 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' GLU . 36.5 Cg_exo -59.61 145.86 96.89 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.657 2.238 . . . . 0.0 112.508 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' PRO . 10.1 tm-20 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.675 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.35 113.18 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.028 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.03 -41.08 99.43 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.19 140.8 0.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.784 0.802 . . . . 0.0 109.928 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.02 88.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.79 0.805 . . . . 0.0 109.84 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.4 156.11 52.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.47 128.2 34.66 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.805 0.812 . . . . 0.0 110.047 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 8' ' ' LEU . 1.4 tt -64.33 -42.47 96.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 59.55 106.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.696 0.76 . . . . 0.0 110.099 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.21 149.22 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.785 0.802 . . . . 0.0 110.158 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.5 mt -68.85 135.26 50.84 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.864 0.84 . . . . 0.0 110.099 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.42 153.95 29.7 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.832 0.825 . . . . 0.0 109.912 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -74.64 150.39 86.59 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.841 -0.537 . . . . 0.0 110.117 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.56 -11.34 26.2 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.766 2.311 . . . . 0.0 111.321 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.0 -53.25 0.98 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.636 -0.665 . . . . 0.0 109.452 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.47 -29.29 69.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.463 -0.773 . . . . 0.0 109.26 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 63.31 -1.44 0.55 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.797 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -79.38 169.33 20.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.543 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.712 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 55.7 Cg_endo -69.2 153.12 71.99 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.362 2.042 . . . . 0.0 112.439 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD21 ' SG ' ' A' ' 13' ' ' CYS . 50.2 mt -111.75 152.69 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.725 0.774 . . . . 0.0 109.703 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' CG ' ' OG1' ' A' ' 30' ' ' THR . 68.3 mm-40 -127.44 139.42 52.83 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.951 0.882 . . . . 0.0 109.734 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.29 128.39 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.57 0.7 . . . . 0.0 109.961 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' ' 24' ' ' ASP . 76.3 ttt180 -124.52 156.92 36.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 23' ' ' ARG . 35.0 t0 17.17 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.637 0.732 . . . . 0.0 110.705 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -141.6 29.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.637 -0.665 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 54.7 mp0 -144.56 167.27 22.92 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.013 0.911 . . . . 0.0 110.053 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.0 mm? -97.16 134.56 40.32 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.345 0.593 . . . . 0.0 109.856 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.51 131.38 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.924 0.868 . . . . 0.0 110.183 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.515 ' SG ' ' OH ' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -70.07 127.71 33.78 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.447 ' OG1' ' CG ' ' A' ' 21' ' ' GLU . 89.1 m -120.24 125.27 47.72 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.818 0.818 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.23 -163.84 37.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.07 -58.14 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.651 -0.911 . . . . 0.0 109.732 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -96.86 15.06 23.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -90.51 163.54 14.58 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.906 0.86 . . . . 0.0 110.014 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.56 -11.31 0.1 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.24 162.37 14.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 110.169 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.67 142.17 48.96 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.657 0.742 . . . . 0.0 109.684 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -127.94 128.13 23.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.92 166.61 26.58 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.391 2.061 . . . . 0.0 112.379 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.4 t -94.04 128.71 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.8 0.809 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -137.89 141.8 40.65 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.63 27.31 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.545 0.688 . . . . 0.0 109.636 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.91 10.84 85.01 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.81 149.55 64.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.466 -1.02 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.18 147.52 54.03 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.371 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 48' ' ' LEU . 97.7 t -84.16 96.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.749 0.785 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.86 38.3 0.45 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 46' ' ' VAL . 53.4 mt -115.71 119.27 35.51 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.155 0.978 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 m -66.04 -29.86 48.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.608 -0.683 . . . . 0.0 109.586 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.98 -43.56 95.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.729 -0.607 . . . . 0.0 109.938 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.7 mp0 -92.05 -4.09 54.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.08 151.42 47.06 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.533 0.682 . . . . 0.0 110.092 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -103.84 143.11 33.26 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.931 0.872 . . . . 0.0 110.024 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 155.92 37.21 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' GLU . 51.0 Cg_exo -47.55 138.96 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.478 2.119 . . . . 0.0 112.949 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' PRO . 80.8 tt0 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.769 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 61.7 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 1' ' ' MET . 55.2 Cg_endo -69.72 147.8 63.91 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.674 2.25 . . . . 0.0 112.499 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 4' ' ' GLU . 63.0 mt 54.94 -176.13 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.779 0.8 . . . . 0.0 110.313 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' LEU . 71.4 mm-40 55.09 163.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.848 0.832 . . . . 0.0 110.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -169.05 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.69 158.5 21.88 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.2 143.05 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.684 -0.892 . . . . 0.0 110.003 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.51 144.27 46.23 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.973 0.892 . . . . 0.0 110.118 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 57.8 mp0 -84.49 -108.4 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.344 0.592 . . . . 0.0 110.071 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.9 pt -92.85 141.44 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.985 0.898 . . . . 0.0 110.36 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -89.96 153.06 20.89 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.917 0.865 . . . . 0.0 109.918 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.66 147.86 30.44 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.932 0.872 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.696 ' SG ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -59.36 159.52 15.94 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-O 121.45 0.643 . . . . 0.0 109.771 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.81 -79.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.607 2.204 . . . . 0.0 112.363 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.78 98.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.456 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.942 0.877 . . . . 0.0 109.951 -179.487 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.78 104.45 15.23 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.676 0.751 . . . . 0.0 109.495 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 30' ' ' THR . . . -177.86 155.49 1.05 Allowed Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 164.05 35.23 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.706 2.27 . . . . 0.0 113.001 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.21 151.21 33.12 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.588 0.708 . . . . 0.0 109.596 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -124.89 120.75 32.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.002 0.906 . . . . 0.0 109.604 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -81.13 135.9 35.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.967 0.889 . . . . 0.0 110.211 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -167.59 143.86 4.16 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.846 0.831 . . . . 0.0 109.973 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.1 t70 54.0 36.42 24.45 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.254 0.549 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . 64.36 18.6 11.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.806 -0.559 . . . . 0.0 109.562 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 53' ' ' ARG . 94.3 mt-10 -132.67 159.63 39.04 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.719 0.771 . . . . 0.0 109.679 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.46 126.3 48.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.7 . . . . 0.0 109.909 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.3 mt -108.58 127.3 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.734 0.778 . . . . 0.0 109.686 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.52 119.87 13.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.729 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 25.1 m -105.82 113.13 26.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.659 0.742 . . . . 0.0 109.652 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.53 169.26 42.21 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.62 -50.51 62.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.726 -0.867 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.3 -0.41 49.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.465 -0.772 . . . . 0.0 108.982 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 94.1 m -81.58 -171.35 3.27 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.721 0.772 . . . . 0.0 110.149 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.99 -9.07 0.96 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.85 160.59 22.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.328 -1.101 . . . . 0.0 110.5 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.88 138.8 48.56 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.58 0.705 . . . . 0.0 109.407 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -124.31 125.07 25.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.28 166.22 24.7 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.412 2.075 . . . . 0.0 112.348 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.16 131.14 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.568 0.699 . . . . 0.0 109.438 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -118.88 120.17 36.52 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.889 0.852 . . . . 0.0 109.76 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 56.87 33.55 23.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.451 0.643 . . . . 0.0 109.797 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.46 -2.36 82.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -99.86 122.85 49.52 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.521 -0.988 . . . . 0.0 109.575 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.17 144.94 27.06 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.676 2.251 . . . . 0.0 112.825 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 48' ' ' LEU . 81.6 t -88.5 128.05 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.607 0.718 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.4 mt -118.4 25.33 10.37 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -100.12 130.48 46.27 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.316 1.055 . . . . 0.0 109.481 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.85 -42.29 94.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.645 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.19 -38.38 88.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.499 -0.75 . . . . 0.0 109.68 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.0 -8.0 58.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.127 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 146.22 54.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.731 0.777 . . . . 0.0 109.971 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 26' ' ' GLU . 90.9 mtm180 -102.13 139.34 37.88 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.721 0.772 . . . . 0.0 110.008 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -89.61 151.9 46.45 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.94 145.42 90.08 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.532 2.155 . . . . 0.0 112.689 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 C--N 1.3 -1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.3 179.468 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_